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Scaffolds composed of extracellular matrix (ECM) and derived from various species and various 
organs have been shown to promote constructive, site-specific tissue remodeling in pre-clinical 
studies and clinical use, including musculoskeletal, urogenital, dermal, cardiovascular, and 
neural applications.  Despite extensive study, the mechanisms of the remodeling process are still 
not thoroughly understood.  The goals of this dissertation were to elucidate the role of 
mechanical loading in the remodeling of ECM scaffolds and the role of bone marrow derived 
cells in the remodeling process.   
To better understand the role of mechanical loading on the remodeling of an ECM 
scaffold, an ECM scaffold derived from the porcine small intestinal submucosa (SIS-ECM) was 
seeded with fibroblasts and subjected to a variety of magnitudes and frequencies of cyclic strain 
using a custom designed Cyclic Stretching Tissue Culture system.  The magnitudes of stretch 
were based on a study of the collagen fiber kinematics of the SIS-ECM under uniaxial and 
biaxial loading conditions.  The cyclic loading experiments showed that mechanical loading led 
to expression of matrix related genes that was consistent with a constructive remodeling response 
with increased expression of collagen type I (Col I), α-smooth muscle actin (SMA), and 
tenascin-C (TN-C), as well as decreased expression of collagen type III (Col III). 
It was also found that bone marrow cells were recruited to the site of ECM remodeling 
and that the cells remained at the site of remodeling for 16 weeks after implantation, unlike an 
autologous tendon repair.  Furthermore, it was found that the bone marrow derived cells did not 
express the hematopoietic marker CD45, but did express Col I, Col III, and SMA.  The cells did 
not show the same expression pattern as normal tendon fibroblast (Col I+, TN-C+), suggesting 
that the cells differentiated towards a myofibroblastic cell as opposed to a normal fibroblast.  The 
results of this study show that an ECM scaffold recruits a bone marrow derived mesenchymal 
progenitor to the site of remodeling, and that those cells differentiate into site specific tissue as a 
result of mechanical and biochemical cues.   
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1.0  NATURALLY OCCURRING EXTRACELLULAR MATRIX 
There are currently six commercially available scaffolds derived from naturally occurring 
extracellular matrix (ECM) that have gained approval from the Food and Drug Administration 
for musculotendinous applications, including GraftJacket® (Wright Medical Technology, Inc., 
Arlington, TN), Restore™ (DePuy Orthopaedics®, Inc., Warsaw, IN), CuffPatch™ (Arthrotek®, 
Warsaw, IN), TissueMend® (TEI Biosciences, Inc., Boston, MA), Zimmer® Collagen Repair 
Patch (Stryker Orthopaedics, Warsaw, IN), and OrthADAPT™ (Pegasus Biologics, Irvine, CA).  
These scaffolds vary in the species of origin, tissue of origin, means of decellularization and 
terminal sterilization, and extent of chemical crosslinking.  Despite their clinical use, there is 
limited information regarding the host response to many of these products or the mechanisms by 
which the host response occurs.  A recent study compared the host response to several of the 
products listed above (all except for OrthAdapt) when they were used to repair the abdominal 
wall in a rat model.269  The results showed that all of the devices tended to exhibit a foreign body 
response to some extent, except for Restore™, which showed a constructive remodeling 
response.  The Restore™ device is composed of porcine small intestinal submucosa (SIS-ECM) 
that is not chemically crosslinked.  These results were consistent with a number of other studies 
that have shown that naturally occurring ECM scaffolds that have been minimally processed 
promote the formation of site specific tissue after injury in a variety of body locations in both 
pre-clinical animal studies and in clinical practice.  The goal of this Dissertation was to elucidate 
some of the mechanisms by which a site specific, constructive remodeling response to a SIS-
ECM scaffold occurs. 
 1
1.1 COMPOSITION AND ULTRASTRUCTURE OF SIS-ECM 
Naturally occurring ECM consists of the structural and functional proteins that provide a 
framework for every organ.  It is isolated by removing the cellular component from a tissue of 
interest through a series of chemical and mechanical treatments.99  Naturally occurring ECM has 
been isolated from the porcine small intestine, urinary bladder, and liver, human dermis, and 
canine fascia lata, among others.24  SIS-ECM is the scaffold that has been most extensively 
characterized.  It is composed primarily of type I collagen with minor amounts of collagen types 
III, IV, V, and VI.13  Despite the chemical treatments that are necessary to decellularize the SIS-
ECM material,  the scaffold retains a variety of glycosaminoglycans including heparin, heparin 
sulfate, chondroitin sulfate, and hyaluronic acid,118 and adhesion molecules such as fibronectin 
and laminin.41, 122  SIS-ECM also contains transforming growth factor-β (TGF-β),197, 274 basic-
fibroblast growth factor (b-FGF),124, 274 vascular endothelial growth factor (VEGF),120 and 
epidermal growth factor (EGF).  Several of these growth factors have been shown to retain 
bioactivity even after terminal sterilization and long-term storage.124, 197  The 3-D architecture 
and ultrastructure of SIS-ECM are largely preserved throughout various processing steps, which 
may explain the retained bioactivity.41, 237  There is histologic evidence that the stratum 
compactum of the small intestine is intact and present in the SIS-ECM.41  The collagen fibers of 
SIS-ECM generally have a preferred alignment along the longitudinal axis of the small intestine, 
and it appears that this preference is a composite of two populations of collagen fibers with their 
centroids shifted ~30° from the longitudinal axis.237  This preferred fiber alignment gives SIS-
ECM a transversely orthotropic mechanical behavior, i.e., the longitudinal axis is stiffer than the 
circumferential axis.237 
 A variety of forms of SIS-ECM scaffolds have shown utility as scaffolds in regenerative 
medicine, including, hydrated and lyophilized single layer sheets, multilaminate sheets, and 
powder.  When constructing multilaminate sheets, it is possible to take advantage of the collagen 
fiber alignment of each layer to create a device with a desired mechanical behavior.  For 
Restore™, ten layers of the ECM are used with 2 layers aligned every 72° to make an isotropic 
device that is strong enough to serve as a functional replacement of a tendon at the time of 
surgery. 
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 In summary, a great deal is known about the composition and structure of SIS-ECM and 
many of its characteristics make it a favorable scaffold for regenerative medicine applications.  
This dissertation takes advantage of this knowledge, specifically related to the collagen fiber 
architecture, and attempts to develop a better understanding of the mechanisms by which ECM 
scaffolds promotes site specific tissue remodeling. 
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2.0  EXTRACELLULAR MATRIX SCAFFOLD REMODELING IN VIVO 
When ECM scaffold material is used to replace or repair a damaged tissue, the ECM has been 
shown to degrade quickly, and is rapidly replaced by new host tissue that is grossly, 
histologically, and functionally similar to the native tissue it is intended to replace.14  Site 
specific remodeling has been shown in a variety of tissues, including blood vessels,11, 239 skin and 
body wall,19, 21, 55, 115, 189, 222, 256 urinary tract,9, 57, 162, 163, 165, 272, 295 tendons and ligaments,13, 76, 180, 
199, 206, 289 heart,22, 26, 152, 233 digestive tract,18, 25, 75 and bone.258  The new host tissue that forms 
does not perfectly recapitulate the native tissue structure, but it does provide functionality that 
scar tissue lacks. 
2.1 SITE SPECIFIC REMODELING OF ECM SCAFFOLDS 
2.1.1 Cellular Infiltration, Collagen Deposition, and Vascularity 
The remodeling process involves a characteristic cell infiltration that begins immediately after 
implantation.21  Within the first few hours, an abundance of polymorphonuclear (PMN) 
leukocytes and mononuclear cells migrate into the ECM scaffold.  The numbers of PMN 
leukocytes decrease so that there are only a few cells (per field) after one week and by two weeks 
the PMN leukocytes are almost entirely gone.  The presence of mononuclear cells persists 
throughout the first month of remodeling, and slowly decreases thereafter until the number of 
mononuclear cells approaches that of normal tissue by 3 to 6 months.  The morphology of the 
mononuclear cells tends to change with time suggesting a change in phenotype by approximately 
45 days.  Initially, the mononuclear cells are rounded in appearance, consistent with the classic 
concept of a macrophage.  The macrophages that infiltrate SIS-ECM in the first two weeks have 
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been shown to predominantly express CD163, which is a distinct surface marker of an anti-
inflammatory/immunoregulatory phenotype.191, 270  This is consistent with the finding that the 
early immune response to the ECM scaffold is a TH-2 restricted response, suggesting a 
accommodation of the device rather than rejection.5    Over time, the percentage of rounded cells 
decreases and the percentage of spindle-shaped cells increases.  The spindle shaped cells 
represent site specific cells such as fibroblasts, endothelial cells, and smooth muscle cells.  It is 
not known with certainty if the change in cell morphology is due to the rounded cells leaving the 
tissue as new spindle shaped cells migrate into the tissue, or if some portion of the rounded cells 
become the spindle-shaped cells.  This dissertation will attempt, at least in part, to answer this 
question. 
In addition to changes in the cellularity of tissue, the connective tissue organization and 
vascularity tend to follow specific trends during the course of remodeling.21  The newly formed 
collagenous connective tissue is disorganized within the first weeks of remodeling.  However, by 
one month, the tissue is moderately to well organized, with the collagen fibers tending to align 
along axes of stress.  At longer time points, the organization continues to improve.  In terms of 
vascularity, an aggressive angiogenic response is observed within the first week of remodeling, 
and the abundant vascularity tends to remain for up to three months.  The causative factors and 
mechanisms of these changes are topics of interest in the present work. 
2.1.2 Mechanical Behavior 
The mechanical behavior of a remodeled ECM scaffold changes over time, and the changes are 
dependent on the tissue that is being replaced and the local mechanical environment.  The 
strength of a remodeled SIS-ECM has been evaluated in a number of applications, including 
several tendinous and ligamentous applications.  In a canine Achilles tendon, a segmental defect 
was created and repaired with a tube of SIS-ECM (native geometry, not laminated).13  The joint 
was immobilized for five weeks, although the limb was allowed to bear weight.  At 1 week after 
implantation, the strength of the tendon repaired with SIS-ECM was less than 100 N, or 1/10th of 
the original strength.  As new collagenous connective tissue was formed, the strength of the 
explanted tendon repaired with SIS-ECM gradually increased until the strength exceeded the 
strength of the insertions of the tendon to the gastrocnemius muscle and the calcaneus by 12 
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weeks after surgery.13  In the rotator cuff application in a dog model, a ten layer multilaminate 
device (Restore™) was used to replace a completely resected infraspinatus tendon, and the 
animals were allowed unlimited cage activity after surgery.76  The failure loads of the tendon 
repaired with SIS-ECM increased approximately three fold from the time of repair, and were 
comparable to failure loads for rotator cuffs subjected to a primary repair, despite having a cross 
sectional area that was smaller by half.76  In the anterior cruciate ligament of a goat knee, a 
remodeled SIS-ECM scaffold showed a decreased strength at 3 months after surgery, followed 
by an increase to a level comparable to a patellar tendon autograft at one year.16   
The mechanical behavior of remodeled ECM scaffolds has been evaluated in a number of 
muscular tissue applications.  An 8-layer SIS-ECM device used to repair the body wall of a dog 
decreased to 50% of its initial strength by 10 days after implantation, but subsequently increased 
to twice its initial strength by 24 months.19  After repair of the canine urinary bladder with a 3-
layer SIS-ECM device,164 it was found that the compliance of the remodeled graft increased 
substantially compared to the initial implant (30 fold difference), to levels that were not 
statistically different from the normal bladder.  Furthermore, the remodeled SIS-ECM showed 
contractility responses that were similar to the normal bladder and the tissue was found to be 
innervated.    A different ECM scaffold derived from the basement membrane and tunica propria 
of the porcine urinary bladder (UBM-ECM) was used for repair of the canine esophagus and 
myocardium.25, 152  For esophageal repair, the ECM graft rapidly remodeled to approach the 
pressure-diameter response and compliance of the adjacent native esophagus within 90 days.25  
The newly formed esophageal tissue also showed signs of peristalsis, although the muscle 
contraction was not synchronous with the adjacent native esophagus.25  In the myocardial repair 
in a canine model, a single layer of ECM (~100 μm) remodeled and showed evidence of 
contractility and improved the regional functional of the heart within 8 weeks.152  
These examples show that in the short term after implantation, ECM scaffolds decrease in 
strength as the graft is rapidly degraded.  However, as new host tissue is formed, the remodeled 
graft tends to match the mechanical behavior of the tissue that it is intended to repair.  In the case 
of the esophagus, the graft became more compliant, while in the case of tendinous or 
ligamentous tissue, the load to failure increased.  Furthermore, after repair of muscular tissues, 
the remodeled ECM scaffold does not simply serve as a passive restraint to load.  New muscle 
tissue forms and innervation is restored so that the tissue can provide active contractility.   
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As stated in the previous section, ECM scaffolds exhibit a characteristic remodeling 
response in the first month after implantation in terms of cellularity, and yet the resulting tissue 
that is formed has different morphologies and mechanical behavior depending on the 
implantation site.  Determining how this tissue differentiation occurs is one of the goals of this 
Dissertation. 
2.1.3 Relationship between Mechanical Properties and Tissue Structure 
An in depth examination of the remodeling events for a single layer of SIS-ECM has been 
conducted in a model of medial collateral ligament (MCL) repair in the rabbit knee,180, 206, 289  
and provides insight into some of the mechanisms by which a constructive remodeling response 
occurs.  The SIS-ECM treated repair of a 6 mm segmental defect was compared to a non-treated 
control and to the sham operated contralateral MCL.  At 12 weeks after surgery,206 the SIS-ECM 
treated and non-treated groups both showed cross sectional areas (CSA) that were substantially 
larger than the sham operated control, although they were not statistically different from each 
other.  In terms of the structural properties of the SIS-ECM treated femur-MCL-tibia complex 
(FMTC), the stiffness and ultimate load were both approximately double the results for the non-
treated control.  In terms of the mechanical properties of the remodeling SIS-ECM treated MCL, 
the tangent modulus and stress at failure (several failures occurred at the tibial insertion) were 
both approximately 50% greater than those for the non-treated MCL.  This represents one of the 
few occasions in which a surgical treatment resulted in enhanced mechanical properties of a 
healing MCL, although the properties were still inferior to those for the sham operated group. 
 The trends observed in the early stages of remodeling continued out to 26 weeks after 
surgery.289  The CSA of the SIS-ECM treated MCL had significantly decreased compared to the 
12 week results, and was found to be statistically less than that of the non-treated group.  The 
tangent modulus and tensile strength were both significantly greater than the non-treated group 
(33% and 50%, respectively).  Interestingly, the tangent modulus for the SIS-ECM treated group 
at 26 weeks was found to be significantly increased compared to the 12 week results.  This is 
contrary to previous results that showed that the mechanical properties of the MCL do not 
change during the course of healing, but rather the structural properties of the FMTC increase as 
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a result of increased CSA.213  The tensile strength at 26 weeks could not be compared to the 
results at 12 weeks since only stress at failure was determined. 
 To develop a better understanding of the mechanisms behind the improvement in the 
mechanical properties of the healing MCL after treatment with SIS-ECM, the morphology and 
composition of the healing MCL were characterized to determine if there were any differences 
compared to the non-treated group.180, 289  Histologic analysis with sections stained with 
Hematoxylin and Eosin (H&E) and Masson’s Trichrome showed that the SIS-ECM group was 
composed of denser collagenous connective tissue that had more uniform alignment along the 
longitudinal axis of the MCL as compared to the non-treated control at both 12 and 26 weeks 
after surgery.  Furthermore, the cells within the SIS-ECM treated ligament were more spindle-
shaped in appearance and also tended to be oriented along the longitudinal axis of the ligament.   
It was determined by immunostaining and collagen typing that the SIS-ECM treated 
group contained less collagen type V (Col V) than the non-treated group at both time points, with 
a Col V/collagen type I ratio that was closer to that of the sham operated control.  Col V has been 
shown to play a role in regulation of the lateral growth of collagen I (Col I) fibrils,34-36, 183, 285 and 
remains elevated in the healing MCL even after one year.210  This leads to the formation of 
collagen fibrils in the healing MCL that are uniformly small,88, 89 as compared to the normal 
MCL, which has been shown to have a bimodal collagen fibril diameter distribution consisting of 
populations of small fibrils and large fibrils.87, 111  If the collagen fibril diameter in a healing 
MCL can be increased, it has been shown that there is an associated increase in the mechanical 
properties of the ligament substance.207  Therefore, transmission electron microscopy (TEM) was 
performed in order to determine the collagen fibril diameter distributions for the SIS-ECM 
treated and the non-treated MCLs.  At 12 weeks, both experimental groups showed uniformly 
small collagen fibril diameters, but the mean diameter for the SIS-ECM treated group was 
approximately 22% greater than the non-treated group.289  Over time, some of the fibrils in the 
SIS-ECM group continued to grow such that a biomodal distribution developed that was similar 
to the sham operated control, although the fibrils were still smaller.180  In contrast, the non-
treated group still showed a uniformly small collagen fibril distribution.180  These studies show 
that SIS-ECM contributes to constructive remodeling of the MCL at least in part by improving 
the collagen alignment, regulating the collagen composition, and increasing the collagen fibril 
diameter, all of which leads to enhanced mechanical properties of the remodeling tissue. 
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2.2 THE ROLE OF ECM DEGRADATION  
2.2.1 Rate of ECM Degradation 
As stated previously, ECM scaffolds appear to degrade quickly after implantation as determined 
by the morphological changes in the tissue under histologic evaluation.14  However, histologic 
evaluation does not give a quantitative evaluation of the degradation kinetics, nor does it provide 
information on the fate of the degradation products.  Both of these issues are critical aspects of 
the remodeling response.  If the ECM degrades too quickly, then the host cannot produce matrix 
quickly enough to take over the mechanical burden served by the scaffold.  Perhaps more 
importantly, since the SIS-ECM is porcine in origin, there may be unknown immunologic effects 
if the degradation products become part of the new tissue or are transported to another location in 
the body and are retained in the long-term.  This would pose a significant regulatory issue. 
To address these concerns, the rate of degradation of SIS-ECM and the fate of the 
degradation products were quantitatively determined during remodeling after repair of the canine 
urinary bladder.229   In order to track the degradation, the SIS-ECM was radiolabeled with 14C 
labeled proline, an amino acid that is the building block for hydroxyproline, which makes up 
about 10% of each collagen molecule. Detailed methods for labeling the ECM can be found in 
Section 7.1.2.   Since 14C labeled proline is integrally bound to every collagen molecule, a 
decrease in the radioactivity per unit weight of tissue corresponds directly to a decrease in the 
mass of the scaffold.  The scaffold was found to degrade quickly after implantation with 40% of 
the scaffold removed from the site of remodeling within 4 weeks.  The degraded ECM scaffold 
was replaced by new ECM (unlabeled) deposited by cells that participate in the remodeling 
process.  14C was undetectable by 90 days.  The remodeling resulted in the formation of site 
specific urinary bladder tissue.  
With regard to the fate of the degraded ECM, radioactivity was found in blood and urine 
almost immediately after surgical implantation.  14C was only detected in the lung and liver after 
repair, and was only present in small amounts detectable by accelerator mass spectrometry 
(AMS), an extremely sensitive method of detection.  These results suggest that the primary fate 
of the ECM is degradation, metabolism, and excretion as urine or exhalation as CO2.   
 9
 The degradation of an ECM scaffold is extremely rapid, with nearly half of the scaffold 
degraded by one month, and complete degradation by 3 months.  Since constructive remodeling 
with site appropriate mechanical behavior has been shown to be possible (as described in Section 
2.1.2), the degradation kinetics also provide insight into the rate of new matrix production.  In 
the early phase of remodeling, degradation occurs quite rapidly before cells have an opportunity 
to populate the scaffold and deposit new collagen, leading to the initial decrease in strength 
observed in many applications.  However, once the cells have established residence and begin 
producing site specific tissue, the rapid remodeling progresses with an increase in the strength of 
the remodeling scaffold and site appropriate mechanical behavior.  In addition, as the scaffold 
rapidly degrades, it is completely removed from the body so there should be no long-term effects 
of the scaffold.  In order to determine the relevance of these results to musculotendinous 
applications, this Dissertation utilized the same model to quantify the degradation of an SIS-
ECM scaffold used to repair a canine Achilles tendon, a tendon that is subjected to some of the 
highest load of any tendon in the body. 
2.2.2 Bioactivity of ECM Degradation Products 
Since ECM scaffold have been shown to degrade so quickly, a number of studies have evaluated 
the biological activity of ECM degradation products.  Several in vitro studies have shown that 
low molecular weight peptides (5-16 kDa) are formed through degradation of ECM scaffolds via 
exposure to a mild acid and heat.39, 176, 241  These peptides exhibit bioactivity, specifically 
antibacterial and chemoattractant properties.   
 Degradation products from SIS-ECM, urinary bladder ECM, and liver ECM have been 
shown to have antibacterial activity against both Gram negative Escherichia coli and Gram 
positive Staphylococcus aureus.39, 241  The bacterial growth was inhibited for at least 13 hours.  
Interestingly, intact SIS-ECM supports bacterial growth,125 suggesting that degradation of the 
ECM is necessary for the antibacterial activity to be realized.  These in vitro studies support a 
number of pre-clinical and clinical studies in which infection was resisted in a surgical site 
repaired with SIS-ECM after deliberate bacterial or gastrointestinal contamination in the case of 
pre-clinical studies12, 23, 138, 252 or prior infection in the clinical study.268 
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 The chemoattractant properties of ECM degradation products have been proven for 
endothelial cells in vitro and in vivo.176  In the in vitro experiments, a Boyden Chamber assay 
was performed in which endothelial cells from the heart, liver, and kidneys were added to the 
upper chamber and ECM degradation products (60 μg/ml), urea extract of SIS-ECM (60 μg/ml), 
a positive control (VEGF; 100 ng/ml), or a negative control (serum free medium) were added to 
the lower well.  The urea extract of SIS-ECM is known to contain abundant VEGF from the 
scaffold, which is a powerful chemoattractant for endothelial cells.120  After a 3-hour incubation 
period, the cells that had not migrated toward the chemotactic agent were removed, while the 
cells that had migrated through the membrane were fixed, stained, and counted.  The results 
showed that ECM degradation products had greater chemoattractant potential than the urea 
extract of SIS-ECM or VEGF alone.  To confirm these findings in vivo, ECM degradation 
products were loaded into a Matrigel plug and implanted subcutaneously into mice.  An 
unloaded Matrigel plug was used as a control.  The unloaded Matrigel plug exhibited no 
angiogenesis, while the plug loaded with ECM degradation products showed abundant blood 
vessel formation.   
 A limitation of these results is that the peptides that comprise the ECM degradation 
products were obtained by acid hydrolysis rather than by a biologically relevant method.  
However, it seems unlikely that peptides exhibiting a variety of bioactivities that are beneficial 
for a wound healing environment would form in an artificial situation, but would not be formed 
in a biological system.  Studies are currently underway to confirm this hypothesis and to 
determine the sequence of the peptides.   
These studies suggest that degradation of an ECM scaffold may be an important and 
necessary event in a constructive remodeling response.20, 175, 240, 296  Stated differently, 
degradation of an ECM scaffold may be a requisite process with bioactive consequences that 
contributes to the overall remodeling phenomenon.  It is logical therefore that inhibition of 
scaffold degradation by chemically crosslinking the ECM may decrease or eliminate the 
beneficial effects of ECM degradation products.  This will be a topic of study in this 
Dissertation. 
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2.3 THE ROLE OF MECHANICAL LOADING 
2.3.1 Effects of Immobilization on ECM Remodeling 
In general, studies have shown that the choice to mobilize or immobilize a joint after ligament or 
tendon rupture can have a substantial effect on the healing process.63, 64, 212, 264, 288  Several animal 
studies have shown better results with non-operative treatment and early mobilization than with 
surgical repair followed by immobilization.213, 284, 288  In a study that compared repair versus non-
repair, both with early mobilization, of a clinically relevant mop-end tear model of the rabbit 
MCL, there were no differences in the varus-valgus rotation of the knee, in situ force of the 
MCL, or tensile properties between the repaired and nonrepaired MCL.284  Due to the large body 
of research related to the effects of early mobilization on healing, the concept of early passive 
range of motion after injury to a ligament or tendon (in some cases after repair) has become 
widely accepted.  Several clinical studies have shown that after acute injury and repair of the 
Achilles tendon, early mobilization led to decreased time required for rehabilitation without 
differences in the re-rupture rate.190, 257  However, despite the early rehabilitation, no differences 
were observed in the thickness of the healing tendon or the strength loss of the relevant 
musculature.190    
Despite the evidence in support of early mobilization for ligaments and tendons with no 
repair or primary repair and the fact that most preclinical studies with SIS-ECM utilized early 
mobilization, some early clinical applications of SIS-ECM utilized immobilization and 
nonweightbearing conditions for a period of time to protect the joint during the phase of rapid 
ECM degradation.  To determine the effects of immobilization on the remodeling of an SIS-
ECM scaffold, a study was performed in which an SIS-ECM scaffold was used to repair a 
segmental defect in a rabbit Achilles tendon with a number of immobilization protocols.119  
Rabbits were separated into five groups.  In four groups, a 1.5 cm section of the Achilles tendon 
was surgically removed and repaired with an SIS-ECM interpositional graft, after which the 
surgically repaired limb was immobilized for two weeks. The first group of animals was 
sacrificed at the end of two weeks as a control.  The other three groups had their hind limb 
braced to allow full range of motion, partial range of motion (60°-90° of flexion), or no range of 
motion for an additional four weeks at which point all animals were sacrificed.   In the control 
 12
group, a sham operation was performed in which the Achilles tendon was exposed, but no defect 
was created and no SIS-ECM material was implanted.  The sham operated hind limb was 
immobilized for two weeks prior to sacrifice.  Histologic analysis of the groups with partial or 
full range of motion showed that similar results to those described in Section 2.1.1.  There was 
no distinguishable SIS-ECM material remaining, and the tissue was composed of dense 
collagenous connective tissue oriented along the longitudinal axis of the tendon.  Spindle shaped 
cells were distributed throughout the tendon and oriented along the longitudinal axis of the 
tendon.  The only difference between the partial and full range of motion groups was that fewer 
cells were found in the center of the remodeled graft with partial motion. 
 The SIS-ECM remodeling process was entirely different with immobilization.  In both 
the control group and the experimental group, there was histologic evidence of the SIS-ECM 
scaffold at the defect site with only limited deposition of new host connective tissue that was 
disorganized in appearance.  The cellularity was limited to the periphery of the graft, with almost 
no cells found in the middle of the device. 
 This study suggests that the constructive, site specific remodeling response that has been 
observed in many studies is not a result of the SIS-ECM scaffold alone.  In a tendinous 
application, the infiltration of the scaffold by cells, deposition of collagenous connective tissue, 
and subsequent organization of the tissue is modulated by the mechanical environment.  It 
appears that the lack of mechanical loading may also slow the degradation process since cells are 
not present throughout the scaffold, which limits the cascade of events promoted by the 
degradation products.  One of the objectives of this dissertation is to develop a better 
understanding of the positive aspects of mechanical loading on the remodeling of an ECM 
scaffold. 
2.4 THE ROLE OF BONE MARROW DERIVED CELLS 
2.4.1 Recruitment of Bone Marrow Derived Cells to ECM Remodeling 
The typical remodeling response for an ECM scaffold shows an abundance of mononuclear cells 
that are present in the remodeling ECM from the first few days through one month after 
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implantation.  Many of these cells appear to be macrophages, which originate in the bone 
marrow.  Since there is an abundance of cells that populate the ECM scaffold that remain at the 
site longer than would be expected for the normal mammalian healing response, and the 
remodeling response to an ECM is different than normal healing, a logical question was whether 
there was a population of cells originating in the bone marrow that participates in the remodeling 
of an ECM scaffold that does not typically participate in normal healing.   
To determine if a bone marrow cell  population was involved in the remodeling ECM 
scaffolds, scaffolds composed of bovine Type I collagen, poly(L)lactic-co-glycolic acid (PLGA), 
SIS-ECM, urinary bladder submucosa (UBS-ECM), and a mixture of PLGA and particulate 
UBS-ECM were implanted subcutaneously in a chimeric mouse model is which bone marrow 
derived cells expressing glucose phosphate isomerase 1a (Gpi-1a) were implanted into a mouse 
that normally expressed glucose phosphate isomerase 1b (Gpi-1b).20  The bone marrow derived 
cells also expressed β-galactosidase (β-gal) to allow for histologic identification of the bone 
marrow derived cells.  There was an abundance of bone marrow derived cells found at the 
implant site for all scaffolds at 7 days, after which the percentage of Gpi-1a positive cells 
decreased at the implant sites of Col I and PLGA scaffolds.  In contrast, the implant sites 
containing SIS-ECM, UBS-ECM, and the PLGA/UBS-ECM composite showed elevated Gpi-1a 
activity for the entirety of the study (56 days) at about 65-75%.  The expression of β-gal 
confirmed that these cells were marrow derived, and provided morphologic information about 
the location and morphology of the cells.   The Col I scaffold contained very few β-gal+ cells 
after 56 days that were spindle shaped in appearance and these cells were confined to the outer 
region of the scaffold.  The PLGA scaffold also contained only a small number of β-gal+ cells 
that had a rounded shape around the periphery of the scaffold after 56 days.  Consistent with the 
Gpi-1a results, there was an abundance of β-gal+ cells found in the remodeled SIS-ECM and 
UBS-ECM.  The β-gal+ cells were distributed throughout the remodeled tissue, and exhibited a 
spindle-shaped morphology consistent with endothelial cells and fibroblasts.  Some of the β-gal+ 
cells lined primitive capillary spaces, and stained positive for PECAM-1 and von Willebrand 
Factor, two ubiquitous endothelial cell markers.  For the PLGA/UBS-ECM scaffold, spindle 
shaped β-gal+ cells were found in the proximity of the PLGA remnants, and were found 
throughout the thickness of the scaffold. 
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This study shows that ECM scaffolds recruit a population of bone marrow derived cells 
to the site of remodeling that participate in the long-term remodeling of the scaffold and become 
part of the regenerated tissue when implanted subcutaneously.  There is specific evidence for 
these cells differentiating into endothelial cells and some of the cells exhibited fibroblastic 
morphology.  The phenotype of the cells is not clear, but it is possible that these cells may 
represent the populations of endothelial progenitor cells and mesenchymal progenitor cells,52, 126, 
131, 194, 224, 228, 278 or a population of partially differentiated circulating cells such as fibrocytes.1, 46, 
59, 60, 112  The mechanism of recruitment is also not clear, but could be a function of the formation 
of chemoattractant peptides during degradation of the scaffold.  The mechanism of recruitment 
and the fate of bone marrow derived cells were topics of study for this Dissertation. 
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3.0  EXTRACELLULAR MATRIX REMODELING IN VITRO 
ECM remodeling in vivo is a complicated process regardless of whether the ECM of interest is a 
naturally occurring scaffold, a component of new connective tissue formed during the healing 
process, or part of intact tissue exposed to a new mechanical environment.  Therefore, a number 
of in vitro models have been developed to facilitate a better understanding of specific aspects of 
ECM remodeling.  Several of these models will be discussed in the following sections.  
3.1 SILICONE MEMBRANE MODEL  
3.1.1 Gene Expression 
A variety of cell types have been seeded on elastic silicone membranes and subjected to cyclic 
mechanical loading to mimic physiological levels of strain and strain rate.  Interpreting the 
effects of mechanical force on protein expression and synthesis can be difficult due to the broad 
range of cell types, scaffolds, and loading regimens that have been studied.  It has been shown 
that cyclic stretching of fibroblasts and smooth muscle cells generally leads to increased 
production of Col I,149, 259, 292 but when endothelial cells are exposed to cyclic mechanical 
stretching, Col I synthesis decreases.260  It has also been shown that cyclic stretching of 
fibroblasts increased synthesis of TGF-β, b-FGF, and VEGF, but decreased production of 
platelet derived growth factor (PDGF).219, 253  Several of the loading regimens utilized to study 
collagen and growth factor production have also been shown to increase the production of a 
variety of enzymes involved in the production of inflammatory mediators, including interleukin-
6 and prostaglandin-E2.177, 254, 280  Expression of tenascin-C (TN-C) has been shown to increase 
substantially and rapidly in response to cyclic mechanical loading.62 
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3.2 COLLAGEN GEL MODEL 
3.2.1 Static Loading 
The collagen gel model, first proposed by Bell and colleagues,28 uses Col I extracted from tissues 
such as rat tail tendon or bovine skin.  The harvested collagen is solubilized, then polymerized to 
a gel composed of greater than 99% Col I.  The advantage of this method is that cells can be 
suspended within the collagen gel, creating a tissue construct. The cells attach to the collagen 
fibers, and the contractile nature of the cells leads to reorganization of the matrix.  In floating 
gels, the total area of the gel decreases uniformly and the magnitude of the change is dependent 
upon the contractility of the fibroblasts.  As the specimen compacts, the collagen fibers and 
fibroblasts tend to align tangent to the perimeter of the gel.  When the gel is fixated at two points, 
the contraction of the fibroblasts leads to the development of a tension between the two points.   
The resulting morphology yields fibroblasts and collagen fibers that are aligned in the direction 
of tension.  It has been hypothesized that the fibers are aligned to the direction of tension to 
provide the greatest stiffness to resist load, and that the fibroblasts align with the fibers to shield 
from high strains.  Further, it has been shown that the development of tension in confined 
fibroblast populated collagen gels (FPCGs) leads to modulation of matrix, adhesion, and 
cytoskeletal protein expression, with increased synthesis of procollagen types I and III 
polypeptides, fibronectin, elastin, actin and glycosaminoglycans, with decreased synthesis of 
procollagenase polypeptides.127, 166 
One of the most notable models that used a confined FPCG was developed by Huang and 
coworkers.127  The FPCGs were formed around stationary posts and maintained in culture for a 
period of 12 weeks.  This study demonstrated mechanical loading of the FPCG increased matrix 
and glycosaminoglycan (GAG) synthesis, as well as crosslink density.  The most dramatic result 
was a 30 fold increase in strength that was observed between week 1 and week 12.   
Another important usage of the collagen gel model, named the Culture Force Monitor 
(CFM), was developed by Eastwood and colleagues.79  This model incorporated highly sensitive 
load sensors to quantify the tension that developed in a FPCG as a means to determine the 
contractility of the fibroblasts.  This method has been used extensively to characterize the 
behavior of fibroblasts.  This model has been important for developing a better understanding of 
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the effect of biological factors on the contractility of cells and the role of cell surface receptors in 
the development of tension in the FPCGs.   
3.2.2 Cyclic Loading 
A number of systems have been developed to apply dynamic external load to a FPCG in addition 
to the tension that develops internally due to cell contraction.50, 80, 141, 168, 249  These systems vary 
in their functionality as well as their utility.    Eastwood and colleagues extended their CFM to 
include motor controlled displacement, naming the new system the tensioning-Culture Force 
Monitor (t-CFM).80  With this system, it was determined that the geometry of the sample greatly 
affected the response of the fibroblasts.  It was demonstrated that a FPCG with a greater aspect 
ratio resulted in increased cell and collagen fiber alignment due to the ability of the FPCG to 
contract to a greater degree in the lateral direction.  Through finite element modeling, it was 
determined that fibroblasts align in the direction of principle stress, and the fibers also align in 
the same direction.  Furthermore, this model showed that fibroblasts exhibit tensional 
homeostasis.44  Stated differently, if fibroblasts at equilibrium are suddenly exposed to an 
increase in the external load, the contractile force of the fibroblasts will decrease until a new 
equilibrium is attained.  This finding is consistent with other in vitro studies that show that cell 
behavior changes in response to the stiffness of the substrate on which it resides.  The rate of 
fibroblast migration and magnitude of force production both increased as the stiffness of the 
substrate increased.49, 78, 282  The t-CFM was also used to study the effect of mechanical loading 
on the synthesis of matrix metalloproteases.220, 221  It was determined that cyclic loading of 
FPCGs elicited significant variations in the production of several matrix metalloproteases.   
A final technique based on the collagen gel model involved forming the gel seeded with 
smooth muscle cells (SMCs) around an elastic silicone tube to form a tubular construct as a 
tissue engineered blood vessel (TEBV).  In this system, circumferential strain was developed by 
radial distention of the silicone membrane with increased intraluminal pressure.  Kanda and 
Matsuda were the first to present this model and demonstrated circumferential alignment of the 
SMCs and collagen fibers around the silicone tube.141  Seliktar and colleagues extended this 
work to include mechanical testing of the scaffolds after mechanical loading.249  In addition to 
confirming the SMC and collagen fiber alignment found by Kanda and Matsuda,141 they also 
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demonstrated that tensile strength and modulus of the constructs increased between 4 and 8 days 
of cyclic loading, primarily as a result of increased crosslinking between the collagen fibers.  
Niklason and colleagues used this model to develop a TEBV with compliance and burst strength 
that were comparable to normal tissue.209  Further, the TEBV was histologically similar to 
normal tissue.  This was performed by contracting multiple cell populated collagen gels over a 
silicone tube.  Each layer was seeded with either endothelial cells or smooth muscle cells in an 
attempt to mimic the native structure.  Finally, ascorbic acid was added to the medium to 
promote the synthesis of new collagen. 
3.3 MECHANISMS FOR ECM GEL REMODELING 
3.3.1 Effects of Cell Alignment on Collagen Fiber Organization 
With the development of these models to study the effect of mechanical loading on the behavior 
of cells, a great deal of work has begun to elucidate the mechanisms by which the observed 
remodeling occurs.  A recently developed model examined the organization of collagen 
produced by cells with different orientations.279  MC-3T3-E1 cells, preosteoblastic cells that 
produce abundant amounts of collagen, were seeded on smooth and microgrooved substrates, 
and maintained in culture for a period of four weeks, producing a layer of cell-produced 
collagen.  The cells cultured on the smooth surface spread freely, and had no preferred 
orientation, while those cultured on the microgrooved surface were elongated in shape and 
aligned with the direction of the microgrooves.  The alignment of the collagen that these cells 
secreted was greatly affected by the orientation of the cells.  With the randomly oriented cells, 
although there were local areas of alignment, there was no global preferred orientation of the 
collagen fibers.  In contrast, the collagen fibers produced by the cells aligned with the 
microgrooves were aligned in the same direction (Figure 3-1).   
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Figure 3-1. The dense collagenous matrix produced by cells on a microgrooved surface show uniformly 
orange under polarized light microscopy, indicating the collagen fibers were aligned in the same direction as 
the microgrooves (green arrow, A).  The collagen matrix produced by cells on a smooth surface showed 
multiple colors (B), in this case orange (green arrow) and blue (white arrow), indicated multiple fiber 
orientations (Bar: 60μm). 279 
3.3.2 Magnitude and Direction of Force from Cells 
There have been a number of studies which have modeled the forces or traction that cells exert 
on their surroundings.49, 78, 94, 279, 293  The forces produced by the cell are directed. The 
lamellipodia of the cell exerts a “backword” directed force at the leading edge of the cell 
(relative to the direct of movement) or a “forward” directed force at the tail of the cell.  The 
studies differ in their conclusions as to whether the maximum forces from the cell are produced 
at the leading edge of the lamellipodia49, 78, 279 or the tail.94  Variations are likely due to biological 
variations or differences in the substrate used.  The magnitude of force generated by the cell was 
dependent on the stiffness of the substrate, with stiffer substrates associated with greater forces.    
While these results are not for cells seeded in collagen gels, they do provide a great deal of 
insight into the mechanisms involved the reorganization of collagen fibers.  As cells are seeded 
into a collagen gel, they will attach to the fibers, and begin to exert traction to them in order to 
migrate.  However, since the fibers are not fixed in space, they will reorient in the direction of 
tension.  This will cause the scaffold to stiffen as more fibers become aligned, which will lead to 
an increase in the force produced by the cell. 
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3.3.3 Generation and Transmission of Force by Cells 
The means by which the cells generate and transmit the traction to remodel the ECM in which 
they reside has been investigated.  The traction from cells develops from the cytoskeletal 
components, such as actin and microtubules.  When fibroblasts are subjected to tension, stress 
fibers form.  These fibers resist the external load on the cell.  Disruption of the actin cytoskeleton 
or microtubules in a collagen gel led to an inhibition of gel contraction or a subsequent decrease 
in the contractile force in the matrix.43, 265   
Transmission of the force from the cytoskeleton to the local environment occurs via 
integrins in the cell membrane, which tie into the cytoskeleton and attach to the extracellular 
matrix.  A number of studies have implicated different β1 integrins in mediating cellular 
contraction of collagen gels, specifically α1 β1 and α2 β1.54, 244  Blocking these integrins with 
antibodies or transfecting cells to block their synthesis led to a partial or complete inhibition of 
FPCG contraction.  Another study demonstrated that competitively inhibiting the attachment of 
integrins to receptors on the ECM not only prevented contraction of a collagen gel, but led to a 
disruption of the actin and microtubules.251  These findings demonstrate the importance of sound 
mechanical attachment between integrins and the surrounding ECM on cell function. 
3.3.4 Long Range Influence of Cells  
The previous section described the interaction between individual cells and the collagen fibers 
immediately surrounding them.  However, it has also been shown that cells have the ability to 
influence the organization of collagen fibers some distance from their location.  This 
phenomenon was studied by placing explanted ligament fibroblasts approximately 1 mm apart in 
a collagen gel.  “Straps” of aligned collagen formed between the two cell explants.242 They 
observed that the collagen fibers aligned quickly between the fibroblasts in the early stages of the 
experiment, while the speed of the advancing cells was slow.  The cells only advanced 
approximately 10 µm, while reorganization of collagen was observed up to 1000 µm away.  
Therefore small movements by the cells led to rapid remodeling of the scaffold.   It is suggested 
that the collagen gel should be considered as an interconnected meshwork of fibers, rather than a 
mixture of individual fibers.  This meshwork concept would explain the large lateral contraction 
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that is observed leading to the development of “straps” between the cell explants.  This 
phenomenon probably plays an important role in remodeling of tissues, which have a greater 
degree of interconnectedness.  However, the effects are probably less dramatic since connective 
tissues are typically more robust than a collagen gel. 
3.3.5 Relevance to ECM Scaffolds 
Many of the mechanisms involved in the remodeling of an ECM gel in vitro are likely involved 
in the remodeling of a naturally occurring ECM scaffold in vivo.  Cells that migrate into the 
ECM scaffold would initially align with the native collagen fiber alignment.  The cells would 
then begin to deposit new collagen that would be aligned with the cell and the cells would begin 
to reorganize the collagen fibers within the scaffold in response to in vivo loading.  However, the 
kinetics and scale of these events are probably quite different than those observed in collagen 
gels due to the robustness of the naturally occurring ECM scaffold.  The collagen fibers within 
the ECM scaffold are more mature (e.g., crosslinked) than the fibers within an ECM gel, and the 
ECM scaffold has a greater rigidity, complex architecture, and interconnectedness.  Therefore, 
the remodeling process probably requires an initiation of proteolytic degradation of the native 
ECM to allow reorganization to take place.  The presence of diverse biochemical molecules 
(GAGs, growth factors, collagens, laminin) and the native architecture of the ECM scaffold 
likely have a further effect on the behavior of the cells under load, although those effects are not 
known. 
  Another important concept is the transfer of load from the collagen fiber to the cells.  
ECM gels are composed of isolated collagen fibers that are interwoven and have a high degree of 
fiber motility, while the ECM scaffolds are composed of a complex arrangement of 
interconnected fibers.  Furthermore, the collagen fiber architecture of the ECM scaffold is 
designed by nature to resist the local mechanical environment of the host organ (e.g., small 
intestine or urinary bladder).  In vivo, these scaffolds are being utilized in a variety of loading 
environments that are quite different from the organ of origin, in many cases after considerable 
processing of the ECM.  The effects of the mechanical loading on the organization of the 
collagen fibers are not well understood, and it is possible that the collagen fibers within each 
tissue will exhibit motility and reorganize after implantation as the scaffolds are degraded.  Since 
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the fiber kinematics is not known, it is difficult to evaluate how a strain applied to the scaffold 
relates to strain transmitted to the cells within the scaffold.     The relationship between scaffold 
strain and cell strain could be an important factor in the remodeling process since cell behavior 
has been shown to be dependent on the magnitude of stretch.  These concepts will be a topic of 
study in this Dissertation.  
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4.0  OVERVIEW 
The previous sections have described the typical site specific remodeling response to an ECM 
scaffold and some of the potential mechanisms of this response.  The cellularity of the scaffold 
increases dramatically after implantation and remains elevated longer than would be expected in 
normal mammalian wound healing.  In the early phase, the cells include a large number of 
mononuclear cells, consistent with macrophage morphology, that exhibit an anti-inflammatory/ 
immunoregulatory phenotype as opposed to a proinflammatory, foreign body response.  The 
morphology of the cells changes to that of a site-specific cell by one month after implantation.  
Among the site-specific cells is a population of bone marrow derived cells that participate in the 
long-term scaffold remodeling.  It is thought that these cells are recruited to the site of 
remodeling by small biologically active peptides formed during scaffold degradation.  The 
specific cells that are recruited and the fate of the cells are not yet known with certainty.  
Population of cells that may contribute to this remodeling response include mesenchymal 
progenitor cells and fibrocytes, which exhibit behavior consistent with the ECM remodeling. 
 The role of the mechanical environment is also important to the remodeling process.  The 
effects of prolonged immobilization on the remodeling ECM scaffold are quite dramatic, with 
minimal cell infiltration into the scaffold and disorganized connective tissue formation.  Early 
mobilization with site appropriate mechanical loading is apparently a requisite part of the 
constructive remodeling response.  Site appropriate mechanical loading may contribute to 
differentiation of bone marrow-derived cells that are recruited to the site of remodeling.  
Furthermore, as shown in a number of in vitro studies, mechanical loading likely regulates 
matrix synthesis and improves the tissue organization, leading to tissue with site appropriate 
mechanical behavior.   
With these previous studies in mind, the following represent the specific aims for this 
Dissertation. 
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5.0  SPECIFIC AIMS 
Specific Aim 1:  To investigate the expression of matrix related genes by fibroblasts seeded on 
SIS-ECM in response to cyclic mechanical loading at physiologically relevant magnitudes and 
frequencies of stretch, and characterize the associated changes that occur to the matrix 
organization and mechanical behavior of the SIS-ECM scaffold. 
 
Specific Aim 1a:  To determine the gene expression of collagen type I (Col I), collagen 
type III (Col III), matrix proteinases-2 (MMP-2), matrix metalloprotease-9 (MMP-9), α-
smooth muscle actin (SMA), tenascin-C (TN-C), transforming growth factor-β1 (TGF-
β1), and transforming growth factor-β3 (TGF-β3) by NIH 3T3 fibroblasts seeded on SIS-
ECM and subjected to cyclic stretch at magnitudes of 5%, 10%, and 15% at frequencies 
of 0.1 Hz, 0.3 Hz and 0.5 Hz.   
 
Specific Aim 1b:  To investigate the effects of cyclic mechanical loading on collagen 
fiber architecture and kinematics, and mechanical properties of naturally derived SIS-
ECM scaffolds seeded with fibroblasts. 
 
Rationale 1:  Matrix proteins and growth factors are integral to tissue remodeling as they 
provide signals to cells which guide tissue development and provide a structural network 
from which the cells can act.  Therefore, it is important to understand how various cyclic 
mechanical loading regimens modulate fibroblast gene expression and alters the existing 
extracellular matrix. 
 
Hypothesis 1:  We hypothesize that the selected mechanical conditioning regimen will 
include increased collagen I expression, decreased collagen III expression, moderate 
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MMP expression, and increased expression of SMA, TN-C, TGF-β1, and TGF-β3.  It is 
further hypothesized that cyclic mechanical loading of SIS-ECM seeded with fibroblasts 
will show increased collagen fiber alignment and increased tensile strength and tangent 
modulus compared with SIS-ECM alone or SIS-ECM seeded with fibroblasts without 
cyclic mechanical loading due to reorganization of existing collagen fibers and deposition 
of new collagen. 
 
Specific Aim 2:  To determine the fate of bone marrow derived cells that are recruited to the site 
of SIS-ECM scaffold remodeling in a mouse model of Achilles tendon repair. 
 
Specific Aim 2a:  To determine if the bone marrow derived cells recruited to the site of 
SIS-ECM remodeling exhibit fibroblastic characteristics after long-term remodeling. 
 
Specific Aim 2b:  To determine if a correlation exists between the process of SIS-ECM 
degradation and the recruitment of bone marrow derived cells to the site of SIS-ECM 
scaffold remodeling.   
 
Rationale 2:  Pre-clinical studies have shown that SIS-ECM remodels into site specific 
tissue and that bone marrow derived cells that are not typically involved in the healing 
process are recruited to the site of SIS-ECM remodeling.  In vitro studies have shown that 
degradation products from SIS-ECM are chemoattractant, and a similar mechanism may 
be responsible for the recruitment of marrow-derived cells. 
 
Hypothesis 2:  We hypothesize that a portion of the bone marrow derived cells recruited 
to the site of SIS-ECM remodeling will show fibroblastic characteristics.  We further 
hypothesize that by chemically crosslinking SIS-ECM, the rate of degradation will be 
decreased and fewer bone marrow derived cells will be recruited to the site of 
remodeling.   
 
Specific Aim 3:  To determine if the population of bone marrow derived cells recruited to the 
site of SIS-ECM remodeling includes circulating fibrocytes. 
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 Specific Aim 3a:  To determine whether mouse fibrocytes are recruited to the 
degradation products of a SIS-ECM scaffold via an in vitro Boyden Chamber Assay. 
 
Specific Aim 3b:  To determine the changes in the expression of Col I, Col III, MMP-2, 
MMP-9, SMA, TN-C, TGF-β1, TGF-β3 by mouse fibrocytes in response to a selected 
cyclic stretching regimen based on the results of Specific Aim 1a. 
 
Rationale 3:  Fibrocytes are bone marrow derived cells that have been shown to migrate 
to the site of tissue injury and exhibit fibroblastic characteristics.  It is reasonable to 
expect that these cells may comprise a portion of the population of bone marrow derived 
cells that are recruited to the site of ECM remodeling.  Their participation in the 
remodeling process may contribute to the change in the default mechanism of healing. 
 
Hypothesis 3:  We hypothesize that fibrocytes will be recruited to the degradation 
products of SIS-ECM in vitro and that they will exhibit a gene profile consistent with a 
constructive remodeling response. 
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6.0  RECRUITMENT OF BONE MARROW DERIVED CELLS TO SITE OF SIS-
ECM REMODELING 
This section deals with experiments that were performed to address Specific Aim 2.  The first 
experiment was performed to determine the rate of degradation of an SIS-ECM scaffold in a 
musculotendinous application (canine Achilles tendon).100  In addition, the time course of 
remodeling was described with a focus on the cellular infiltrate and the tissue organization.  With 
this study as a basis for the remodeling of ECM scaffolds in a tendinous application, the second 
study attempted to determine whether bone marrow derived cells are involved in the long-term 
remodeling of tendinous tissue, and the fate of those bone marrow derived cells.296 
6.1 DEGRADATION AND REMODELING OF SIS-ECM IN A CANINE ACHILLES 
TENDON MODEL 
Although there are now six naturally derived ECM scaffolds on the market for musculotendinous 
repair, the only quantitative assessment of the rate of degradation for any ECM scaffold was 
performed for native SIS-ECM in the context of urinary bladder repair by integrally labeling the 
scaffold with 14C (Details in Section 2.2.1).229  14C is an effective tracking biomolecules in an 
animal model due to its stability and the development of sensitive detection methods.47, 171  It is 
important to determine the rate of ECM scaffold degradation in a musculotendinous application.  
In the present study, 14C-labelled SIS-ECM was used to determine the rate of ECM degradation 
and the fate of the degradation products when used as an interpositional graft in the canine 
Achilles tendon.  In addition, a histological analysis was performed to determine the temporal 
changes in the appearance of the SIS-ECM scaffold during the remodeling process. 
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6.1.1 Animal Care Compliance  
The production of 14C-labeled SIS-ECM and the surgical procedure performed as part of this 
study were approved by the University of Pittsburgh Radiation Safety Committee and 
Institutional Animal Care and Use Committee of the University Pittsburgh (protocol number 
0306682).  The animal care complied with the NIH Guidelines for the Care and Use of 
Laboratory Animals.   
6.1.2 Preparation of 14C Labeled SIS-ECM 
The methods for labeling the SIS-ECM with 14C have been reported previously.229  Briefly, 
piglets were given weekly intravenous injections of 10µCi of 14C labeled proline (Amersham 
Life Science; 256mCi/mmol, 50µCi/ml) beginning at 3 weeks of age and continuing until the 
time of sacrifice. At approximately 26 weeks of age, the animals were sacrificed and the small 
intestine was harvested.  The small intestine was mechanically abraded to remove the tunica 
muscularis externa and the majority of the tunica mucosa.  The remaining tunica submucosa and 
basilar portion of the tunica mucosa was then disinfected and decellularized in a 0.1% PAA 
solution followed by two rinses PBS and deionized water.  
To produce each Achilles tendon repair device, a ten layer construct of the hydrated 
sheets of 14C labeled SIS-ECM was created such that each sheet was oriented with the 
longitudinal axis of the small intestinal submucosa oriented in the same direction.  SIS-ECM has 
a preferred collagen fiber orientation along the long axis of the small intestine,237 therefore 
creating the construct in this uniaxial orientation provided increased strength in the direction 
aligned with the repaired tendon.  The ten layer construct was then laminated by a vacuum-
pressing technique.90  The construct was placed between two perforated stainless steel sheets, 
and the stainless steel plates were placed between sheets of sterile gauze.  The entire construct 
was then sealed in vacuum bagging, and subjected to a vacuum of 710-730 mm Hg for 
approximately 8 hours.  The multilaminate device was cut into 2 cm x 3 cm sheets, with the 
preferred fiber direction corresponding to the 2 cm axis.  The final construct was terminally 
sterilized by exposure to ethylene oxide. 
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6.1.3 Study Design and Surgical Procedure 
Twelve adult female mongrel dogs weighing approximately 20 kg were divided into six groups 
of 2 dogs each.  All dogs were subjected to segmental resection of 1.5 cm of the Achilles tendon, 
and the defect was repaired with the bioscaffold composed of 14C-labeled SIS-ECM.  One group 
of animals was sacrificed at each of the following time points:  3, 7, 14, 28, 60, and 90 days post-
surgery.   
 Surgical plane anesthesia was produced in each dog by induction with sodium thiopental 
(12-25 mg/kg IV) followed by intubation and maintenance with 2-3% Isofluorane.  The animals 
were prepared for surgery by shaving the surgical site and scrubbing with Betadine solution.  
Antibiotics (Cephalexin) were administered intramuscularly pre-operatively and then post-
operatively twice a day for 7 days.  For each dog, the Achilles tendon of a randomly selected 
hind limb was dissected free of surrounding tissue and a 1.5 cm segment was excised from the 
mid-tendinous region.  The tendon defect was repaired with a 2 cm x 3 cm graft of the 14C 
labeled SIS-ECM scaffold folded accordion style, such that 2-3 mm of the 2 cm length 
overlapped each end of the tendon defect, using 4-0 proline suture to mark the ends of the defect 
(Figure 6-1).  The paratenon was sutured with 4-0 PDS suture and the skin incision closed using 
standard surgical technique.  The animals were placed in a tube splint (modified Robert Jones 
bandage) to allow immediate partial weight bearing without allowing the tendon unit to stretch 
(Figure 6-2).  The splint was removed after 28 days and the dogs were allowed free ambulation 
without external support.   
At regular time intervals after surgery, urine, blood, and fecal samples were collected to 
determine the route of elimination of the degraded 14C-labeled materials from the body.  At the 
time of sacrifice, the remodeled SIS graft and the contralateral non-operated control were 
harvested for microscopic examination and quantification of the 14C concentration within the 
tissue.  The specimen prepared for histology contained remodeled normal tendon and remodeled 
ECM so that the transition between the two tissues could be evaluated. The specimen for 14C 
analysis was taken from the middle of the remodeled ECM graft.  Tissue samples were collected 
from the skin, skeletal muscle, mesenteric fat, spleen, liver, kidney, pancreas, lymph nodes, lung, 
heart, and brain to determine if 14C had collected in these organs. 
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Figure 6-1.  Schematic of the surgical placement of the SIS-ECM graft in the Achilles tendon defect.  The 2 
cm x 3 cm graft was folded accordion style, and woven through the bundles of the Achilles tendon and fixed 
with a mattress suture. 
 
 
Figure 6-2.  Modified Robert Jones bandage utilized to splint the repaired Achilles tendon for 28 days post-
operatively. 
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6.1.4 Liquid Scintillation Counting of 14C 
The radioactivity in each sample was measured by liquid scintillation counting using a LS1800 
B-counter (Beckman Coulter, Somerset, NJ).  For urine, 0.2 ml urine was added directly to 10 ml 
scintillation fluid (Ultima Gold, Perkin Elmer, Boston MA). The radioactivity in urine was 
reported as CPM/ml.  For the SIS-ECM graft at time zero, the remodeled tendon, and all other 
harvested tissues, approximately 80 mg of tissue was incubated with 1 ml of Solvable (Packard 
Instruments, Meriden, CT) at 50°C for 2-4 hours.  Ten ml of scintillation fluid was then added to 
each sample and the radioactivity was determined.  The tissue radioactivity was reported as 
CPM/g. 
Blood samples were incubated with 1:1 mixture of Solvable:Isopropanol (Fisher 
Scientific, Pittsburgh, PA) at 60°C for 30 minutes.  The samples were the treated with 30% H2O2 
(Spectrum, Gardena, CA) to quench endogenous peroxidase activity and incubated at 60°C for 
an additional 30 minutes.  Fifteen ml of scintillation fluid was added to each sample and the 
radioactivity was measured.  The blood radioactivity was reported as CPM/ml.  To measure the 
radioactivity in a fecal sample, approximately 20 mg of feces was rehydrated with 0.1 ml of 
water for 30 minutes at room temperature.  One ml of Solvable was added to each sample, and 
the samples were incubated in a 50°C oven for 1-2 hours.  0.5 ml of Isopropanol was added 
before the final 2 hour incubation at 50°C.  Peroxidases were quenched with 0.2 ml of 30% 
H2O2, and 10 ml of Ultima Gold was added.  The radioactivity of the feces was reported as 
CPM/g. 
6.1.5 Histologic Analysis Methodology 
A portion of each tendon was harvested and trimmed to include the remodeled SIS-ECM graft 
and the adjacent native tendon proximal and distal to the remodeled graft.  The tissue was fixed 
in 10% neutral buffered formalin, sectioned longitudinally, and stained with both Hematoxylin 
and Eosin and Masson’s Trichrome stains for microscopic examination.  The cellularity of the 
remodeled graft was assessed by obtaining five microscopic images from each section at 40x 
magnification for subsequent counting using MetaVue Software (Universal Imaging 
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Corporation, Downingtown, PA).  The cells were classified as neutrophils or mononuclear cells.  
The data is presented as the average number of cells per 40x field.  For statistical comparisons, a 
student t-Test was performed between groups with statistical significance set at a p-value < 0.05. 
6.1.6 Surgical Outcomes 
All animals recovered well from surgery, and tolerated the splinting for one month.  After 
removal of the splint, all animals returned to normal gait.  Gross evaluation of the remodeled 
tendons after sacrifice showed no evidence of tendon rupture at any time during the 
postoperative period.  By visual inspection, there did not appear to be any change in the total 
tendon length or length of the repair site.   
6.1.7 Time Course of Degradation and Fate of Labeled ECM 
The values for 14C concentration of the remodeling SIS-ECM tissue for each dog are listed and 
the average values at each time point are plotted in Figure 6-3.  Approximately 10% of the 
scaffold material had been degraded and removed from the site of remodeling by as early as 3 
days post-surgery.  By 14 days, approximately 20% of the scaffold material had been degraded 
and at 28 days, approximately 60% of the scaffold material had been degraded.  By 60 days post-
surgery, the amount of 14C in the remodeled tissue was equal to background levels (<8%) 
indicating complete scaffold degradation and removal from the site of remodeling.   
The only other tissues in which 14C activity could be detected were blood and urine.  The 
blood showed positive 14C activity at 3 days and 7 days after surgery.  14C activity could be 
detected in the urine at 3, 7, and 14 days post-surgery.  All other tissue samples were negative 
(i.e., below background values) for 14C activity at all time points.  
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Figure 6-3.  Graphical representation of the average 14C% remaining at the graft site at each time point.  The 
shaded area indicates the background 14C level observed at approximately 8%.  The actual measurements for 
14C% is included next to each data point. 
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 6.1.8 Histologic Description of Remodeling 
Histologic examination of the SIS-ECM graft prior to implantation showed a laminate structure 
of dense, organized, collagenous tissue with no cellularity (Figure 6-4). 
Tissues harvested from the remodeling SIS-ECM tendon tissue showed that at 3 days 
post-surgery, the acellular scaffold material had been infiltrated with a large number of host 
inflammatory cells characterized by an approximately equal number of neutrophils and 
mononuclear cells (p = 0.55) (Table 6-1).   Early evidence for scaffold degradation included the 
separation of the individual sheets within the multilaminate structure by infiltrating host cells and 
loss of distinct scaffold architecture at the periphery of the graft material.  There was no 
histologic evidence for deposition of new host ECM based upon the distinct margins of the graft 
and cut end of the native tendon. 
By 7 days (Figure 6-5), the cellular infiltrate had increased in amount and consisted 
almost exclusively of mononuclear cells (Table 6-1).  A moderate degree of scaffold degradation 
was present and the host-cell infiltrate progressed from the periphery of the SIS-ECM graft 
material to the center of the graft material.  New host ECM was present at the remodeling site 
based upon the presences of amorphous connective tissue between the native tissue and the SIS-
ECM graft material. 
By 14 days (Figure 6-6), the entire SIS-ECM scaffold material was infiltrated with host 
cells that were primarily mononuclear in morphology with only a few scattered neutrophils 
present.  This time point showed the greatest cellularity over the time course of remodeling with 
an average 271 ± 133 cells per 40x field (Table 6-1).  Graft degradation was characterized by 
separation of the various layers of the multilaminate sheet and loss of a distinct boundary 
between newly deposited host ECM and the original SIS-ECM graft material.  New host ECM 
deposition was present, especially at the periphery of the graft.  The distinct line of demarcation 
between the SIS-ECM scaffold material and the cut end of the native Achilles tendon to which it 
was attached was no longer evident by 14 days.  
By 28 days (Figure 6-7), there was a decrease in the cellularity similar to the numbers 
observed at 7 days after implantation (Table 6-1).  The mononuclear cells were still abundant, 
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and were uniformly distributed throughout the remodeled ECM graft.  No neutrophils were 
observed.  There was loss of almost all morphologic evidence of the SIS-ECM graft material 
which was replaced by a relatively homogeneous deposition of new host derived ECM material.  
The remodeled ECM was beginning to show regions of organization by this time point. 
At 60 days (Figure 6-8), there was replacement of the SIS-ECM by organized, aligned 
host ECM and spindle cells consistent with the morphologic appearance of fibroblasts.  The total 
cellularity was not statistically different from the cellularity at 28 days (Table 6-1).  The 
remodeled SIS-ECM graft was replaced by organized connective tissue and the site could only 
be identified from the native tissue by the presence of the Prolene suture.  
The 90 day tissue samples (Figure 6-9) showed a slight decrease in the number of spindle 
cells present within the graft material compared to the 60 day sample and the cellularity was not 
statistically different from the normal Achilles tendon (Table 6-1).  The collagen fiber 
organization and vascularity was also qualitatively similar to that of normal tendon tissue.   
6.1.9 Significance of Degradation Results  
The results of this study show that SIS-ECM, when used as a biologic scaffold for Achilles 
tendon reconstruction is rapidly degraded after implantation, with approximately 60% of the 
mass degraded and resorbed within 4 weeks.  Degradation of the SIS-ECM appears to be 
complete by 3 months.  These findings are almost identical to the degradation rate of SIS-ECM 
when this biologic scaffold was used for reconstruction of the urinary bladder.229   The resorbed 
14C labeled degradation products in the present study were eliminated from the body primarily 
via urinary excretion.  No detectable 14C was found in any of the parenchymal organs that were 
examined.   
The non-linear temporal degradation of the SIS-ECM correlated with the extent and 
distribution of the host cellular infiltrate.  At the time of implantation, there were no cells present 
within the SIS-ECM scaffold.  As cells infiltrated the graft, the rate of scaffold degradation 
increased.  By four weeks post surgery, the cell infiltrate lessened and the rate of scaffold 
degradation began to diminish.  The distinctive laminated architecture of the SIS-ECM graft was 
no longer distinguishable by 28 days, and the remodeled scaffold showed a relatively uniform 
accumulation of homogenous collagenous connective tissue.   
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The Achilles tendon is subjected to some of the highest stresses of any tendon in the 
body.96, 145, 156, 291  It would therefore seem logical that an ECM scaffold which is subjected to 
rapid degradation, such as SIS-ECM, would be at risk of failure when used as a repair device for 
the Achilles tendon under physiologic loading, especially during the first 4-8 weeks after 
surgery.  In fact, this concern has been the rationale for chemically crosslinking many ECM 
scaffolds including one commercially available device derived from SIS-ECM (CuffPatch™, 
Arthrotek, Inc.).2, 173, 271  In the present study, a tube splint that allowed for partial weight bearing 
was utilized for the first month after implantation to prevent failure due to suture pull-out while 
still allowing the ECM scaffold to bear load.  The application of load early in the remodeling 
process has been shown to be important for constructive tissue remodeling.119  It is also likely 
that other tendons that run parallel to the Achilles tendon, such as the flexor hallucis longus 
tendon shared some of the load across the SIS-ECM graft.  After removal of the splint, the 
remodeled SIS-ECM scaffold was sufficiently strong to withstand unrestricted cage activity in 
this animal model without evidence of rupture.  The remodeled scaffold showed organized, 
aligned collagenous tissue after removal of the tube splint at 28 days.  Although mechanical 
testing was not performed in this study, a previous study using the same canine model of 
Achilles tendon repair showed that the strength of the remodeled Achilles tendon exceeds the 
strength of the insertion to the gastrocnemius muscle and the calcaneus by 12 weeks after repair 
with SIS-ECM.13   
6.1.10 Limitations 
A limitation of the present study is the small number (n=2) of animals that were evaluated at 
each time point.  The low numbers were a result of practical considerations including the cost of 
the study and the complexity involved in producing the SIS-ECM labeled with 14C.  Despite 
these limitations, this study showed rapid degradation of an SIS-ECM scaffold used for repair of 
a musculotendinous tissue, an application for which SIS-ECM is currently in clinical use.  This 
study also shows that as degradation occurs, the graft remodels into dense collagen rich 
connective tissue with an organization, cellularity, and vascularity similar to that of native 
tendon tissue. 
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Table 6-1.  Cellularity of normal tendon and the remodeled SIS-ECM graft.  All data is presented as the 
average number of cells in five 40x field.  Statistical significance was set at p<0.05.  † indicates statistical 
significance compared to the cellularity for the native tendon. 
Tissue Mononuclear Cells Neutrophils Total Cells 
Native Tendon 54 ± 17 0 54 ± 17 
SIS-ECM Device 0 0 0 
Day 3 53 ± 15 58 ± 8 
49 ± 10† 
86 ± 34†
102 ± 15† 
144 ± 29†
Day 7 154 ± 35
† 
166 ± 30†
4 ± 6 
0 
158 ± 31† 
166 ± 30†
Day 14 377 ± 15
† 
152 ± 38†
14 ± 8† 
0 
390 ± 23† 
152 ± 38†
Day 28 105 ± 31
† 
184 ± 24†
0 
0 
105 ± 31† 
184 ± 24†
Day 60 116 ± 24
† 
146 ± 67†
0 
0 
116 ± 24† 
146 ± 67†
Day 90 63 ± 5 82 ± 24 
0 
0 
63 ± 5 
82 ± 24 
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Figure 6-4.  Histological section of the SIS-ECM device prior to implantation.  The section shows a laminate 
structure of dense organized collagen and no cellularity. (20x) 
 
 
Figure 6-5. Histological section of the interface between the remodeled SIS-ECM graft and the remodeled 
Achilles tendon at 7 days after surgery stained with Masson’s Trichrome.   The section showed an abundant 
cellular infiltrate that consisted almost exclusively of mononuclear cells surrounded by new host ECM.  There 
was also evidence of angiogenesis, with blood vessels indicated by ‘BV’.  A moderate degree of scaffold 
degradation was indicated by the marked change in the architecture of the SIS-ECM graft.  (40x)   
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Figure 6-6.  Histological section of the interface between the remodeled SIS-ECM graft and the remodeled 
Achilles tendon at 14 days after surgery stained with Masson’s Trichrome.   The section showed that the 
entire SIS-ECM scaffold material was infiltrated with host cells that were almost exclusively mononuclear in 
morphology.  There was also evidence of angiogenesis, with blood vessels indicated by ‘BV’.  The graft was 
well integrated with the newly deposited host tissue. (20x) 
 
 
Figure 6-7.  Histological section of remodeled SIS-ECM at 28 days after surgery stained with Masson’s 
Trichrome.  Dense sheets of exclusively mononuclear cells populated the remodeled ECM scaffold.  There was 
a loss of morphologic evidence of the SIS-ECM scaffold with relatively homogeneous deposition of new host 
derived ECM that was disorganized in its orientation. (20x) 
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Figure 6-8.  Histological section of remodeled SIS-ECM graft at 60 days after surgery stained with Masson’s 
Trichrome.   The section showed that the SIS-ECM graft was replaced with organized, aligned host ECM and 
spindle cells consistent with the morphologic appearance of fibroblasts.  The repair site between the SIS-
ECM graft and the native tissue could not be identified and was replaced by a uniform and organized 
connective tissue. (20x) 
 
 
Figure 6-9.  Histological section of remodeled SIS-ECM graft at 90 days after surgery stained with Masson’s 
Trichrome.   The section showed that the remodeled SIS-ECM graft was completely replaced with dense, 
organized, aligned host ECM and spindle-shaped cells consistent with fibroblast morphology.  The cellularity 
and vascularity were qualitatively similar to that for normal tendon tissue. (20x) 
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6.2 RECRUITMENT OF BONE MARROW DERIVED CELLS TO THE SITE OF 
SIS-ECM REMODELING IN A MOUSE ACHILLES TENDON MODEL 
It is generally accepted that following tendon injury, the healing process is characterized by an 
infiltration of inflammatory cells that shift from primarily neutrophils during the acute phase 
(e.g., first 6-72 hours) to a primarily mononuclear macrophage population thereafter.  In the 
absence of complicating factors such as infection, the inflammatory cells become less abundant  
within 10-14 days as fibroblasts migrate into the remodeling tendon from the adjacent tissue.8, 48, 
81  However, the cells that populate the SIS-ECM scaffold after surgical implantation are almost 
exclusively mononuclear in morphology after day 3 and these mononuclear cells progressively 
increase in number for at least 14-28 days.  This unusual cellular response is associated with new 
ECM deposition by the host and a site specific constructive remodeling process.  In a previous 
study in which SIS-ECM was implanted subcutaneously,20 it was shown that a portion of the 
cells that participated in the remodeling of SIS-ECM were bone marrow-derived cells, and they 
participated in the remodeling beyond the immediate post surgical inflammatory response.  The 
objective of the present study was to determine if bone marrow-derived cells participate in the 
long term remodeling of a musculotendinous tissue when SIS-ECM is used in a mouse model of 
Achilles tendon repair.    
6.2.1 Preparation of SIS-ECM 
Briefly, the small intestine was mechanically delaminated to remove the tunica muscularis 
externa and the majority of the tunica mucosa.  The remaining tunica submucosa, muscularis 
mucosa, and basilar portion of the lamina propria was then disinfected and decellularized in a 
0.1% peracetic acid solution followed by two rinses each in phosphate buffered saline and 
deionized water.  This process yielded an acellular material, which was then lyophilized and 
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terminally sterilized with ethylene oxide.  A single layer form of SIS-ECM was used such that 
the long axis of the device corresponded with the direction of preferred fiber alignment of SIS.237 
6.2.2 Chimeric Mouse Model 
Six to eight-week-old female C57BL/6J mice were lethally irradiated with 11Gy of gamma 
irradiation (96cGy/per minute) administered in 2 doses divided by 4 hours using a 137Cs 
irradiator (Nordion, Kanata, Canada). The lethally irradiated C57BL/6J mice were transplanted 
via tail injection with 5 X 106 low-density mononuclear cells isolated from female 
B6.ACTbEGFP mice that express green fluorescence protein (GFP) in all of their cells.  
Recipient animals were tested at monthly intervals to assay for the level of donor cell chimerism 
via sampling of peripheral blood cells. Stable chimerism post-transplant was achieved in four 
months. When the blood of the host animals was 100% donor origin (GFP positive), the mice 
were considered ready for use in the scaffold implantation study.294 
6.2.3 Study Design and Surgical Procedures 
All procedures were performed as approved by the Institutional Animal Care and Use Committee 
at the University Pittsburgh (Protocol #0405959) and the animal care complied with the NIH 
Guidelines for the Care and Use of Laboratory Animals.   
Forty chimeric mice that expressed GFP in all of their bone marrow-derived cells were 
anesthetized with inhalant Isofluorane using a nose cone. The right hind limb of each animal was 
shaved and prepared for surgery using sterile technique. Under magnification, the Achilles 
tendon was exposed through an anterolateral skin incision and the surrounding paratenon incised. 
Two 7-0 Vicryl sutures (Ethicon, Somerville, NJ) were placed proximal and distal in the Achilles 
tendon. The spacing of the two sutures was 3 mm. In group one (n=20), the proximal and distal 
suture were stitched through the intervening tendon tissue creating two loops of suture (Figure 
6-10A).  The tendon was then transected within each loop, creating the autologous tendon graft.  
The two suture loops were pulled tight and knotted to secure the graft.  In group two (n=20), a 2 
mm segment of the tendon was resected and a 3 x 2 mm single layer sheet of lyophilized SIS-
ECM was attached to the free ends of the tendon via the two placed sutures (Figure 6-10B).  
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Prior to closing the skin, the graft was rehydrated with sterile saline and the graft was tubularized 
around the free ends of the tendon (Figure 6-10B).  In both groups the wound was closed in 
layers using 7-0 Vicryl sutures. Remodeling was evaluated in four animals in each group at time 
points of 1, 2, 4, 8 and 16 weeks after surgery.   
After sacrifice, the experimental and contralateral Achilles tendons were harvested from 
each animal and fixed in 4% paraformaldehyde.  The tissue was then embedded in paraffin and 
5µm sections were obtained.  Unstained sections were used to visualize the GFP protein, and 
adjacent sections were processed for staining with H&E or Masson’s Trichrome.  The 
unprocessed section was examined with fluorescent microscopy for the presence of GFP+ cells, 
and photomicrographs were obtained at 20x.  A photomicrograph was also obtained for the same 
area of the tendon from adjacent tissue sections that were stained with H&E or Masson’s 
Trichrome to assess the histological appearance in the vicinity of the cells expressing GFP. 
6.2.4 Surgical Outcomes 
All animals tolerated the surgical procedure without adverse events and all animals were 
ambulatory immediately after surgery without apparent lameness. 
6.2.5 Histologic Findings for the Native Murine Achilles Tendon 
Histologically, the native Achilles tendon was composed of a highly organized collagenous 
matrix. Scattered spindle-shaped fibroblasts could be seen between highly aligned collagen 
fibers. In the paratendinous tissue, vascular structures were aligned longitudinal to the tendon.  
No GFP expressing marrow-derived cells were found in the intact Achilles tendon. 
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Figure 6-10.  (A) The control procedure was performed by first (i) placing 7-0 prolene suture loops 2 cm 
apart in the midsubstance of the tendon.  The tendon was then (ii) cut within the suture loops to hold the 
explanted tendon in place.  The sutures were finally (iii) pulled taught and knotted to secure the autologous 
tendon graft.  (B) The SIS repair procedure was performed by first (i) cutting a 2 cm length from the 
midsubstance of the tendon.  (ii) A single layer of lyophilized SIS-ECM was then secured to the cut ends of 
the tendon with 7-0 prolene suture.  Finally, the sutures were finally (iii) pulled taught and knotted to secure 
the SIS-ECM graft and the graft was hydrated with saline. 
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6.2.6 Histologic Findings for the Autologous Tendon Repair Group 
At necropsy, all tendon repairs remained intact.  Gross examination showed that the 
reconstructed tendon of both groups had a slightly increased diameter when compared to the 
intact contralateral tendon at all time points.  One week after surgery, the autologous tendon 
implant was difficult to identify because of the presence of dense granulation tissue.  
Histological examination at 1 and 2 weeks after surgery showed a dense infiltration of 
mononuclear cells and abundant new blood vessels (Figure 6-11A).  A robust accumulation of 
GFP-expressing marrow-derived cells was observed at the site of remodeling, generally 
associated with areas of angiogenesis and inflammation (Figure 6-11B).  By four weeks after 
surgery, the remodeled tendon consisted of organized collagenous tissue, and the cellularity had 
diminished to near normal.  At 4, 8, and 16 weeks, no GFP expressing marrow-derived cells 
were observed in the tendon body, but occasional green fluorescent cells could be identified 
around or within vascular structures of the paratendinous tissue.  Representative 
photomicrographs of the autologous repair group 4 weeks after surgery are shown in Figure 
6-12.  Figure 6-13 shows the histologic appearance of remodeled tissue 16 weeks after surgery.  
Table 6-2 provides a semi-quantitative summary of the inflammatory cells, bone marrow-derived 
cells, mononuclear cells, and collagenous tissue of the autologous tendon repair and SIS-ECM 
repair groups compared to normal tendon at each time point. 
6.2.7 Histologic Findings for the SIS-ECM Repair Group 
As with the autologous tendon repairs, no graft ruptures were observed at any time point.  The 
SIS-ECM graft was still distinguishable 1 week after surgery, but by 2 weeks the SIS-ECM was 
incorporated into the remodeling tendon and could not be identified as a discrete entity.  Similar 
to the autologous tendon repair group, the SIS-ECM repair group showed a dense mononuclear 
cell infiltration and a rich blood supply at 1 and 2 weeks after surgery.  An abundant population 
of GFP expressing marrow-derived cells was observed in the remodeling tendon both in the 
vicinity of vascular structures and in the tendon body (Figure 6-14).  At 4 weeks post surgery 
(Figure 6-15), a dense mononuclear cell population persisted at the site of scaffold placement, 
and these cells consisted of both mononuclear round cells and spindle-shaped cells.  There was 
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no morphologically distinguishable SIS-ECM scaffold material remaining and the suture lines 
between the native tissue and the healing tissue could not be identified.  The SIS-ECM repair 
group showed more marrow-derived green fluorescent cells when compared to the autologous 
tendon repair group at 4 weeks. The cellularity of the SIS-ECM scaffold site had diminished by 8 
weeks after surgery, but was still greater than would be found in normal tendon tissue.  No 
obvious inflammatory response could be seen at the 8 week time point.  At both eight and sixteen 
weeks, the remodeled tendon of the SIS-ECM group continued to show GFP positive marrow-
derived cells distributed uniformly throughout the graft segment.  The green fluorescent marrow-
derived cells within the body of the tendon were typically spindle-shaped and GFP positive cells 
were also noted in the paratendinous tissue (Figure 6-16).    
6.2.8 Significance of the Presence of Bone Marrow Derived Cells  
This study confirms that SIS-ECM supports constructive remodeling of the Achilles tendon in a 
mouse model, and showed that a bone marrow-derived cell population was involved in the long-
term remodeling process.  While the role of these cells in the remodeling process is not yet fully 
understood, it has been observed that they remain beyond the inflammatory stage of healing and 
are found throughout the midsubstance of the tendon when healing is complete.  At least some of 
these cells differentiate along a site appropriate fibroblastic lineage and become part of the new 
tissue.  It is possible that the cells may also differentiate down other cell lineages.   The 
recruitment, persistence, and site specific differentiation of bone marrow derived cells is not 
generally observed during “normal” adult mammalian tissue remodeling.  These findings suggest 
that the bone marrow-derived cells that populate the SIS-ECM may represent a population of 
cells that can become appropriate site specific cells that reside in normal tendon tissue, such as 
fibroblasts and/or endothelial cells.  In the absence of SIS-ECM, no bone marrow-derived cells 
are found within the body of the remodeled tendon.  In the current model, it was expected that 
the autologous tendon control would heal well because the tissue used in the repair was healthy, 
and the devitalized autologous tendon graft was replaced immediately after the defect was 
created.  In the clinical scenario, the control group would more closely resemble an acute 
Achilles tendon injury and repair.  A neglected Achilles tear with tendon retraction would 
require a method to “fill” the gap.  In these cases of neglected repair and retraction, the presence 
 47
of a bone marrow derived cell with the potential to differentiate into a tissue specific cell may 
have a beneficial effect on tissue healing and remodeling. 
Marrow-derived mesenchymal progenitor cells have been identified to have the potential 
to differentiate into a variety of types of cells in vitro and in vivo.52, 224  Their potential to 
improve healing is part of the rationale for autologous transplants of bone marrow aspirates for 
bone repair in the clinical setting.185, 287 There is increasing evidence that marrow-derived 
mesenchymal progenitor cells can enter circulation and participate in remodeling of tissue during 
development and homeostasis, or following injury.84, 161, 181, 263  A chimeric mouse model in 
which all of the bone marrow derived cells expressed green fluorescent protein (GFP) showed 
that marrow-derived cells populated a number of organs, including the heart, lung, kidney, small 
intestine, and skin due to normal homeostasis.84  When an injury was created in the skin, it was 
observed that a population of non-hematopoietic bone marrow-derived cells was present in the 
wound site, was synthesizing collagen types I and III, and had a histological resemblance similar 
to fibroblasts. In another study,144 a portion of fetal mouse small intestine was transplanted into a 
chimeric mouse expressing GFP in all of its bone marrow cells.  Non-hematopoietic marrow-
derived cells were observed in the lamina propria of the implanted intestinal tissue.  This same 
layer of the small intestine, i.e., the lamina propria, is included in the SIS-ECM scaffold material.  
Similar findings were observed in both mice and humans in which female recipients received 
bone marrow from a male donor.40  Myofibroblasts positive for the Y chromosome were 
observed in the lamina propria of the small intestine.   The same events that recruit these bone 
marrow derived cells to the site of injured and remodeling tissue may also be involved in the 
recruitment of the same cells to the site of ECM scaffold remodeling. 
In the present study, no GFP expressing marrow-derived cells were observed within the 
native tendon or within the fully remodeled autologous tendon tissue graft.  Occasional marrow-
derived cells were observed in the vicinity of new blood vessels and in the paratendinous tissue 
of the Achilles tendon repaired with autologous tendon tissue.  These findings suggest that the 
marrow-derived cells are not typically involved in the homeostasis or long-term remodeling after 
injury of the native Achilles tendon.  
As described in Section 1.2.5, it has recently been shown in vitro that small peptides (5-
16 kDa) formed during chemical and physical degradation of ECM bioscaffolds, including SIS-
ECM, are chemoattractant for numerous cell types, including endothelial cells.175  A similar 
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chemoattractant mechanism may also be responsible for the recruitment of marrow-derived 
mesenchymal progenitor cells to the site of the ECM remodeling.  We speculate that the 
constructive remodeling process associated with naturally derived ECM scaffolds is due at least 
in part to the participation of autogenous circulating marrow-derived progenitor cells that are 
recruited by the degradation products of the SIS-ECM.  It is plausible that such cells would then 
differentiate in response to local environmental cues and thus contribute to tissue organization 
and differentiation. Factors that inhibit the ECM degradation process, such as chemical 
crosslinking, may interfere with the biological activities that have been demonstrated by the 
products of ECM degradation. 
The results of this study show that a population of marrow-derived cells participates in 
the long-term remodeling of a degradable ECM scaffold when used as a repair device in this 
murine model of Achilles tendon repair.  It further suggests that at least a portion of these cells 
differentiate down a fibroblastic lineage, and it has been shown previously that these cells can 
also differentiate down an endothelial cell lineage.20  Such cells do not contribute to tendon 
healing in the absence of the ECM biologic scaffold.  The translation of these findings to the 
tendon healing process in humans remains to be shown.   
 
 
 
  
  
 
 
 
Table 6-2.  Qualitative prevalence of inflammatory cells, bone marrow derived cells, mononuclear cells, and collagenous tissue in the autologous tendon 
repair group (Control) and the SIS-ECM group compared to normal tendon. 
 Inflammatory Cells Bone Marrow Derived Cells Mononuclear Cells Collagenous Tissue 
Weeks Control SIS-ECM Control SIS-ECM Control SIS-ECM Control SIS-ECM 
1 +++ +++ +++ +++ +++ +++ ↓ ↓↓ 
2 +++ +++ +++ +++ +++ +++ ↓ ↓ 
4 ++ + + ++ ++ ++ ― ― 
8 + ― ― + + + + + 
16 ― ― ― + + + + + 
+++, robust increase; ++, moderate increase; +, slight increase;  ―, normal level; ↓, slight decrease; ↓↓, moderate decrease
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Figure 6-11.  (A) At two weeks after surgery, the autologous tendon repair group showed a dense mononuclear cell infiltration, abundant blood vessels, 
and acute inflammation (Masson’s Trichrome 20x). (B)  A robust accumulation of GFP expressing marrow-derived cells were found in the vicinity of 
new blood vessel formation and inflammation (FITC 20x).   
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Figure 6-12.  (A) At four weeks after surgery, the autologous tendon repair group showed organized collagenous tissue and a diminished cell infiltration 
compared with two weeks after surgery (Masson’s Trichrome 20x).  (B)  GFP expressing marrow-derived cells only in the vicinity of new blood vessels 
or areas of increased cellularity (FITC 20x).   
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Figure 6-13.  At sixteen weeks after surgery, the autologous tendon repair group showed diminished cell 
infiltration to near normal, and the remodeled tendon was organized collagenous tissue.  No GFP cells were 
observed in the tendon body (Masson’s Trichrome 20x). 
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Figure 6-14.  (A) At two weeks after surgery, the SIS-ECM repair group showed dense mononuclear cell infiltration, abundant blood vessels, and acute 
inflammation (Masson’s Trichrome 20x).  (B)  There was a robust accumulation of GFP expressing marrow-derived cells in the vicinity of new blood 
vessel formation and inflammation, as well as in the tendon body (FITC 20x). 
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Figure 6-15.  (A)  At four weeks after surgery, the SIS-ECM repair group showed diminished cellular infiltration compared with 2 weeks after injury, 
but greater cellularity than normal tendon.  The remodeling tendon is organized collagenous tissue (Masson’s Trichrome 20x). (B)  A robust 
accumulation of GFP expressing marrow-derived cells in the vicinity of new blood vessel formation and inflammation, as well as in the tendon body 
(FITC 20x). 
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Figure 6-16.  At 16 weeks after surgery, the SIS-ECM repair group showed that the cellularity had decreased 
to near normal, and the tendon consisted primarily of organized collagenous tissue with increased vascularity 
compared to normal tendon.  The inlays show the GFP expressing marrow-derived cells present within 
organized collagenous tendon tissue (Masson’s Trichrome 20x; insets FITC 20x). 
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6.3 FATE OF BONE MARROW DERIVED CELLS TO THE SITE OF SIS-ECM 
REMODELING IN A MOUSE ACHILLES TENDON MODEL 
An ECM scaffold changes the default mammalian wound healing process in part by recruiting a 
population of bone marrow derived cells that participates in the long-term remodeling process.  
To understand the role that these cells play in the remodeling process, it is necessary to examine 
the change in phenotype of these cells during the course of remodeling.  In a subcutaneous 
implant model,20 ECM scaffolds were found to recruit bone marrow derived cells that expressed 
endothelial cell markers 3 months after implantation.  It is possible that these cells represented a 
population of endothelial progenitor cells that originated in the bone marrow.  There were also 
cells that exhibited fibroblastic morphology, but this phenotype was not confirmed by cell 
surface markers or gene expression patterns.  When ECM was used for repair of a mouse 
Achilles tendon,296 the morphology and location of the bone marrow derived cells was consistent 
with a fibroblastic phenotype, but again, this was not verified by phenotypic analysis.  Therefore, 
the mouse Achilles tendon model was repeated to determine whether a portion of the bone 
marrow derived cells recruited to the site of ECM remodeling differentiate into fibroblasts.  In 
addition, to determine if degradation of the scaffold was important for the recruitment and 
persistence of the bone marrow derived cells, recruitment of bone marrow derived cells was 
compared between natural SIS-ECM and SIS-ECM that had been chemically crosslinked with 
carbodiimide. 
Phenotypic analysis to verify that a cell is a fibroblast is challenging because fibroblasts 
do not have a profile of gene expression or surface markers that is specific only to fibroblasts.  A 
few previous studies have defined fibroblasts based on expression of Col I, Col III, TN-C, and 
Thy-1.6, 84, 158, 159   SMA is a marker that can be associated with myofibroblastic cells.  All of 
these genes are expressed by a variety of cells, so the expression of any one of these genes does 
not guarantee that the cell is a fibroblast, however, for a cell to express several of these genes 
would certainly suggest that the cells are fibroblast-like.  Coupled with the expression of these 
markers, the loss of expression of a distinct hematopoietic marker (i.e., CD45) by a bone marrow 
derived cell would strongly suggest differentiation of the cells towards a fibroblastic lineage. 
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6.3.1 Study Design and Surgical Procedures 
All procedures were performed as approved by the Institutional Animal Care and Use Committee 
at the University Pittsburgh (Protocol #0405959) and the animal care complied with the NIH 
Guidelines for the Care and Use of Laboratory Animals.   
Fifty-six chimeric mice that expressed GFP in all of their bone marrow-derived cells 
(Section 7.2.2) were anesthetized with inhalant Isofluorane using a nose cone. The right hind 
limb of each animal was shaved and prepared for surgery using sterile technique. Under 
magnification, the Achilles tendon was exposed through an anterolateral skin incision and the 
surrounding paratenon incised. Two 7-0 Vicryl sutures (Ethicon, Somerville, NJ) were placed 
proximal and distal in the Achilles tendon. The spacing of the two sutures was 3 mm. A 2 mm 
segment of the tendon was resected and a 3 x 2 mm 3 layer multilaminate sheet of SIS-ECM was 
attached to the free ends of the tendon via the two placed sutures (Figure 6-10B).  Half of the 
animals received a natural SIS-ECM device (n = 28), and the other half received a device that 
had been chemically crosslinked by soaking the material in 10mM of ethyl-3(3-dimethylamino) 
propyl carbodiimide for 24 hours.32  So that the rate of ECM degradation could be compared 
between the natural and chemically crosslinked groups, 12 the devices from each group were 
made using SIS-ECM that was labeled with 14C.  Prior to closing the skin, the graft was 
rehydrated with sterile saline and the graft was tubularized around the free ends of the tendon 
(Figure 6-10B).  In all animals, the wound was closed in layers using 7-0 Vicryl sutures. Seven 
animals in each group (n = 4 native, n = 3 radioactive) at time points of 2, 4, 8 and 16 weeks 
after surgery.  During preparation of the specimens for histologic examination, technical 
difficulty was experienced while try to obtain histologic sections of the tendons treated with 
chemically crosslinked SIS-ECM, so only data on the native SIS-ECM is reported herein. 
6.3.2 Tissue Collection 
After sacrifice, the experimental and contralateral Achilles tendons were harvested from each 
animal and snap frozen.  The tissue was then embedded in OCT and 5µm sections were obtained.  
Unstained sections were mounted onto microdissection slides so that the GFP+ cells could be 
visualized and isolated by laser microdissection (mmiCellcut®, Molecular Machines Industries, 
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Knoxville, TN).  Adjacent sections were processed for staining with Masson’s Trichrome or 
immunostaining for GFP and CD45.  The Masson’s Trichrome stained slides were compared to 
slides stained for GFP and CD45 to assess the histological appearance of the tissue in the vicinity 
of positive cells. 
6.3.3 Collagen Expression by GFP+ Cells in the SIS-ECM Repair Group 
The unstained sections mounted onto microdissection slides for the 16 week animals (non-
radioactive) were viewed with FITC to detect the GFP.  Fifty regions were laser dissected from 
the section and transferred to Eppendorf tube with an adhesive cap.  The dissected regions were 
obtained from the midsubstance of the tendon and included cells that were spindle shaped in 
appearance.  Care was taken not to dissect cells that did not express GFP.  As a control, fifty 
regions were also microdissected at random from one native mouse Achilles tendon.  RNA 
isolation and RT-PCR was performed for GAPDH, Col I, Col III, TN-C, and SMA as described 
in Section 6.2.3.   
6.3.4 Immunofluorescent Staining for GFP and CD45 
Immunohistochemistry was performed using fluorescent secondary antibodies 
(AlexaFluor) to visualize GFP and CD45 together. Tissues were frozen in optimal cutting 
temperature solution (OCT, Tissue Tek) and sectioned on a cryostat at 8 μm and placed on 
slides. The cryosections were thawed to room temperature, fixed in acetone for 5 min at room 
temperature,  rinsed in PBS and then incubated in 1.5% goat serum (Vector) for 30 min in a 
37°C humidified chamber to block nonspecific binding of antibodies. Serum for blocking was 
goat serum.  Following incubation in blocking serum, sections were incubated in a solution with 
two primary antibodies in a 37°C humidified chamber for 1 hour and then rinsed in PBS.  The 
primary antibodies used were rat anti-mouse CD45 (#550539, BD Pharmingen) at a 1:40 dilution 
and rabbit anti-GFP (#Ab290, Abcam) at 1:500.   Sections were then incubated in a dual 
secondary antibody solution for 30 min in a humidified 37°C chamber and again rinsed in PBS.  
The secondary antibodies used were goat anti-rat IgG (#A11081, AlexaFluor) and goat anti-
rabbit IgG (#A11008, AlexaFluor).  The secondary antibodies were both used at dilutions of 
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1:500.  Following the final PBS rinse the slides were coverslipped with Vectashield containing 
DAPI (#H1200, Vector) to allow individual cell nuclear material to be visualized.  Each PBS 
rinse in the protocol was for 5 min at room temperature, replacing the PBS 3 times, with 
occasional agitation. 
6.3.5 Immunohistochemical Staining for CD45 
Immunohistochemistry was performed using the Vectastain advin-biotin peroxidase method 
(Elite ABC Kit, # PK-6100, Vector Laboratories). Tissues were frozen in optimal cutting 
temperature solution (OCT, Tissue Tek) and sectioned on a cryostat at 8 μm. The sections were 
thawed to room temperature, fixed in acetone for 5 min at room temperature and rinsed in PBS. 
The sections were then treated with 0.3% hydrogen peroxide in methanol at room temperature 
for 30 min to quench endogenous peroxidase activity, rinsed in PBS, and incubated in 1.5% 
rabbit serum (Vector) for 30 min in a 37°C humidified chamber to block nonspecific binding of 
antibodies. Following incubation in blocking serum, sections were incubated in the primary 
antibody (rat anti-mouse CD45, 1:20 dilution (#550539, BD Pharmingen)) in a 37°C humidified 
chamber for 1 hour and rinsed in PBS. Sections were then incubated in the secondary antibody 
(biotinylated rabbit anti-rat IgG, 1:500 dilution (#BA-4000, Vector)) for 30 min in a humidified 
37°C chamber and again rinsed in PBS. Sections were then incubated in Vectastain ABC reagent 
for 30 min in a humidified 37°C chamber, rinsed 3 times in PBS for a total of five minutes, and 
incubated in 4% diaminobenzadine substrate solution at room temperature while being viewed 
on a microscope until slides showed the desired darkness of antigen labeling; finally, slides were 
rinsed in DI water to stop the development of the diaminobenzadine substrate. Each PBS rinse in 
the protocol was for 5 min at room temperature, replacing the PBS 3 times, with occasional 
agitation. 
6.3.6 Histologic Findings for the Native Murine Achilles Tendon 
Histologically, the native Achilles tendon was composed of a highly organized collagenous 
matrix. Scattered spindle-shaped fibroblasts could be seen between highly aligned collagen 
fibers. In the paratendinous tissue, vascular structures were aligned longitudinal to the tendon.  
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No CD45 or GFP expressing cells were found in the intact Achilles tendon by immunostaining.  
RNA isolated by microdissection showed expression of Col I, but expressions of Col III and TN-
C were undetectable (Figure 6-17). 
6.3.7 Findings for the Native SIS-ECM Repair Group 
At 16 weeks after implantation, the remodeled tendon repaired with SIS-ECM showed GFP 
positive marrow-derived cells distributed uniformly throughout the graft segment.  Only a small 
portion of the GFP+ cells also expressed CD45, indicating that they were not of the 
hematopoietic cell lineage.  The green fluorescent marrow-derived cells within the body of the 
tendon typically exhibited a spindle-shaped morphology.  There were also a large number of 
GFP positive cells present in the peritenon (Figure 6-18).   
  The RNA isolated from the GFP+ cells located within the midsubstance of the tendon 
were shown to express Col I, Col III (although not in all samples), and SMA.  The expression of 
Col I was generally less than that found in normal tendon fibroblasts, while the expressions of 
Col III and SMA were greater in the bone marrow derived cells. TN-C was only found in the 
fibroblasts isolated from the normal tendon fibroblasts.  (Figure 6-17) 
6.3.8 Findings for the Crosslinked SIS-ECM Repair Group 
Due to complications with this group, including self mutilation, low humidity, and early death, 
the remodeled tendons in this group were not able to be used for histology or microdissection. 
 
6.3.9 Significance of the Differentiation of Bone Marrow Derived Cells 
It was shown in previous studies that an ECM scaffold recruits a population of marrow derived 
cells to the site of remodeling that does not participate in the normal mammalian wound healing 
response.  A small portion of the bone marrow derived cells to express CD45.   It is possible that 
CD45- bone marrow derived cells are included in the population of cells that were recruited to 
 61
the site of ECM remodeling, or that a population CD45+ bone marrow derived cells was recruited 
to the site and then differentiated into a mesenchymal cell.  The specific phenotypic origin of 
these cells is not clear, but it they may represent a population of mesenchymal progenitor cells.  
The gene expression profile of the GFPP+ cells could lead to several interpretations of the 
results.  One interpretation is that the bone marrow derived cells become site specific cells, in 
particular fibroblastic cells, and participate in the long term remodeling by synthesizing Col I 
and Col III.  Under this interpretation, the expression of SMA by these cells suggests that they 
exhibit a myofibroblastic phenotype or that they represent the population of circulating 
fibrocytes.     Another interpretation is that these bone marrow derived cells represent remnants 
of blood vessels that formed in the tissue during the initial phase of remodeling.  Col III and 
SMA are both markers for vascular tissue. 
Since these cells constitute a relatively small portion of the total cell population of the 
remodeled tissue (~30%), the full extent of their role in the remodeling process is not clear.  The 
cells certainly contribute to constructive remodeling by synthesizing new collagen and helping to 
organize the tissue structure, but they may also guide the behavior of other cells in the 
remodeling tissue by synthesizing growth factors or by direct cell:cell communication. 
 It is possible that since the application of interest for the study was the Achilles tendon, 
mechanical loading played an important role in the differentiation of these cells.  It has been 
shown in vitro that the presence of appropriate mechanical loading, as well as the administration 
of growth factors, can lead to differentiation of bone marrow progenitor cells into fibroblastic 
cells.  As bone marrow derived cells are recruited to the site of ECM remodeling, the local 
mechanical and biochemical environment causes at least a portion of these cells to become site 
specific cells.  This cell recruitment and differentiation process would explain, at least in part, the 
constructive remodeling response that has been repeatedly observed when ECM scaffolds are 
used for tissue reconstruction.  Additional work will be necessary to determine the specific bone 
marrow cell population(s) that are recruited, the specific environmental cues that guide the 
differentiation in different tissue locations, and the specific peptides that recruit the cells to the 
site of remodeling.  
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Figure 6-17.  Gel electrophoresis of PCR products from RNA isolated from mouse Achilles tendon that was 
repaired with SIS-ECM (Columms 1-3) and native Achilles tendon.  The bone marrow derived cells isolated 
from the SIS-ECM treated Achilles tendon expressed Col I, Col III (in two of three samples), and SMA.  The 
native fibroblasts expressed Col I and TN-C.  This suggests that the bone marrow derived cells become a 
myofibroblastic cell as opposed to a normal fibroblast. 
 
 63
 
Figure 6-18.  Histological sections of the mouse Achilles tendon 16 weeks after repair with SIS-ECM.  A) 
With immunofluorescence, it was shown that GFP+ bone marrow derived cells were still present in the body 
of the tendon (Green), but only a few of those cells were double stained for CD45 (Red).  The cellularity was 
increased in the tendon as shown with the DAPI staining (Blue).  B) The primary delete verifies that the 
staining observed was real.  C)  Immunohistochemical stainingof CD45 was also attempted to verify the 
results for the immunofluorescence, and again only a few scattered CD45 positive cells were detected.  D)  
The Masson’s Trichrome stain show the morphology of the tendon, which is generally organized and with 
dense collagen aligned along the longitudinal axis of the tendon.  The tissue is not a aligned as the native 
Achilles tendon. 
 64
7.0  IN VITRO MECHANICAL LOADING OF SIS-ECM 
This section describes the experiments that were performed in order to complete Specific Aim 1.  
Section 7.1 describes a study to determine the fiber kinematics of SIS-ECM under uniaxial and 
biaxial load.98  These results were used as a basis to choose the magnitudes of stretch that should 
be applied to SIS-ECM in vitro.  Since the collagen fiber architecture of SIS-ECM is specific to 
the behavior of the small intestine, a better understanding of the fiber kinematics was necessary 
in order to obtain a sense for the degree of strain that would be transferred from the fibers to the 
cells seeded on the scaffold.  Section 7.2 describes the development of an in vitro system that 
allowed scaffolds seeded with cells to be cyclically stretched.  Section 7.2 goes further to 
describe the effects of a variety of cyclic mechanical loading regimens on the expression of 
several matrix related genes by fibroblasts seeded on SIS-ECM and the possible implications of 
these changes for the remodeling of an ECM scaffold.101 
7.1 FIBER KINEMATICS OF SIS-ECM 
Despite extensive use, the pre-clinical and clinical applications of SIS-ECM and other 
biologically derived collagenous tissue scaffolds have yet to be optimized because of a limited 
understanding of the mechanical behavior of the native tissue.  In addition, cell seeding coupled 
with in vitro mechanical stretching is being considered as a means to modify biologic scaffolds, 
such as SIS-ECM, to make them more suitable for repair of load bearing tissues such as urethral 
slings 186, 187 and tendons and ligaments.7, 206  Ultimately, there is a need for constitutive models 
to guide the in vitro remodeling process and to predict how ECM scaffolds will behave in vivo 
immediately after implantation.  
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Structural approaches have been utilized to model tissue behavior under multiaxial 
loading states.70, 71, 238  Structural constitutive models integrate information on tissue composition 
and structure to avoid ambiguities in material characterization, and offer insight into the 
function, structure, and mechanics of tissue components. Moreover, extension of current 
structural approaches to multi-scale simulations can provide a means to estimate the force and 
displacement fields surrounding the constituent cell population resulting from tissue 
deformations.   Full realization of structural approaches, however, requires direct quantitative 
structural information to either validate structural model predictions or for direct implementation 
into the model.  Given the inherent complexity of soft tissues,69 a detailed knowledge of the fiber 
kinematics of the scaffold under load is essential for accurate model development.   
Several techniques have been developed to investigate the stretch and orientation of 
collagen fibers in tissue constructs in response to mechanical load, as well as how strain is 
transmitted from collagen fibers to cells.80, 154, 155, 247, 266, 275, 297  In general, these techniques 
incorporate a mechanical loading apparatus with an imaging system (confocal or polarized light 
microscopy) to visualize the nuclei of the cells 80, 247 or matrix fibers 154, 155, 266, 275, 297 under an 
applied load.  While these systems offer great opportunities for increased understanding of fiber 
kinematics and cell strain, their utility is limited when it comes to dense collagenous scaffolds 
such as SIS-ECM due to difficulty visualizing cells and fibers through the thickness of a 
specimen.  More importantly, these methods are not designed to provide angular distributions of 
large populations of collagen fibers, nor are they able to describe changes in these distributions 
with applied stress. 
Small angle light scattering (SALS) has been demonstrated to be an accurate means to 
determine fiber distributions in planar collagenous tissues.234, 237  In the current study, we 
investigated the fiber kinematics of SIS-ECM using SALS in response to uniaxial and biaxial 
strain states using a modified version of a biaxial stretching device integrated with the SALS 
apparatus 33.  An important advance from previous studies was the ability to obtain the angular 
collagen fiber distributions of SIS-ECM in real-time.  Moreover, SIS-ECM collagen fiber 
kinematics was evaluated under several biaxial stretching protocols to determine path 
dependency, as well as under uniaxial strain parallel and perpendicular to the preferred fiber 
direction.  Finally, an affine deformation model was applied to the experimental data to 
determine if the fiber kinematics of SIS-ECM could be predicted for the selected strain paths. 
 66
7.1.1 SALS-Biaxial Testing Instrumentation  
The testing system was modified from Billiar and Sacks 33 and consisted of a biaxial stretching 
apparatus (Figure 7-1) positioned such that SALS measurements of the tissue could be obtained 
while monitoring and controlling the strain level (Figure 7-2).    A mirror with a 1 cm diameter 
hole in the center was placed in front of the specimen at a 45° angle.  The hole allowed the laser 
beam to pass unimpeded to the specimen, while the angled mirror made it possible for a CCD 
camera to be set-up orthogonal to the path of the laser while allowing tracking of the strain 
markers.  The biaxial stretching device (Figure 7-1) consisted of 4 lead screws coupled via a 
series of gears to two computer-controlled stepper motors.  The test specimens were mounted 
using sutures that were threaded over pulleys that were free to rotate, thereby insuring that the 
loads on the specimen were evenly distributed and allowing shear to occur. 
A SALS system was used to determine the collagen fiber distribution of the test 
specimen.234  Briefly, the system consisted of a 4 MW HeNe (632.8 nm) continuous unpolarized 
wave laser.  As the beam passed through the tissue, it was scattered onto a ground glass screen.  
The resulting scattering pattern was recorded with a CCD camera system and was analyzed using 
custom software.  The scattering pattern, I(θ), represented the angular distribution of collagen 
fibers within the light beam envelope.234  For these experiments, a beam diameter of 1 mm was 
used to reduce variability that may have resulted from local differences in the collagen fiber 
distribution, which may have been detected during movement of the specimen. 
From the scattering pattern the preferred fiber orientation and an orientation index (OI) 
were calculated.  The OI has been defined as an angle about the preferred fiber direction that 
contained 50% of all fibers.234  In the present study, the OI was normalized to simplify 
comparisons between strain states.  The normalized orientation index (NOI) was defined as NOI 
= (90° - OI)/90° x 100%.  An NOI of 100% indicated that the collagen fibers in the tissue were 
perfectly aligned and an NOI of 0% indicated random fiber alignment. 
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Figure 7-1. Photograph of the Biaxial Mechanical Stretching Device (28cm x 33cm x 10cm). The biaxial 
stretching device consisted of 4 lead screws coupled via a series of gears to two computer-controlled stepper 
motors.  The specimens were mounted using sutures that were threaded over pulleys that were free to rotate.  
The geometry of the specimens is also shown.  The extensions of the specimen were folded to increase the 
suture retention strength, and four graphite markers were fixed to the specimen for strain tracking.  
 
(a) (b)  
Figure 7-2. A) Schematic and B) photograph of the SALS – Biaxial Fiber Kinematics Testing System.  The 
biaxial stretching device is mounted on the SALS device in a reservoir for holding PBS or other media.  The 
laser passes through a 1 cm hole in the mirror to impact the specimen.  The mirror is mounted at 45° to the 
specimen to reflect the image to a CCD camera which is set-up orthogonal to the path of the laser to allow 
simultaneous fiber architecture measurement and tracking of the strain markers.  This allows the user to 
obtain real-time measurements of the collagen fiber distribution under load. 
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7.1.2 SIS-ECM Specimen Preparation  
Briefly, the small intestine was mechanically delaminated to remove the tunica muscularis 
externa and the tunica mucosa.  The remaining tunica submucosa and basilar portion of the 
tunica mucosa consisted of extracellular matrix and the constituent cells.  The SIS-ECM was 
then disinfected and decellularized in a 0.1% peracetic acid (PAA)/4% ethanol solution followed 
by two rinses each in phosphate buffered saline (PBS) and deionized water.  This process yielded 
an acellular material, which was lyophilized and terminally sterilized with ethylene oxide (EtO).  
The thickness of the specimens was approximately 100 µm. 
The specimens for biaxial testing were prepared by cutting the SIS-ECM into 35 mm 
square crosses with extensions that were 15 mm wide and 10 mm long (Figure 7-1).  Fifteen 
specimens were cut such that the principal axes of the specimen was aligned with the 
longitudinal axis of the small intestine, which has been shown to correspond to the preferred 
collagen fiber direction (PD).215, 216, 237  The geometry of the specimen was chosen to reduce the 
stress concentrations at the corners of the specimen and obtain more uniform strain at the interior 
of the specimen, based on the results of finite element modeling.261  For uniaxial testing, the SIS-
ECM was cut into a dog bone shaped specimen with an 8 mm x 40 mm midsubstance.  A total of 
ten specimens were tested, with five samples cut such that the long axis of the specimen was 
parallel to the PD.  The other five specimens were cut such that the long axis was perpendicular 
to the PD, in other words, corresponding to the cross preferred fiber direction (XD).  For both the 
uniaxial and biaxial samples, the portion of the tissue used to mount the specimen to the testing 
device was folded to increase suture retention strength.  For strain tracking, four graphite 
markers (0.5 mm diameter) were fixed to the tissue in a 5 mm square pattern using cyanoacrylate 
adhesive. 
7.1.3 Fiber Kinematics Analysis Methodology 
The lyophilized SIS-ECM was mounted in the mechanical testing device with the strain axes 
aligned to the PD and XD directions.  The specimen was allowed to hydrate for 15 minutes in 
PBS prior to obtaining the initial reference dimensions.286  Unlike previous studies, it is was not 
necessary to clear the material to obtain SALS measurements, which eliminated the need for 
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repeated dehydration/rehydration cycles used in the previous study.33 The magnitude of stretch 
applied was monitored for each specimen, with accuracy within ±0.001.   For biaxial specimens, 
one of three loading paths was used to obtain an equibiaxial strain state (βEB in Figure 7-3).  
These paths included 1) stretching first in the PD to a stretch of 1.10 while maintaining the XD at 
a stretch of 1.00 (strip biaxial stretch to βPD), then stretching in the XD to a stretch of 1.10 while 
maintaining the PD at 1.10 (equibiaxial stretch at βEB), 2) stretching in the XD to 1.10 while 
maintaining the PD at a stretch of 1.00 (strip biaxial stretch to βXD), then stretching in the PD to 
a stretch of 1.10 while maintaining the stretch in the XD at 1.10 (equibiaxial stretch at βEB), and 
3) stretching simultaneously in both directions equally to equibiaxial stretch of 1.10 (equibiaxial 
stretch at βEB).  The loading paths were repeated five times, and the strain and collagen fiber 
distribution was obtained for the unloaded state, the strip biaxial state (if applicable), and the 
equibiaxial state of each cycle.    
For uniaxial fiber kinematics testing, all specimens were subjected to a stretch of 1.25 in 
intervals of 0.05 stretch.  The stretch states are referred to as βi where the subscript i indicates 
the percent strain.  Each loading path was performed once, and the collagen fiber distribution 
was obtained for the unloaded state and at each stretch interval. The transverse axis of the 
specimens was unconfined and the specimens were permitted to contract laterally.  Each stretch 
state was maintained for one to two minutes prior to obtaining the collagen fiber distribution.  
 
Figure 7-3.  Graphical representation of the biaxial stretching protocols utilized.  Angular fiber distributions 
were obtained at β0 and βEB for each test of each specimen, and at βXD and βPD when strip biaxial stretch was 
applied. 
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7.1.4 Strain Analysis  
Using the strain tracking data, the in-plane Green’s strain tensor E was computed as described 
previously.235, 236  Briefly, the in-plane deformation gradient tensor F was first computed in real 
time from the marker positions.  The Green’s strain tensor E was then calculated using E=½(FTF 
– I), where I is the identity tensor.  The shear angle α  was computed from E to an accuracy of 
±0.1° using 
   1 12
11 22
2E sin
1 + 2E 1 + 2E
−α =    (6-1). 
Polar decomposition of the deformation gradient tensor was performed in order to 
remove small rigid body rotations that occurred during experimentation.  The deformation 
gradient tensor is the product of the right stretch tensor U and the rotation matrix R as: 
     F = R·U    (6-2).  
For ease of comparison, the rotation is presented as the angle of rigid body rotation Θ , 
which was also calculated from components of F using: 
        1 21 12
11 22
F F tan
F F
− −Θ = +     (6-3).   
Note that the resulting experimentally obtained statistical fiber distributions were shifted 
back to their actual orientations by the angle Θ.  The components of U were then used as input 
for the affine deformation model.  The term UPD represents stretch in the preferred fiber direction 
and UXD represents stretch in the cross-preferred fiber direction.  Note that the use of U instead 
of F greatly simplified the following formulations with no loss of accuracy, since the rigid body 
rotations can easily be added back to get actual fiber angles in the deformed state, as done here. 
7.1.5 Approach for Modeling Fiber Kinematics  
For comparisons between the various loading conditions, it was necessary to determine the 
statistical distribution function of the angular distribution of collagen fibers, R(θ), as described 
previously.238  R(θ)dθ is defined as the fraction of collagen fibers oriented between θ and θ + dθ 
and subjected to the normalization constraint.  R(θ) was determined directly from the mean 
scattered light distribution I(θ) for each loading condition for each specimen using  
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    (6-4), 
where Δθ = π/180 since I(θ) is measured in discrete 1° increments.234  The statistical fiber 
distribution for the initial unloaded state, R0(θ) was then used as input to the affine deformation 
model.   
From the work of Billiar and Sacks,33 assuming a homogeneous affine deformation with 
stretch tensor U, the rotation of fibers at an angle θ in the reference (unloaded) state to the angle 
β in the deformed state is given by [Eq. (20) and (21) from 169] 
               11 12
22
Ucot( ) cot( ) U
U
β = θ + .   (6-5) 
Further assuming that the number of fibers within a differential angular element does not 
change from the reference state, dθ, to the deformed state, dβ, then NR(θ) dθ = NR(β) dβ 
where R0(θ) is the angular fiber distribution in the reference state and N is the total number of 
fibers in the region of interest.  This gives 
    θβ = θ β0
dR '( ) R ( )
d
    (6-6). 
Taking the derivative of Eq. (6-5) and utilizing the general form of the relationships from 
[Eq. (18) and (21), 169],  
      ( ) 22 2 2 2 211 11 12 22 22 12 22 2sinU cos 2U U U sin cos U U 1 sin U sin
θθ + θ θ + + θ = β  (6-7),  
we obtain a function for θβ
d
d
, which can then be substituted in Eq. (6) to obtain a transformation 
between the initial and the deformed angular fiber distributions that includes the shear term U12, 
 ( )β = θ θ + θ + θ + θ22 2 2 2 222 120 11 22 12
11 22 11
U U1R '( ) R ( ) U cos U sin sin U sin(2 )
U U U
 (6-8), 
where R’(β) is the angular fiber distribution in the deformed state as a function of the deformed 
state angle β.  In the case that U12 is small (as was the case in the present study), Eq. (6-8) can be 
reduced to the simplified form  
         ( )θβ = ⋅ θ + θ 2 2 2 20 PD XDPD XD
R ( )R'( ) U cos ( ) U sin ( )
U U
  (6-9), 
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in which PD of the specimen corresponded to the 11 direction of the specimen, and XD of the 
specimen corresponded to the 22 direction.  β represents the direction θ after deformation and is 
calculated by 169 
                                    
⎛ ⎞β = ⎜⎝ ⎠
XD
PD
Ucot tan( )
U
θ ⎟     (6-10).  
7.1.6 Statistics  
The correlation, r2, of the predicted angular fiber distribution from the affine model compared to 
the experimental data was assessed by calculating the ratio of the mean square error (MSE) to the 
variance of the experimental data.  To determine the MSE, R’(β) was first interpolated to obtain 
the affine transformation in terms of θ and is referred to as R’(θ).  The MSE was obtained by 
dividing the total sum of squares of the normalized intensity residuals between the 
experimentally determined deformed statistical fiber distribution, RD(θ), and the interpolated 
affine transformation, R’(θ), by the number of measurements, n, where n = 180 for the current 
experiments:  
          
θ θ∑180 2D i i
i=1
(R ( )-R'( ))
MSE =
n
   (6-11). 
The correlation, r2, was then calculated as  
    = − θ
2
D
MSEr  1
Var R ( )
    (6-12).  
To evaluate statistical significance of changes in the NOI, shear angle, and rigid body 
rotation, the one-way ANOVA with multiple comparisons was used at significance level of p = 
0.05.   For the comparison of NOI, a one-tail test was used for uniaxial and strip biaxial stretch, 
and a two-tail test was used for equibiaxial stretch. 
7.1.7 Biaxial Fiber Kinematics Results  
The experimental test system was able to precisely apply biaxial stretch regimens to βPD, βXD, 
and βEB, and uniaxial stretches to βi (Table 7-1).  The average NOI for all specimens in the 
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unloaded configuration was found to be 49.1% ± 3.1%, suggesting that the samples had a 
moderate degree of alignment.  For all biaxial loading conditions, no difference in the collagen 
fiber distributions was observed with successive cycles of stretch, so all data presented is for the 
fifth and final application of stretch.  It was observed that strip biaxial stretch to βXD led to a 
decrease in the intensity of the angular fiber distribution, which indicates a decrease in collagen 
fiber alignment (Figure 7-4A).  The NOI of 45.6% ± 3.7%, was significantly less than that for 
the unloaded condition (p<0.05), with a ΔNOI between the unloaded condition and that for strip 
biaxial load in the XD of -2.9% ± 1.0% (Table 7-2).  In contrast, it was found that 10% strip 
biaxial stretch to βPD led to an increase in fiber alignment in the preferred fiber direction as 
indicated by an increase in the maximum intensity for RPD(θ) (Figure 7-5A).  The NOI for 
specimens subjected to strip biaxial stretch in the PD was 51.2% ± 3.1%, which is statistically 
greater than the NOI obtained for the unloaded specimens (p<0.05).  The ΔNOI for specimens 
under this loading condition was 2.7% ± 1.8% (Table 7-2).  Due to variability in the PD from 
specimen to specimen, the preferred collagen fiber direction of the specimen did not always 
coincide with the direction of stretch.  However, it was observed that the PD of the specimen 
shifted toward the direction of stretch by 7.2° ± 5.7°.  For strip biaxial stretch in either PD or 
XD, the affine deformation model yielded predictions with high correlation to the experimentally 
derived angular fiber distributions.  The average r2 value for strip biaxial stretch in the PD and 
XD were found to be 0.984 ± 0.016 and 0.987 ± 0.009, respectively (Table 7-3).  The affine 
prediction, R’(βXD), for strip biaxial stretch in the XD (Figure 7-4A) showed a decrease in the 
intensity of the distribution that had a similar shape to the experimental data.  Likewise, the 
affine prediction for strip biaxial stretch along the PD, R’(βPD), showed a distribution that 
compared well to the shape of the experimentally determined collagen fiber distribution (Figure 
7-5A). 
When the specimens were stretched to βEB under equibiaxial stretch, no statistical 
difference was observed between the angular fiber distributions for equibiaxial stretch condition 
and the initial unloaded condition (p=0.31).  The NOI for 10% equibiaxial stretch was found to 
be 49.2% ± 5.3% with a ΔNOI of 0.3% ± 1.8% (Table 7-2).  Fig. 6-6 shows a set of typical 
statistical distribution functions for one specimen loaded to βEB under 10% equibiaxial stretch.  
Similarly, no statistical differences were detected between the NOI for unloaded specimens and 
specimens subjected to 10% equibiaxial stretch subsequent to a 10% strip biaxial stretch in either 
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the XD or PD (48.3% ± 3.6% and 49.7% ± 3.6%, respectively) (Table 7-2).  The angular fiber 
distributions for these loading conditions are shown in Figure 7-4B and Figure 7-5B, 
respectively.  Affine deformation fiber kinematics predicted the changes in the collagen fiber 
distribution with high correlation for 10% equibiaxial stretch.  The average r2 value was found to 
be 0.982 ± 0.020 (Table 7-3).  Representative predictions for each condition (shown in Figure 
7-4, Figure 7-5, and Figure 7-6) show that the affine predictions match the shape and intensity of 
the experimental data well.   
7.1.8 Uniaxial Fiber Kinematics Results  
For the uniaxially tested specimens, the initial NOI for all samples was found to be 51.3% ± 
3.8% in the initial unloaded configuration.  For samples stretched along the PD, the NOI tended 
to increase, and became significantly greater than the initial NOI at a stretch of 1.15 (p<0.05) 
(Table 7-2).  The maximum NOI was found to be 58.3% ± 2.3% at a stretch level of λ = 1.25, 
with a ΔNOI of 7.8% ± 2.7%.  The NOI and ΔNOI for each stretch interval is presented in Table 
2.  Due to the variability of the specimens, it was found that the PD deviated from the stretch 
direction by up to 12°.  The PD tended to shift and was found to be aligned with the direction of 
stretch after the sample had been subjected to 10% stretch (Figure 7-7A).   
When the samples were stretched along the XD, the fiber kinematics differed 
substantially.  At a stretch up to 1.15, the NOI was found to be significantly less than that 
observed for the unloaded condition (p<0.05).  However, when subjected to stretches of 1.20 or 
greater, no significant differences were found between the NOI for the unloaded and loaded 
conditions (Table 7-2).    In addition, a dramatic shift in the PD was observed.  Since the sample 
was prepared such that the long axis of the sample corresponded to the XD, the initial deviation 
of the PD from the stretch direction was large (70° ± 8.9°).  However, it was observed that the 
PD of the specimens had shifted towards the stretch direction by a stretch of 1.15 (Figure 7-8A).   
The affine deformation model did not provide a good prediction of the change in the 
collagen fiber orientation when the samples were subjected to uniaxial stretch in either the PD or 
XD (Table 7-3).  The predictions for stretch in the PD were good for low strain with an r2 = 
0.985 ± 0.011 for a stretch of 1.05, but the predictions became progressively worse with 
increased stretch to an r2 = 0.667 ± 0.100 for a stretch of 1.25.  The r2 value for stretch in the XD 
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was 0.880 ± 0.180 for a stretch of 1.05 and progressively decreased to 0.309 ± 0.230 for a stretch 
of 1.25.  Representative predictions for stretch in the PD and XD at a stretch of 1.25 are shown in 
Figure 7-7B and Figure 7-8B, respectively. 
7.1.9 Shear and Rigid Body Rotations  
The shear angle α was found to be 2.3° ± 1.7° for the 10% equibiaxial stretch of the specimens 
oriented with the preferred fiber alignment.  The shear angle was quite small regardless of the 
orientation of the specimens, which indicated that the assumption for the affine deformation 
model of negligible shear was appropriate for this study.  The shear angle was also found to be 
small for both uniaxial stretching conditions with values of α = 3.8° ± 2.6° for stretch in the PD 
and 1.9° ± 1.6° for stretch in XD.  The rigid body rotations Θ were found to be 2.4° ± 1.2°, 2.3° 
± 1.0°, and 1.8° ± 0.9° for equibiaxial stretch, strip biaxial stretch in the PD, and strip biaxial in 
the XD, respectively.  None of these values were statistically different from zero (p>0.05).  
Uniaxial stretch likewise caused only small rigid body rotations with Θ = 1.7° ± 0.8° for stretch 
in the PD and 0.5° ± 0.4° for stretch in the XD.  None of the values for α or Θ were found to be 
statistically different from zero (p >0.05). 
7.1.10 Summary of Current Experimental Approach and Findings  
The current study used a testing system which incorporated SALS measurements and strain 
tracking to obtain fiber kinematics of SIS-ECM under a number of uniaxial and biaxial strain 
paths.  A novel aspect of this experimental design was the ability to obtain real-time fiber 
kinematics by taking advantage of the natural translucency of SIS-ECM that has been 
lyophilized and then rehydrated in PBS.  To limit the complexity of the hardware, the system 
was designed to operate such that stretch-scan steps were required, however it can be envisioned 
that the entire system could be automated. 
The results of this study demonstrated that strip biaxial stretch in the preferred fiber 
direction (UPD:UXD = 1.10:1.00) led to an increase in the collagen fiber alignment, while strip 
biaxial stretch in the cross-preferred fiber direction (UPD:UXD  = 1.00:1.10) yielded a decrease in 
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collagen fiber alignment.  Equibiaxial stretch (UPD:UXD =1.10:1.10) did not substantially change 
the fiber distribution compared to the initial unloaded configuration.  Moreover, all three paths to 
βEB resulted in collagen fiber distributions that were not statistically different from the initial 
unloaded distribution for that specimen.  Differences in the collagen fiber distribution in 
response to different strain paths to the same deformation state would imply path dependency 
due to reorientation of the collagen fibers, a hypoelastic response.  Therefore, SIS-ECM exhibits 
hyperelastic behavior.70, 71, 92    For all biaxial strain paths, the change in the fiber distribution 
was able to be modeled with an affine deformation model with high correlation (r2 > 0.98).   
Under uniaxial stretch in the PD, the collagen fiber distributions initially rotated towards 
the direction of stretch with a progressive increase in the collagen fiber alignment.  The affine 
deformation model tended to predict distributions that were much more aligned than those 
obtained experimentally.  This lack of correlation may have been due to interconnectivity 
between the fibers.   Stretch in the XD led to an initial decrease in collagen fiber alignment 
followed by a subsequent increase in alignment to that observed in the unloaded condition, and 
the preferred fiber direction changed by up to 70° to align with the direction of stretch.  Similar 
large “ensemble” rotations of a collagen fiber population have been observed in bovine 
pericardium under strip biaxial stretch levels of 1.00:1.30.33  The changes in the collagen fiber 
distribution under uniaxial stretch in the XD could not be modeled using an affine deformation 
model due to the large apparent fiber rotations observed.    
7.1.11 Comparison to Previous Studies  
In a previous study,103 the affine deformation model corresponded well to the fiber kinematics 
for native SIS under equibiaxial stretch of UPD:UXD = 1.12:1.12 and strip biaxial stretch of 
UPD:UXD = 1.30:1.00.  However, strip biaxial stretch levels of UPD:UXD = 1.00:1.30 led to 
separation of the population into a dual-fiber distribution due to the presence of two 
subpopulations of collagen fibers which are oriented at approximately ± 30° from the PD,237 and 
could not be modeled with the affine deformation theory.  The differences in fiber kinematics 
and attainable strains are likely attributable to the preparation of the specimens.  In the earlier 
study, native untreated SIS-ECM was analyzed while in the current study, the SIS-ECM was 
treated with 0.1% PAA to disinfect and decellularize the material, lyophilized for storage, and 
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terminally sterilized with EtO.  The additional processing was done to mimic the methods used 
to manufacture a device composed of SIS-ECM that is clinically available (i.e. Oasis®, Cook 
Biotech).  PAA treatment has been associated with the formation of dityrosine and disulfide 
crosslinks due to its reactivity with oxygen-free radicals,45, 200, 283 which may alter collagen fiber 
motility.  Furthermore, in response to uniaxial tensile testing of ECM scaffolds, material that had 
been lyophilized and rehydrated tended to have an ultimate strain that was ~2/3 of that measured 
for hydrated material.91 
7.1.12 Limitations  
A limitation of the current study is that the maximum biaxial stretch that could be consistently 
applied was only 10% equibiaxial stretch, which was a consideration in the investigation of 
larger uniaxial strains.  However, this range of stretch represents the most likely level of stretch 
that the material will be subjected to in vivo.  The strains observed during normal motion for the 
rotator cuff and Achilles tendon, which are two of the most common sites treated with SIS 
clinically, are reported to be in the range of 1-5%,31, 85, 188, 230 with failure strain of the Achilles 
tendon midsubstance reported to be approximately 10%.291  Furthermore, early after surgical 
implantation, the patient is generally limited only to passive range of motion exercises or 
controlled loading conditions. 
An additional limitation was the single application of stretch for the uniaxial stretch 
experiments.  The choice not to precondition the specimen was based on the inability to 
repeatedly apply high magnitudes of stretch to the scaffold without causing damage to the 
scaffold.  Furthermore, over five cycles of 10% equibiaxial stretch, no differences were observed 
in the deformed collagen fiber distributions.  However, it is possible that the lack of 
preconditioning may have lead to a lack of reproducibility of the results. 
7.1.13 Applications  
The results of this study may prove useful in designing mechanical conditioning protocols to 
guide remodeling of SIS-ECM in vitro to develop scaffolds that are better suited for tissue 
specific repairs, such as tendons and ligaments.  These protocols must be designed with 
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appropriate magnitudes of stretch for specific types of ECM scaffolds as the fiber architectures 
and kinematics can vary greatly.  Based on this study, it is evident that stretch along the PD 
could lead to remodeling of the scaffold such that the collagen fibers could become more 
aligned.  It is still unknown how strain applied to collagen fibers within a naturally derived ECM 
scaffold is transferred to cells, which will ultimately determine the cellular response with regard 
to cell differentiation and tissue remodeling.217, 296  For in vivo applications it has been 
demonstrated that SIS-ECM is completely resorbed by 3 months after implantation in a dog 
model,229 with up to 40% of the mass loss occurring in the first two weeks.  Thus, fiber 
kinematics of an implant is likely to change very quickly after surgery.  However, the initial fiber 
kinematics is an important consideration for designing the initial strength of the material.  By 
applying a prescribed stretch to SIS-ECM during the manufacturing of lyophilized or 
multilaminate devices, the mechanical behavior of the device could be modified. 
A primary goal of the present study was to verify that the affine fiber kinematics model 
was valid for SIS-ECM under all relevant strain paths, so that fiber orientation data can be used 
to develop a structural model of SIS-ECM.238  Such a model could be used to predict the loading 
environment to which cells are exposed in the initial phase of migration into the scaffold for a 
variety of implantation sites.  A structural constitutive model would also be beneficial in the 
design of devices made from SIS-ECM for site specific tissue repair.  Results of the present 
study suggest that the affine model is appropriate for biaxial deformations within the strains 
applied.  However, based on the current results for uniaxial deformations, a non-affine approach 
that incorporates collagen fiber bending or variations in crosslinking density may have to be 
utilized to obtain a complete prediction of SIS-ECM fiber kinematics under large strains.4, 27, 56, 
73, 113, 114 
 
 
  
 
 
 
 
 
Table 7-1.  Components of the stretch tensor obtained for each biaxial and uniaxial stretch conditions. 
  PD XD EB 
  UPD UXD UPD UXD UPD UXD
β0 1.001 1.002 1.001 1.001 1.000 1.000 
βPD 1.100 1.002     
βXD   1.004 1.103   
B
i
a
x
i
a
l
 
βEB 1.103 1.102 1.102 1.102 1.102 1.101 
β0 1.000 1.002 1.000 1.000   
β 5 1.053 0.948 0.936 1.052   
β 10 1.105 0.856 0.841 1.103   
β 15 1.152 0.768 0.761 1.151   
β 20 1.203 0.667 0.692 1.200   
U
n
i
a
x
i
a
l
 
β 1.253 0.604 0.651 1.248   25
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Table 7-2.  Normalized Orientation Index (NOI) for biaxial and uniaxial stretch conditions and the ΔNOI relative to the initial unloaded condition.   Statistical 
significance relative to the unloaded NOI. ( † p < 0.05) 
 PD XD EB 
 NOI ΔNOI NOI ΔNOI NOI ΔNOI 
βPD 51.2% ± 3.1% † 2.7% ± 1.8%   49.7% ± 3.4% 0.0% ± 1.9% 
βXD   45.6% ± 3.7% † -2.9% ± 1.0% 48.3% ± 3.6% -0.4% ± 1.3% 
B
i
a
x
i
a
l
 
βEB     49.2% ± 5.3% 0.3% ± 1.8% 
β ס 49.8% ± 4.0%  53.1% ± 2.1%    
β 5 52.0% ± 4.0% 2.2% ± 4.2% 45.8% ± 4.3% † -6.9% ± 3.2%   
β 10 54.7% ± 3.1% 4.9% ± 3.8% 48.0% ± 4.8% † -5.1% ± 3.2%   
β 15 57.1% ± 3.7% † 7.3% ± 3.2% 46.7% ± 6.7% † -6.4% ± 4.9%   
β 20 57.6% ± 2.5% † 7.8% ± 1.8% 48.2% ± 6.5% -4.9% ± 5.2%   
U
n
i
a
x
i
a
l
 
β 58.3% ± 2.3% † 7.8% ± 2.7% 48.6% ± 9.4% -4.7% ± 10.8%   25
 
Table 7-3.  Correlation coefficients for the affine transformation predictions of collagen fiber distributions for uniaxial, strip biaxial, and equibiaxial stretch. 
 PD XD EB 
βPD 0.984 ± 0.016  0.981 ± 0.022 
βXD  0.987 ± 0.009 0.989 ± 0.007 
B
i
a
x
i
a
l
 
βEB   0.983 ± 0.018 
β 5 0.985 ± 0.011 0.880 ± 0.180   
β 10 0.964 ± 0.018 0.750 ± 0.225   
β 15 0.908 ± 0.036 0.692 ± 0.207   
β 20 0.717 ± 0.144 0.520 ± 0.289   U
n
i
a
x
i
a
l
 
β 0.667 ± 0.100 0.309 ± 0.230   25
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(a) (b)  
 
Figure 7-4.  Representative statistical distribution functions of the angular distribution of collagen fibers for specimens subjected to A) 10% strip 
biaxial stretch along the XD and then to B) 10% equibiaxial stretch.  The initial collagen fiber distribution is represented as R(θ), the collagen fiber 
distribution for strip biaxial stretch in the XD is represented as  RXD(θ), and the collagen fiber distribution for equibiaxial stretch is represented as 
REB(θ).  Strip biaxial stretch along the XD led to a widening of the collagen fiber distribution as indicated by the decrease in normalized intensity.  The 
average change in normalized orientation index was -2.9% ± 1.0%.  The prediction of the deformed statistical fiber distributions, R’(βXD) and R’(βEB), 
are also shown in each graph.  The predicted distribution accurately predicted the results observed experimentally. 
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(a) (b)  
 
Figure 7-5.  Representative statistical distribution functions of the angular distribution of collagen fibers for specimens subjected to A) 10% strip 
biaxial stretch along the preferred fiber direction and then to B) 10% equibiaxial stretch.  The initial collagen fiber distribution is represented as R(θ), 
the collagen fiber distribution for strip biaxial stretch in the PD is represented as  RPD(θ), and the collagen fiber distribution for equibiaxial stretch is 
represented as REB(θ).  Strip biaxial stretch of 10% in the PD led to an increase in the collagen fiber alignment as indicated by the increase in 
normalized intensity.  The average change in normalized orientation index was 2.7% ± 1.8%.  The prediction of the deformed statistical fiber 
distributions, R’(βPD) and R’(βEB), are also shown in each graph.  The predicted distribution accurately predicted the results observed experimentally. 
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Figure 7-6.  Representative statistical distribution functions of the angular distribution of collagen fibers for specimens subjected to 10% equbiaxial 
stretch.  The initial collagen fiber distribution is represented as R(θ) and the collagen fiber distribution for equibiaxial stretch is represented as REB(θ).  
No detectable change in the collagen fiber distribution was observed.  The average change in normalized orientation index was 0.3% ± 1.8%.  %.  The 
prediction of the deformed statistical fiber distribution, R’(βEB), is also shown in the graph.  The predicted distribution accurately predicted the results 
observed experimentally. 
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(a) (b)  
 
Figure 7-7.  Representative statistical distribution functions of the angular distribution of collagen fibers for specimens subjected to increasing 
magnitudes of uniaxial stretch up to 25% the PD.  The initial collagen fiber distribution is represented as R(θ) and the deformed collagen fiber 
distributions are represented as R5(θ), R10(θ), R15(θ), R20(θ), and R25(θ), where the subscript indicates the percentage of uniaxial stretch. A) The 
distribution tends to become more aligned and shifts toward the direction of stretch. B) The prediction of the deformed statistical fiber distribution at 
25% stretch, R’(β25), is also shown.  The predicted distribution predicted a degree of alignment much greater than that observed experimentally. 
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Figure 7-8.  Representative statistical distribution functions of the angular distribution of collagen fibers for specimens subjected to increasing 
magnitudes of uniaxial stretch up to 25% the XD.   The initial collagen fiber distribution is represented as R(θ) and the deformed collagen fiber 
distributions are represented as R5(θ), R10(θ), R15(θ), R20(θ), and R25(θ), where the subscript indicates the percentage of uniaxial stretch.  A) A 
dramatic shift in the preferred fiber orientation towards the stretching direction was observed, while the degree of orientation initially decreased and 
then tended to approach the NOI for the unloaded condition. B) The prediction of the deformed statistical fiber distribution at 25% stretch, R’(β25), is 
also shown.   The predicted distribution did not accurately predict the rotation or degree of alignment observed experimentally. 
(a) (b)  
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7.2 GENE EXPRESSION BY FIBROBLASTS SEEDED ON SIS-ECM SUBJECTED 
TO CYCLIC STRETCHING 
A number of in vitro models have been developed to study the basic interactions between cells 
and ECM in response to mechanical loading have shown that static and dynamic uniaxial tensile 
loading leads to regulation of matrix synthesis by cells,127, 166, 220, 221 increased alignment of 
fibroblasts and collagen fibers in the direction of stretch,80, 127 and enhanced mechanical 
properties of the scaffold.127, 147  The response of cells seeded on SIS-ECM to mechanical 
loading may more closely mimic the in vivo condition as compared to cells seeded on a purified 
collagen matrix because SIS-ECM retains its native 3-D tissue architecture98, 103, 237 and has a 
diverse biochemical composition including active growth factors, glycosaminoglycans, and 
fibronectin. 118, 120, 122, 274    Therefore, the research question was whether the response of 
fibroblasts seeded on SIS-ECM to mechanical loading in vitro alters the expression of various 
matrix related genes in such a way that would be predictive of the constructive remodeling 
response observed in vivo. 
The first objective of the present study was to investigate the changes in the gene 
expression of fibroblasts seeded on an SIS-ECM scaffold and subjected to cyclic mechanical 
loading regimens (5%, 10%, and 15% @ 0.1 Hz, 0.3 Hz, and 0.5 Hz).  The matrix related genes 
of interest were Col I, collagen III (Col III), SMA, TN-C, matrix metalloprotease-2 (MMP-2), 
MMP-9, TGF-β1, and TGF-β3.  It was hypothesized that the changes in expression of these genes 
will be consistent with a constructive remodeling response, specifically increased collagen 
expression, increased expression of TN-C and SMA, moderated expression of MMP-2 and 
MMP-9, and increased expression of TGF-β1 and TGF-β3. 
The second objective of the present study was to determine the changes in the mechanical 
behavior of the SIS-ECM scaffold during the course of the stretching experiment and attempt to 
correlate these changes with the gene expression patterns noted above.  The combined objectives 
of characterizing changes in the gene expression of cells on a scaffold and changes in the 
mechanical behavior of the scaffold required the development of a Cyclic Stretching Tissue 
Culture (CSTC) System with the capabilities of 1) operation in a cell culture environment (i.e., 
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maintaining cell viability without contamination) for extended periods of time, 2) application of 
precise displacement waveforms to the scaffold, and 3) continuous measurement of the load 
within the scaffold.  Development of the CSTC System was necessary so that load in each 
scaffold could be monitored independently.  This allowed for the application of identical 
preloads to each scaffold to reduce the effects of scaffold to scaffold variability.  Furthermore, it 
allowed for application of different magnitudes and frequencies of stretch to different scaffold 
simultaneously, thereby reducing the effects of cell preparation on separate experiments. 
7.2.1 Development of the Cyclic Stretching Tissue Culture System 
The CSTC system specifically developed for this study consisted of eight independently 
operating stations. (Figure 7-9)  Each station consisted of a culture chamber, tissue clamps, a 
linear actuator, and a load cell. Components were made from stainless steel and polycarbonate to 
allow sterilization and operation in a standard cell culture incubator for extended periods of time 
(days to weeks) without corrosion.  The bottleneck of a vented culture flask was fixed to the 
culture chamber to allow for gas exchange and aspiration of media.168  Tissue clamps with 
sinusoidal grips to limit slippage were connected to shafts that passed through the culture 
chamber walls to attach to the linear actuator and the load cell.  Self aligning connectors allowed 
for removal of the chamber from the incubator. 
The linear actuator (HSI, Inc., Waterbury, CT, Series 43000, Captive, Size 17) had a 
travel of 25.4 mm.  A miniature submersible load cell (Sensotec, Columbus, OH, Model 31, 
range 0-10 lb.) was chosen to monitor loads in the humidified environment. To control the 
motors and monitor loads, custom LabVIEW virtual instruments (VIs) were created to work in 
concert with a four axis stepper motor drive (National Instruments (NI), Austin, TX, MID-7604) 
that received signals from a motion control card (NI, PCI-7334), and an analog to digital data 
acquisition card (NI, PCI-6023E).218  These programs allowed the user to apply a preload to each 
sample independently, define the displacement profile, temporarily suspend operation for 
aspiration of the media, and process the data. 
The CSTC system has been in operation in a standard culture environment for a period of 
24 months without corrosion.  Stretching experiments have been conducted for up to 4 weeks 
with media changes every three days and no evidence of bacterial or fungal contamination.  The 
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testing system was shown to accurately control linear displacement and monitor load.  
Displacements were found to be accurate and repeatable within 0.02 mm.  With the overall 
displacements to be in a range of 2-6 mm, the repeatability has been within 1%.  Using a spring 
with a known spring constant of 0.42 ± 0.04 N/mm, the system yielded a calculated spring 
constant of 0.41 ± 0.01 N/mm (R2 > 0.99) following cyclic stretching for 72 hours.   
7.2.2 Methodology for Cyclic Stretching Experiments  
Porcine small intestine was harvested from market weight pigs (~110-130kg) immediately after 
euthanasia.  After rinsing, the tunica muscularis externa and the majority of the tunica mucosa 
were removed.  The remaining tunica submucosa and basilar portion of the tunica mucosa 
consisted of extracellular matrix and the constituent cells.  The SIS-ECM was then disinfected 
and decellularized in a 0.1% PAA/4% ethanol solution followed by two rinses each in phosphate 
buffered saline and deionized water.  This process yielded an acellular material, which was then 
lyophilized and terminally sterilized with EtO.  
Thirty SIS-ECM scaffolds were rehydrated in Dulbecco’s Modified Eagle Medium 
(Invitrogen, Life Technologies, Carlsbad, CA) supplemented with 10% bovine calf serum 
(HyClone, Logan, UT) and 1% penicillin/streptomycin (Invitrogen, Life Technologies) (DMEM-
CS) and cut into dog bone shaped specimens (Length: Width; 4.0 cm:0.8 cm).  The long axis of 
the specimen corresponded to the longitudinal axis of the small intestine, which has been shown 
to be the direction of preferred collagen fiber alignment.237   
All cell culture was performed at 37°C in a humidified incubator with 5% CO2.  Each 
specimen was seeded with 1.6x106 NIH 3T3 fibroblasts (0.5x106 cells/cm2) (ATCC, Manassas, 
VA) and 8 hours were allowed for cell attachment.  NIH 3T3 fibroblasts as opposed to a primary 
cell line because it was expected that an immortalized cell line would yield more repeatable 
results, minimizing the variability of the experiments.  The cell seeded scaffolds were transferred 
to the individual stations of the CSTC system, where they were allowed to acclimate in DMEM-
CS plus 50μg/ml ascorbic acid (Sigma-Aldrich, Inc., St. Louis, MO) (DMEM-AA) for 36-40 
hours prior to stretching.  After the acclimation period, the media was aspirated and fresh 
DMEM-AA was added to the specimens.  For all specimens, a 0.05N preload was applied to 
establish the zero position.  The scaffolds to be subjected to cyclic stretch were elongated to 
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baseline stretch of 2.5%. Cyclic stretching regimens were then applied to 5%, 10%, or 15% 
stretch at 0.1 Hz, 0.3 Hz, and 0.5 Hz for 20 minutes, 3 times daily at 8 hour intervals for 3 days.  
The frequency of stretch generally mimicked the frequency of stretch during normal walking,202 
and the magnitude of stretch was based on a study of the fiber kinematics of SIS-ECM in which 
5% uniaxial stretch caused rotation of collagen fiber towards the direction of stretch while 10% 
and 15% stretch increased the degree of alignment.98  Three SIS-ECM/cell constructs were 
subjected to each stretch regimen.  The cyclic load elongation data was obtained throughout the 
stretching period at a frequency of 10 Hz.  Elongation of the scaffold occurred as a result of 
cyclic stretching; therefore the specimens were returned to their zero configurations and the 
0.05N preload was reapplied at the end of each 24 hour period.  The displacement required to 
reach the preload was recorded.  The stiffness for the last 1 mm of elongation was calculated for 
the 10th cycle during each 20 minute interval.  Intermittent stretching and reapplication of the 
preload was performed based on preliminary studies which showed that continuous cyclic 
stretching of SIS-ECM led to a load relaxation of approximately 50% within 24 hours.   
7.2.3 RNA Isolation and RT-PCR  
The cell/scaffold complexes were snap frozen in 350μl of RLT solution from an RNeasy kit 
(Qiagen, Valencia, CA) and stored at -80°C until needed for further analysis (maximum of two 
days).  After thawing, an additional 350μl of RLT solution was added to the cell/scaffold 
complex and the suspension was vortexes.  The RLT solution was then removed, placed into two 
QIAshredder spin columns (Qiagen), and centrifuged at >8000 rpm for 2 minutes.  RNA was 
isolated from the flow through from the QIAshredder using an RNeasy kit (Qiagen) per the 
manufacturer’s instructions.  The concentrations of the resulting RNA solutions were measured 
using a spectrophotometer (BioMate 3, Thermo Spectronic, Rochester, NY) at 260nm.   
cDNA was synthesized from 1μg total RNA using the Superscript™ First-Strand 
Synthesis System for RT-PCR (Invitrogen, Life Technologies) per the manufacturer’s protocol.  
Semi-quantitative PCR was performed using the synthesized cDNA and gene primers specific 
for murine Col I, Col III, SMA, TN-C, MMP-2, MMP-9, TGF-β1, TGF-β3 and GAPDH (Table 
1) in EasyStart™ Micro100 tubes (Molecular BioProducts, Inc., San Diego, CA).  The PCR 
reactions were performed in an Eppendorf Mastercycler with a typical reaction having the 
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following parameters: initial five minute denaturation 95oC, a gene specific number of cycles  
(Table 7-4) consisting of 30 seconds denaturation at 95oC, primer specific annealing temperature 
(Table 7-4) for 30 seconds, and elongation at 72oC for 1 minute.   
The PCR products were separated on a 2% agarose gel, stained with ethidium bromide, 
visualized on a Kodak Image Station (Kodak, Rochester, NY) equipped with an ultraviolet light 
and digitally photographed using a 600WB35 filter.  Densitometry was performed using the 
Kodak 1D software.  Relative values were determined for each band and analyzed using GAPDH 
as the internal standard.  Examples of the bands obtained for Col I and Col III are shown in 
Figure 7-11. 
7.2.4 Actin Staining  
Six additional SIS-ECM scaffolds were seeded with NIH-3T3 fibroblasts and subjected to cyclic 
mechanical stretching as described above.  At the end of the stretching regimen, the specimens 
were fixed in 2% paraformaldehyde and cell membranes were permeablized with 0.1% Triton X-
100 (Spectrum Chemical, Gardena, CA) for 30 minutes.  The specimens were then washed with 
0.5% bovine serum albumin (BSA) (Sigma-Aldrich, Inc.), and incubated with Phalloidin Alexa 
488 (Sigma-Aldrich, Inc.) for 1 hour.  The specimens were washed again with 0.5% BSA and 
stained with Hoechst for 1 minute.  The specimens were then viewed with a confocal microscope 
(FluoView 1000, Olympus, Melville, NY).  Stacked digital micrographs were obtained at 40X 
and 100X and three-dimensional reconstructions were created using MetaMorph software 
(Molecular Devices, Sunnyvale, CA). 
7.2.5 Statistics 
Comparisons between the relative expression of each gene for fibroblasts were seeded on SIS 
without stretch and on TCP were made using a Student t-test with significance set at p < 0.05.  
For determination of the effects of magnitude and frequency of stretch on the gene expression of 
fibroblasts seeded on SIS and on the stiffness and elongation of the scaffold, a two-way ANOVA 
was performed with the Tukey post hoc analysis using the SAS® statistical software package 
(SAS Institute Inc., Cary, NC).  Again, statistical significance was set at p < 0.05. 
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Figure 7-9.  Photograph of the 8 station Cyclic Stretching Tissue Culture System.  From left to right, each 
station consists of a linear actuator, sterile stretching chamber with tissue clamps to submerge the scaffold, 
and a submersible load cell to monitor the load generated by the scaffold.  The tissue clamps are connected to 
the linear actuator and load cell with stainless steel shafts that pass through the wall of the stretching 
chamber and link to self aligning connectors. 
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Table 7-4. Sequences for murine specific primer sets and conditions for PCR reaction. 
Primer Sequence (5’-3’) Amplimer Size 
Annealing 
Temperature 
Number of 
Cycles Reference 
GAPDH S 
GAPDH AS 
CGCAACGACCCCTTCATTGACC 
CGATGAGCCCTTCCACAATGCC 432bp 55°C 35 
174 
Col IA S 
Col IA AS 
CGGGATCCGCCAAGAAGACATCCCTGAAG 
CGCAAGCTTTCATTGCATTGCACGTCAT 142bp 56°C 40 
174 
Col III S 
Col III AS 
CGCAAGCTTATGCAGCCACCTTGGTCAGTC 
CGGGATCCAGGCCAGGGTCACCATTTCTC 284bp 60°C 40 
246 
SMA S 
SMA AS 
CGGGATCCAAACAGGAATACGACGAAG 
CGCAAGCTTCAGGAATGATTTGGAAAGGA 135bp 56°C 40 
246 
TN-C S 
TN-C AS 
CGGATCCGTTTGGAGACCGCAGAGAAGAA 
CGCAAGCTTTGTCCCCATATCTGCCCATCA 365bp 56°C 40 
211 
MMP-2 S 
MMP-2 AS 
CGCAAGCTTCCTTTTTATGGCTTTCAGCA 
CGGGATCCCACAGAGTGAGGAGGGGAAC 322bp 64°C 40 
105 
MMP-9 S 
MMP-9 AS 
CGCAAGCTTGCAGACCAAGAGGGTTTTCT 
CGGGATCCCTGGAAGATGTCGTGTGAGTT 279bp 68°C 55 
105 
TGF-β1 S 
TGF-β1 AS 
CGCAAGCTTCTTCAGCTCCACACAGAGAAGAACTG 
CGGGATCCCACAATCATGTTGGACAACTGGTCC 391bp 68°C 45 
246 
TGF-β3 S 
TGF-β3 AS 
GCTCTTCCAGATACTTCGAC 
AGCAGTTCTCCTCCAGGTTG 439bp 48°C 45 
178 
 
 
7.2.6 Fibroblast Survival and Alignment 
Cells survived well after seeding on SIS-ECM and exposure to cyclic mechanical loading 
regimens.  A Live/Dead Assay showed that >95% of the cells on the scaffold were alive.  Actin 
staining showed that the fibroblasts responded to the cyclic stretching regimens by aligning 
along the direction of stretch.  It can be seen that the fibroblasts were elongated in the direction 
of stretch and contained prominent aligned actin filaments (Figure 7-10). 
7.2.7 Gene Expression in Response to Cyclic Stretching  
Changes in the Col I expression were found to be more dependent on the frequency of stretch 
than the magnitude.  Even though no difference were detected between the expression of Col I at 
a frequency of 0.1Hz stretch for all magnitudes compared to 0% stretch, the expression was 
significantly greater in response to cyclic stretch at 0.3 Hz and 0.5 Hz for all magnitudes of 
stretch.  There was a five fold increase in Col I expression at 0.5 Hz and 10% stretch.  At each 
magnitude of stretch, the Col I expression increased in a frequency dependent manner, except for 
the 15% stretch for which there was no statistical difference between 0.3 Hz and 0.5 Hz  (Figure 
7-11A & B) (Table 7-5). 
The expression of Col III was also found to be primarily dependent on the frequency of 
stretch, although the expression tended to decrease with increasing frequency and the extent of 
change was less dramatic.  The maximum change observed was approximately a 25% decrease 
between fibroblasts seeded on SIS-ECM stretched at 0.3Hz compared with no stretch. The only 
statistically significant differences were between stretching 0.3 Hz compared to both the no 
stretch condition on SIS-ECM and to stretch at 0.1 Hz (Figure 7-11C & D) (Table 7-5). 
SMA expression by fibroblasts seeded on SIS-ECM subjected to stretch at 0.3 Hz and 0.5 
Hz approximately doubled as compared to fibroblasts on SIS-ECM without stretch.  Statistical 
significance between the frequency groups were found for every comparison except for no 
stretch and stretch at 0.1 Hz, although the degree of change between 0.3 Hz and 0.5 Hz was 
small.  Furthermore, all magnitudes of stretch were found to significantly increase the expression 
of SMA by fibroblasts seeded on SIS (Figure 7-12A) (Table 7-5).  
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Tn-C expression was significantly decreased in response to cyclic stretching at 0.1 Hz as 
compared to TN-C expression by cells seeded on SIS-ECM without stretch.  Increased frequency 
then led to increased TN-C expression in a frequency dependent manner.  The differences 
between each frequency of stretch were statistically significant, but the expression at 0.3 Hz and 
0.5 Hz stretching were not significantly different from the 0% stretch condition.  No significant 
effects were detected with respect to the magnitude of stretch (Figure 7-12B) (Table 7-5).   
The expression of MMP-2 followed a similar pattern to that observed for Col III 
expression.  The decrease in expression was primarily a result of changes in the frequency of 
stretch.  The only significant differences that were detected were between 0.3 Hz and both the 
0% stretch condition and 0.1 Hz.  A 50% decrease in MMP-2 expression was observed for 
stretch of fibroblasts at 15% stretch at 0.3 Hz compared to fibroblasts seeded on SIS-ECM with 
no stretch (Figure 7-13A) (Table 7-5). 
MMP-9 tended to change in response to both magnitude and frequency of stretch.   No 
statistical differences were found between the stretch and no stretch conditions, but expression of 
MMP-9 stretch at 0.1Hz was found to be significantly less than expression at 0.3 Hz and 0.5 Hz.  
The difference was approximately 30%.  Although statistical significance was not detected, the 
expression of MMP-9 tended to increase in a magnitude dependent manner at frequencies of 0.3 
Hz and 0.5 Hz (Figure 7-13B) (Table 7-5). 
The changes in TGF-β1 expression were dependent on the frequency of stretch (p < 0.05) 
and approached dependence on the magnitude of stretch (p = 0.068).  In comparing the effects of 
frequency, the only comparison that did not show significant differences was between fibroblasts 
on SIS without stretch and fibroblasts on SIS subjected to 0.1 Hz stretch.  TGF-β1 expression 
increased in a frequency dependent manner.  With regard to the effects of the magnitude of 
stretch, TGF-β1 expression was significantly greater in response to 10% stretch and 15% stretch 
as compared to 0% stretch (Figure 7-14A) (Table 7-5). 
There significant increases in TGF-β3 expression at 0.5 Hz as compared to 0.1 Hz and 0.3 
Hz, and in response to 10% stretch as compared to 5% stretch.  Although no statistical 
significance was shown, TGF-β3 expression tended to increase in a frequency dependent manner 
at 10% and 15% stretch (Figure 7-14B) (Table 7-5). 
No differences were observed between the gene expression NIH-3T3 fibroblasts seeded 
on SIS-ECM with 0% stretch and fibroblasts seeded on standard TCP, except for SMA.  
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However, in the case of SMA, significance was due to the small standard deviation.  The real 
difference was less than 10% (Table 7-5). 
7.2.8 Changes in Stiffness of SIS-ECM Scaffolds  
In terms of the mechanical behavior of the fibroblasts seeded SIS-ECM, the stiffness and 
maximum load decreased during each 24 hour period (i.e., Initial to Interval 3, Interval 4 to 
Interval 6, Interval 7 to Interval 10) (Figure 7-15).  Upon reapplying the preload to the specimen, 
an increase in the stiffness and maximum load was observed, along with an increase in the initial 
elongation required to reach a preload of 0.05N  (ranging from 1.7% ± 0.9% for 15% stretch at 
0.5Hz to 11.4% ± 3.4% for 10 % stretch at 0.3 Hz) (Table 7-6).  This finding indicates that the 
specimens were experiencing permanent creep as a result of cyclic stretching.   In addition, the 
stiffness of the SIS-ECM scaffolds varied considerably (Table 7-6).  The stiffness increased for 
all specimens over the course of the experiments, but no dependence was shown between the 
percentage increase in stiffness and either the frequency or magnitude of stretch. 
A new CSTC System has been developed to study the effect of cyclic mechanical loading 
on cells seeded on a scaffold of interest.  The system is capable of independently applying cyclic 
load to eight cell-seeded scaffolds for periods lasting several weeks (preliminary studies have 
been performed for up to 4 weeks).  A major advantage of the new testing system is its ability to 
independently apply precise displacement waveforms to each specimen while accurately and 
continuously monitoring the loads.  This functionality provides real-time feedback about changes 
in the mechanical behavior of cell-seeded biologic scaffolds in response to cyclic stretching. 
7.2.9 Relevance of Changes in Gene Expression to In Vivo Remodeling  
The present study used the new CSTC system to investigate the expression of matrix-related 
proteins by fibroblasts seeded on SIS-ECM after the application of cyclic mechanical stretch as a 
basis for developing a better understanding of the role of mechanical loading in the constructive 
remodeling response observed with ECM scaffolds in vivo. The expression of Col I showed the 
most substantial increase in response to cyclic stretching in a frequency dependent manner, while 
the expression of Col III decreased slightly.  Most in vitro studies that have investigated the 
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expression of Col I and Col III have shown that both genes are increased in response to a 
mechanical stimuli.149, 184, 292  If the SIS-ECM environment in the presence of mechanical 
loading encourages a more normal Col III to Col I ratio210 and a more normal distribution of 
collagen fibril diameters in the healing tissue,35, 170 then this could partially explain the improved 
mechanical properties that have been reported in in vivo studies.180, 206 
The increased expression of SMA and TN-C, along with increased expression of TGF-β1, 
suggests that the fibroblasts seeded on SIS-ECM became more contractile with increasing  
frequency of stretch.61, 86, 298  If the fibroblasts exhibit a contractile phenotype, then the cells will 
tend to align along the direction of stretch,80, 127 and this alignment was confirmed in the present 
study.  It has been shown previously that alignment of fibroblasts leads to alignment of newly 
synthesized and existing collagen in the same direction.80, 192, 279  The results for TGF-β3 are 
difficult to explain since it is thought to play a role in scarless fetal wound healing and has been 
shown to reduce the contractility of cells.51, 204  The increased expression of TGF-β3 may 
moderate the contractile behavior. 
It has been suggested that MMP-9 is involved in collagen degradation, while MMP-2 is 
involved in collagen degradation and remodeling.250, 281  The present finding of increased 
expression of MMP-9 suggests that the collagen present within a SIS-ECM scaffold will be 
degraded and removed from the scaffold as opposed to being incorporated into the new host 
tissue.  Several studies that have investigated the degradation and fate of an ECM scaffold 
implanted in vivo have shown complete removal of the scaffold from the remodeling site within 
60-90 days after implantation accompanied by complete replacement with host tissue.100, 229  
Further study is necessary to understand and confirm this phenomenon. 
7.2.10 Significance of Changes in the Stiffness of the SIS-ECM Scaffolds 
The stiffness varied considerably from scaffold to scaffold, which is likely due to the natural 
variability of SIS-ECM.227  This study showed that the stiffness of each scaffold increased 
moderately over the course of each mechanical conditioning regimen, although there was no 
correlation between the magnitude and frequency of stretch to the magnitude of the increase in 
stiffness.  It was also shown that each scaffold became slack during the stretching regimen such 
that it was necessary to elongate the specimen in order to reapply the preload.  It is likely that 
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this elongation was solely responsible for the increase in stiffness that was measured, effectively 
leading to stiffness measurements further into the linear region of the load-elongation curve after 
fiber reorientation had taken place.7 
7.2.11 Limitations 
The present study was intended to evaluate the response of fibroblasts seeded on SIS-ECM to a 
range magnitudes of stretch are that structurally relevant to SIS-ECM based on the fiber 
kinematics results presented in Section 6.1 and a range of frequencies that are physiologically 
relevant.202  There may be other stretching regimens that would add to our knowledge of how 
fibroblasts seeded on SIS-ECM contribute to a constructive remodeling response.  In particular, 
the effects of strain rate on fibroblast gene expression may be important.  Furthermore, the CSTC 
system is capable of performing load control experiments and could also be easily modified to 
allow the application of more complex loading regimens to simulate in vivo conditions.139 
7.2.12 Application of Model to Other Cell Types 
The present study shows that cyclic stretching of fibroblasts seeded on SIS-ECM leads to 
changes in the gene expression that are suggestive of tissue remodeling towards a tendon or a 
ligament.  It has been shown that a wide variety of cells participate in the remodeling of SIS-
ECM scaffolds, beginning with neutrophils and macrophages in the immediate post-implantation 
period with a transition to tissue specific cell lineages (i.e., fibroblasts, smooth muscle cells, 
epithelial cells) within 4 to 8 weeks.21, 100  SIS-ECM also recruits bone marrow derived cells to 
the site of remodeling, and these cells participate in the long-term remodeling process.20, 296  This 
population of bone marrow derived cells may include mesenchymal progenitor cells that 
differentiate into site appropriate cells in response to the local mechanical environment.84, 161, 224  
Previous in vitro studies have shown that cyclic mechanical loading promotes differentiation of 
bone marrow cells into fibroblastic cells, smooth muscle cells, and osteoblastic cells.6, 109, 195  In 
future studies, a variety of different cell types will be tested using the new CSTC system expand 
our understanding of the role of mechanical environment on the remodeling of ECM scaffolds in 
vivo. 
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Figure 7-10.  3-D reconstruction of actin and Hoechst staining of NIH-3T3 fibroblasts cells seeded on SIS-
ECM and subjected to cyclic stretch of 10% at a frequency of 0.1Hz.  The cells generally align with the 
direction of stretch which is indicated by the white arrow.  (Background: 40X, Insert: 100X) 
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Figure 7-11.  Relative expression of (A) collagen I (Col I) and (B) collagen III (Col III) to GAPDH for the NIH-3T3 fibroblasts seeded on small intestinal 
submucosa in response to a number of stretching regimens (0%, 5%, 10%, 15%; 0.1Hz, 0.3 Hz, 0.5 Hz).  Col I expression significantly increased in 
response increasing frequencies of stretch.  Col III expression significantly decreased in response to stretch at a frequency of 0.3 Hz.  Cells cultured on 
TCP were used to determine the basal level of Col I expression.  The bands of (C) Col I and (D) Col III RT-PCR product from ethidium bromide gels 
are also shown. 
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Figure 7-12.  Relative expression of (A) smooth muscle actin (SMA) and (B) tenascin-C (TN-C) to GAPDH for the NIH-3T3 fibroblasts seeded on small 
intestinal submucosa in response to a number of stretching regimens (0%, 5%, 10%, 15%; 0.1Hz, 0.3 Hz, 0.5 Hz).  SMA expression significantly 
increased in response increasing frequencies of stretch.  TN-C expression tended to increase with an increase in the frequency to stretch.  Cells cultured 
on TCP were used to determine the basal level of SMA and TN-C expression. 
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Figure 7-13.  Relative expression of (A) matrix metalloprotease-2 (MMP-2) and (B) matrix metalloprotease-9 (MMP-9) to GAPDH for the NIH-3T3 
fibroblasts seeded on small intestinal submucosa in response to a number of stretching regimens (0%, 5%, 10%, 15%; 0.1Hz, 0.3 Hz, 0.5 Hz).  MMP-2 
expression significantly decreased in response to stretch at a frequency of 0.3 Hz.  MMP-9 expression tended to increase with increasing magnitude of 
stretch at frequencies of 0.3 Hz and 0.5 Hz.  Cells cultured on TCP were used to determine the basal level of MMP-2 and MMP-9 expression. 
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Figure 7-14.  Relative expression of (A) transforming growth factor-β1 (TGF-β1) and (B) transforming growth factor-β3 (TGF-β3) to GAPDH for the 
NIH-3T3 fibroblasts seeded on small intestinal submucosa in response to a number of stretching regimens (0%, 5%, 10%, 15%; 0.1Hz, 0.3 Hz, 0.5 Hz).  
TGF-β1 expression significantly increased in response increasing frequencies of stretch.  TGF- β3 expression tended to decrease at a frequency of 0.1 Hz, 
but tended to increase at frequencies of 0.3 Hz and 0.5 Hz.  Cells cultured on TCP were used to determine the basal level of TGF-β1 and TGF- β3 
expression. 
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Figure 7-15.  Load-elongation curves for one specimen subjected to cyclic stretch of 10% at a frequency of 0.1Hz.  The maximum load and stiffness 
decreased during each 24 hour period (i.e., Initial to Interval 3, Interval 4 to Interval 6, Interval 7 to Interval 10), and subsequently increased upon 
reapplication of the preload.  The initial elongation increased for the reapplication of the preload causing the curves to move to the right on the graph. 
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Table 7-5. Statistical comparisons from the Two-Way ANOVA for the effects of stretch frequency (A) and stretch magnitude (B) on the expression of 
matrix related genes.  * indicates significant differences at a p<0.05. 
A 0% - 0.1 Hz 0% - 0.3 Hz 0% - 0.5 Hz 0.1 Hz - 0.3 Hz 0.1 Hz - 0.5 Hz 0.3Hz - 0.5 Hz 
Col I  * * * * * 
Col III  *  *   
SMA  * * * * * 
TN-C *   * * * 
MMP-2  *  *   
MMP-9   * *   
TGF-β1  * * * * * 
TGF-β3   *  *  
B 0% - 5% 0% - 10% 0% - 15% 5% - 10% 5% - 15% 10% - 15% 
Col I * * *    
Col III       
SMA * * *    
TN-C       
MMP-2       
MMP-9       
TGF-β1  * *    
TGF-β3    *   
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Table 7-6.  Mechanical characteristics of fibroblast seeded SIS-ECM under various cyclic mechanical stretching regimens. 
 Initial Stiffness (N/mm) 
Final Stiffness 
(N/mm) %Δ Stiffness % Elongation 
 5% 
0.1 Hz 0.19 ± 0.06 0.22 ± 0.06 15.0% ± 17.5% 3.3% ± 0.6% 
0.3 Hz 0.32 ± 0.29 0.46 ± 0.45 44.4% ± 42.4% 2.7% ± 1.9% 
0.5 Hz 0.15 ± 0.03 0.19 ± 0.11 23.7% ± 39.8% 1.7% ± 0.9% 
 10% 
0.1 Hz 0.83 ± 0.34 1.06 ± 0.54 10.1% ± 17.2% 2.9% ± 0.7% 
0.3 Hz 0.99 ± 0.66 1.03 ± 0.46 12.8% ± 27.1% 3.5% ± 2.1% 
0.5 Hz 0.33 ± 0.24 0.57 ± 0.19 116.7% ± 108.2% 4.6% ± 0.5% 
 15% 
0.1 Hz 0.63 ± 0.85 0.79 ± 0.82 69.0% ± 76.4% 8.6% ± 4.3% 
0.3 Hz 0.56 ± 0.45 0.70 ± 0.49 40.8% ± 77.0% 11.4% ± 3.4% 
0.5 Hz 0.28 ± 0.20 0.45 ± 0.26 94.6% ± 90.0% 7.4% ± 4.6% 
7.3 RECRUITMENT AND MECHANICAL LOADING OF FIBROCYTES SEEDED 
ON SIS-ECM  
Some of the preceding studies have shown that SIS-ECM scaffolds used to repair a 
musculotendinous injury degraded within 60 days of implantation in a dog model and that there 
was an abundant infiltration of mononuclear cells that persists for more than one month.  The 
cells produced a dense organized collagenous tissue that was histologically similar to the normal 
Achilles tendon.  In a similar mouse study, it was shown that a portion of the mononuclear cells 
that were recruited to the site of ECM remodeling were derived from the bone marrow and 
remained as part of the new tissue even after 16 weeks of remodeling.  Although the exact fate of 
these cells was unclear, they showed some fibroblastic characteristics, including expression of 
Col I and Col III.  It is hypothesized that this phenotypic fate was a result, at least in part, of 
appropriate mechanical cues. 
A second set of studies focused on the role of mechanical loading in the remodeling of 
SIS-ECM in vitro.  First, the collagen fiber kinematics of SIS-ECM was determined to provide a 
basis for the magnitudes of stretch that should be applied to the SIS-ECM in vitro.  Second, the 
gene expression of NIH-3T3 cells seeded on SIS-ECM was evaluated in response to various 
magnitudes and frequencies of stretch using a new Cyclic Stretching Tissue Culture System.  
Despite being an immortalized cell line rather than a primary cell, mechanical stretching of these 
cells on SIS-ECM led to changes in the gene expression that were consistent with the 
constructive, site-specific remodeling response that was observed in the in vivo studies.  
Obviously, it would be desirable to evaluate the changes in gene expression by the same cells 
that are recruited in vivo to the site of ECM remodeling in response to mechanical loading.   
The goal of the present study was to evaluate the response to cyclic stretching by a 
population of cells that may be representative of the cells that are recruited from the bone 
marrow to the site of ECM remodeling, specifically the fibrocyte. The fibrocyte is a bone 
marrow derived mesenchymal cell that has been suggested to play an important role in wound 
repair.1, 46  Fibrocytes exhibit unique surface markers (Col I+, CD11b+, CD13+, CD34+, 
CD45RO+, MHC class II+, CD86+), have been shown to enter a wound bed from circulating 
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blood, and have been found in connective tissue scars.  These cells have also been shown to 
home to the site of injury, potentially due to recruitment by secondary lymphoid chemokine.1   
Fibrocytes express α-smooth muscle actin (SMA), and have been shown to contract collagen gels 
in vitro, suggesting that they may play a role to tissue organization.1  Fibrocytes also promote 
angiogenesis by secretion of proangiogenic factors such as VEGF, bFGF, interleukin-8, and 
platelet derived growth factor, and by releasing matrix metalloprotease-9 (MMP-9) to allow 
endothelial cell migration into tissue.112  An in vivo Matrigel study showed that fibrocytes and 
fibrocyte conditioned media both promote blood vessel formation.112   Many of these 
characteristics of fibrocytes are consistent with the behavior of cells that participate in 
remodeling of an ECM scaffold (i.e., recruitment of a bone marrow derived cell population, 
deposition and organization of collagen, promotion of angiogenesis). To simulate the in vivo 
ECM remodeling situation, fibrocytes will be isolated and a chemoattractant assay will be used 
to isolate fibrocytes that are recruited to the degradation products of SIS-ECM.  The recruited 
fibrocytes will then be seeded on SIS-ECM and subjected to cyclic stretching and the gene 
expression by those cells will be assessed. 
7.3.1 Fibrocyte Isolation 
Mouse perpherial blood (PB) was collected four times and bone marrow (BM) was harvested 
eight times.  All PB samples were collected in heparinized collection tubes while bones were 
gently crushed with a mortar and pestle to liberate the marrow.  All samples were then spun (at 
2,000 RPM for 30 min. at RT) through a density gradient (Lymphocyte Separation Medium) to 
isolate the buffy coat.  The low density mononuclear cells were then plated onto either collagen 
type I or fibronectin coated plates (2 PB and 6 BM on collagen and 2 PB and 2 BM on 
fibronectin) at densities ranging from 720,000 to 1,536,000 PB cells per well of a 6-well plate 
and from 3,090,000 to 95,000,000 BM cells per well.  Cells were then cultured at 37ºC with non-
adherent cells removed after 48 hours.  All cultures were maintained for at least 7 weeks with 
medium (DMEM + 10% FBS + 2% Pen./Strep.) changed 2-3 times per week. 
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7.3.2 Chemical and Physical Methods of ECM Degradation  
Lyophilized SIS-ECM was ground into a particulate form using a Wiley Mill as previously 
descibed.97  The resulting particulate SIS-ECM was then hydrated with phosphate buffered saline 
(PBS) plus Protease Inhibitors.  The hydrated particulate SIS-ECM was then be digested in 0.5N 
acetic acid at 120oC under 2 atmospheres of pressure. The temperature was ramped to 120oC in 
55 minutes, held at 120oC for 30 minutes, and was brought down to 60oC in 2 minutes and to 
room temperature within an additional 15 mintues.  The resulting digest was sequentially filtered 
through cheesecloth, Reeve Angel filter paper, and Whatman No.42 filter paper and then 
lyophilized and stored at -80oC.  The digest was resuspended at 200mg dry weight per ml in 
[0.1M sodium phosphate / 0.15M sodium chloride], pH 6.8 buffer, centrifuged at 12,000 RPM 
for 1 hour at room temperature, and then filtered through a 45μm syringe filter to recover the 
solubilized material. Total protein concentration were estimated with a BCA protein assay 
(Pierce Biotechnology) and the protein concentration was adjusted to 10mg/ml in [0.1M sodium 
phosphate / 0.15M sodium chloride], pH 6.8.  
An ammonium sulfate precipitation step was then used to remove those components such 
as glycosaminoglycans that increase the viscosity of the digest.  Extensive preliminary studies 
have been conducted evaluating the optimal concentration of ammonium sulfate to use in this 
precipitation step.  Interestingly, while fractionating the ECM digest by precipitating at 0% - 
100% saturation of ammonium sulfate at 10% intervals, we have identified biologic activities in 
fractions that precipitate at different ammonium sulfate concentrations. After precipitation, the 
pellets  were resuspended in [0.1M sodium phosphate / 0.15M sodium chloride], pH 6.8 plus 
protease inhibitors, snap frozen on dry ice, and stored at -80oC.  The supernatant and suspended 
pellet samples were then desalted, concentrated using either a Microcon YM-3 centrifugal filter 
device (molecular weight cutoff of 3,000 daltons) or float-a-lyzer dialysis devices (MWCO of 
3,000 daltons), and then assayed for total protein.  These fractions were then ready for screening 
for bioactivity in our chemotactic assays described below.    
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7.3.3 Boyden chamber assay for Chemotaxis  
The Boyden chamber assay was used for initial screening of ECM digest fractions.  The 
fibrocytes was starved for 12-16 hours prior to the beginning of the assay.  The filters used (will 
vary with each cell line) had a pore size of 3, 8 or 12 microns.  The filters were uncoated or 
coated with either gelatin or collagen.  A 48 well chamber was to be used for the assays. A 
sample of the unknown (i.e., a fraction of ECM) or a positive control chemoattractant was to be 
placed in each well beneath the filter, and then in the wells above the filter the fibrocytes were 
suspended in solution for 12 hours.  The nonrecruited were to be scraped from the top of the 
filters, and in preliminary experiments the filters were to be stained and cells attached to the 
underside of the filter were to be counted.  The stain used for this assay was DiffQuik. Assays 
were to be run as triplicates.  In separate experiments, the recruited cells were to be harvested for 
use in a cyclic stretching experiment using the CSTC System as described in Section 7.2.2.   
7.3.4 Fibrocyte Isolation Results  
Only one of the twelve cultures appeared to contain fibrocytes, as detected by spindle-shaped 
cell morphology, and that culture was sorted in an attempt to isolate the fibrocytes.  The cells 
were sorted using the phenotype of CD34+/CD45+/collagen type I+ using a FACSVantage cell 
sorter.  Due to a lack of staining with the collagen type I antibody, we were unable to identify 
any cells positive for collagen type I expression, and so cells that were double positive for CD34 
and CD45 were sorted.  Following the sort the cells were replated onto a fibronectin coated plate.  
All of the cells died within one week.  All other cultures developed mesenchymal-like cell 
morphology and were discarded.  Since no fibrocytes were isolated, this experiment could not be 
completed.  We are continuing our efforts to isolate fibrocytes so that this work can progress.  
We have been in contact with Dr. Richard Bucala, the investigator that first described the 
isolation and phenotypic characteristic of fibrocytes and he has offered suggestions on how to 
improve our results.  This is not a trivial task, and the remainder of the dissertation work was 
completed with the exception of the successful isolation of this cell population. 
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8.0  CONCLUSIONS 
This Dissertation examined two major aspects of the remodeling of a naturally occurring ECM 
scaffold, specifically the fate of bone marrow derived cells the site of ECM scaffold remodeling 
in a musculotendinous application and role of mechanical loading on the remodeling of an ECM 
scaffold using in vitro systems.  The following section summarizes the major findings from the 
studies performed and addresses the Specific Aims that were not completed.  Finally, potential 
future studies are described to extend this work. 
8.1 DISSERTATION SYNOPSIS 
8.1.1 Degradation of SIS-ECM in a Musculotendinous Application 
  The first component of this Aim was to quantify the rate of degradation of the SIS-ECM 
scaffold and relate the degradation to the remodeling events (i.e., cellularity, cell morphology, 
collagen organization).  It was found that the profile for degradation of SIS-ECM in the Achilles 
tendon location was similar to the profile observed for implantation to the urinary bladder.229  
The rate of degradation appeared be slightly faster for the Achilles tendon with no scaffold 
detected by 60 days after implantation.  Degradation was noted as early as 3 days post 
implantation, although the extent of degradation was only a few percent.  The degradation rate 
increased after 7 days of remodeling, which corresponded to the time that was required for an 
abundance of mononuclear cells consistent with macrophage morphology to enter the scaffold.  
The 14 day time point was the peak for cellularity, and the time frame from 7 – 14 days 
represented the period of most rapid ECM scaffold degradation.  Beyond 14 days, the cellularity 
of the scaffold began to decrease, and the rate of degradation also began to slow down.  By 28 
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days, the mononuclear cells begin to show site specific cell morphology, primarily as fibroblasts.  
The origin of the cells was not definitively determined in this study, nor did these cells show any 
fibroblastic markers.  A number of attempts were made to examine the phenotype of the cells 
(CD68 staining for macrophages, RNA isolation for Col I RT-PCR), but these analyses were 
conducted in retrospect and the specimens had already been fixed in 10% neutral buffered 
formalin which limited our options.  By 60 days, the scaffold was not detectable, and the 
organization and cellularity of the tissue approached that of the normal tendon.  An important 
factor in the remodeling response was the external bracing of the Achilles tendon during the 
early stage after surgery that immobilized the joint but still allowed the limb to bear load.  After 
the splint was removed, the animals were allowed unrestricted cage activity.  Based on previous 
studies, we speculate that without the presence of an appropriate mechanical environment, a 
constructive, site specific remodeling response would not have occurred.   
8.1.2 Recruitment and Fate of Bone Marrow Derived Cells 
In the early phase of ECM remodeling, a massive cell infiltration occurs with most of the cells 
originating in the bone marrow.  In a mouse Achilles tendon model, it was shown that a portion 
of these bone marrow derived cells remain at the site of ECM remodeling for at least 4 months; a 
finding that is at least contrary to normal mammalian wound healing.  In this model of tendon 
repair, the bone marrow derived cells generally did not express CD45 and expressed Col I, Col 
III, and SMA, suggesting several possiblilities.  First, these cells could be myofibroblastic cells 
or circulating fibrocytes that were recruited from the bone marrow.  Another interpretation is that 
these cells represent the remnants of blood vessels that formed during the initial phase of 
remodeling.   The facts that these cells were spindle shaped in appearance and were found within 
the body of the tendon favors the former explanation.  It is possible that the bone marrow derived 
cells responded to local environmental cues to become site specific cells.  Appropriate 
mechanical and biochemical cues would have led the cells to be fibroblastic cells.  In other 
locations, the cells differentiate into other cells types, such as endothelial cells as has been shown 
previously.  This site specific cell differentiation would help to explain, at least in part, the 
constructive remodeling process that occurs at the site of ECM remodeling. 
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8.1.3 Fiber Kinematics of SIS-ECM 
In order to develop a better understanding of the role of mechanical loading in the remodeling of 
an ECM scaffold, we first studied the collagen fiber kinematics of SIS-ECM under a number of 
loading regimens.  In general, the fiber kinematics behaved as expected, with increases in the 
degree of collagen fiber alignment when the scaffold was stretched along the preferred collagen 
fiber direction of the tissue, and with decreases in the alignment with stretch in the cross 
preferred direction.  In the initial phase of stretch, rotation of the collagen fiber population was 
observed towards the direction of stretch, and this was particularly noticeable for uniaxial stretch 
along the longitudinal axis of the intestinal.  Under equibiaxial and strip biaxial stretch, the ECM 
scaffold behaved in an affine manner, so the fiber kinematics could be modeled.  However, under 
uniaxial stretch, the fiber kinematics deviated from the affine deformation model.  For stretch 
along the preferred fiber direction, the experimentally obtained collagen fiber distribution was 
less aligned than the predicted value, which suggested a greater level of interconnectedness 
between the collagen fibers than assumed by the affine model.    The results for uniaxial stretch 
in the cross-preferred direction suggested a dramatic global fiber rotation towards the direction 
of stretch as opposed to a separation of the two subpopulations that have been identified in the 
SIS-ECM.  It is suspected that these results are an artifact of the experimental procedure.  It is 
possible that the lateral contraction that occurred in the unconfined direction led to a form of 
collagen buckling.  In this case, the fibers would fold forming a zig-zag arrangement.  At the size 
scale of the laser, this zig-zag arrangement could lead to a diffraction pattern that would appear 
to be aligned in the direction of stretch as opposed to the global longitudinal axis of the collagen 
fiber; however, this was not confirmed experimentally. 
 The results for the fiber kinematics of SIS-ECM under uniaxial stretch along the 
longitudinal axis of the SIS-ECM formed the basis for the selection of stretch magnitudes for in 
vitro mechanical loading studies of SIS-ECM seeded with fibroblasts.  The fiber kinematics 
results showed that at 5% stretch, the collagen fiber population experienced a global fiber 
rotation toward the direction of stretch with no increase in the degree of alignment.  It was 
assumed that this would translate to minimal stretch to the fibroblasts seeded on the SIS-ECM.  
At 10% stretch, the degree of orientation had increased by approximately 3%, and 15% stretch 
caused a 6% increase in the degree of orientation.  Above 15% stretch, the degree of alignment 
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did not increase.  It was assumed that 10% stretch would therefore cause a moderate stretch to 
the fibroblasts and a stretch of 15% would cause excessive stretch.  Future work will be 
necessary to determine the exact relationship between scaffold stretch and cell stretch. 
8.1.4 Cyclic Stretching of SIS-ECM Seeded with Fibroblasts 
The Cyclic Stretching Tissue Culture (CSTC) system was developed to apply a variety of cyclic 
stretching regimens to SIS-ECM seeded with fibroblasts.  Each of the 8 stations can apply a 
different loading regimen simultaneously, while a load cell monitors the force developed within 
the scaffold.  The CSTC system was used to evaluate the effects of magnitude and frequency of 
stretch on the expression of several genes that are involved ECM remodeling.  In addition, load 
vs. elongation behavior was obtained and the stiffness of the scaffold was calculated over time.  
The findings showed that cyclic mechanical loading of SIS-ECM seeded with fibroblasts led to 
significant changes in the gene expression.  The greatest change in expression level was for Col 
I, which showed a five-fold increase in expression at 0.3 Hz and 15% stretch compared to the 
non-stretched control.  SMA, TN-C, TGF-β1, and MMP-9 expression also tended to increase in 
response to cyclic loading.  Col III expression tended to decrease with cyclic stretching, which is 
contrary to other findings in literature.  However, decreased Col III expression is consistent with 
a constructive remodeling response since Col III is elevated in scar tissue.  Along with the 
increase in Col I, this in vitro study suggests that an ECM scaffold might restore the normal Col 
III/Col I ratio of remodeling tissue.  The increased expressions of SMA, TN-C, and TGF-β1 
suggest that the fibroblasts exhibit a contractile phenotype, such as that associated with 
myofibroblasts, which might contribute to the development of tissue organization.  Finally, the 
increased expression of MMP-9 suggests that the scaffold itself is degraded and removed from 
the site of remodeling, which is consistent with the in vivo degradation studies that have shown 
complete removal of the scaffold from the implant site within 60-90 days.   
 Interestingly, the changes in gene expression tended to be more dependent on the 
frequency of stretch rather than the magnitude of stretch.  This finding supports the need for 
additional work to determine the relationship between the magnitude of scaffold strain and the 
magnitude of cell strain.  Furthermore, it leads to questions regarding the importance of cycle 
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number and strain in the gene expression.  Additional studies are currently underway to attempt 
to address these questions.   
Another Specific Aim was to examine the changes in the collagen fiber architecture and 
kinematics of the SIS-ECM scaffold after seeding with fibroblasts and subjecting the scaffold to 
a regimen of long-term cyclic stretch.  A series of four experiments (n=8 per experiment) was 
attempted in order to accomplish this Aim, but technical difficulties forced reconsideration of 
this Specific Aim.  The first problem was that after 1-2 weeks of culture, there was a high 
incidence of scaffold damage due to cyclic stretch.  Another issue was cell proliferation that 
occurred over the period of the experiment.  After 2 weeks of culture, the media became acidic 
prior to the three day standard media change.  It is likely that the media would have to be 
changed daily, which was not economically feasible at this time.  Given the interesting results of 
the gene expression after a few days, it was decided that a better use of time and resources would 
be to begin looking at alternative stretching parameters and other cell types.   
8.1.5 Effects of Mechanical Loading on Fibrocytes 
Specific Aim 3 was designed to determine if one group of cells from the bone marrow, 
the circulating fibrocyte, is included in the population of bone marrow cells that are recruited to 
the site of ECM remodeling, eventually becoming a site specific cell.  These cells have been 
found to circulate through the body and are well characterized.  Due to technical difficulties in 
isolating these cells from circulating blood (mouse and human) and from bone marrow (mouse 
only), these studies were not completed (see Section 7.3.4).  If we can successfully isolate 
circulating fibrocytes, we will systematically address this question. 
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8.2 FUTURE STUDIES 
A number of future studies are suggested.  From the in vitro mechanical stretching experiments, 
a limited number of magnitudes, frequencies, and stretch/rest intervals were evaluated.  Future 
studies should expand on these parameters in order to development of a clearer understanding of 
the effects of mechanical loading on the behavior of cells on the scaffold.  Of particular interest 
is whether cycle number or strain rate has a greater effect on the behavior of cells seeded on SIS-
ECM, since it was found that frequency has a significant effect on the gene expression by cells.   
In addition, the analysis should be expanded beyond gene expression of subset of matrix 
related proteins to include protein synthesis, integrin expression, stress fiber formation, cell 
traction forces, cell migration, and matrix degradation.  A specific example of a future study that 
could contribute to the understanding of the mechanisms of ECM remodeling would be to 
investigate the effects of mechanical loading on the rate of cell migration into the scaffold.  As 
described in Section 2.3.1, when an ECM scaffold is implanted in vivo and immobilized, one key 
observation was that the interior of the scaffold was devoid of cells, whereas the scaffold subject 
to load had cells distributed throughout the remodeling ECM.  It would be interesting to 
determine whether cells migrate into an ECM scaffold faster in vitro when the scaffolds are 
cyclically loaded as opposed to static cell culture.   
Further study is also needed to understand the signals that cells receive from the SIS-
ECM both in the static condition and in response to mechanical loading.  It is possible that 
stretch exposes different motifs in the protein structure that signal the cells to behave in a 
different way.  In addition, additional study is needed to determine how the SIS-ECM scaffold is 
remodeled by the cells.  Specifically, analysis of the collagen fiber architecture and kinematics 
and biomechanical characterization of the remodeled SIS-ECM are needed. 
It will also be necessary to expand the studies to include other cell types that are involved 
in the remodeling of ECM scaffolds.  This could include primary fibroblasts from adjacent 
injured tissues, macrophages, and bone marrow derived cells. 
Future studies should also be conducted in order to determine the specific mechanisms by 
which the bone marrow derived cells are recruited to the site of ECM remodeling and the 
specific cells that are recruited.  There is now substantial evidence, albeit circumstantial, that the 
degradation of ECM scaffolds plays an important role in the constructive remodeling response 
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through the release of small peptides that exhibit bioactivity.  It is important to determine which 
peptides are involved in the recruitment of bone marrow derived cells and to verify these 
peptides form naturally. 
 It will also be important to determine the role of different environmental cues on the 
differentiation of those cells.   Specifically, the effects of the mechanical environment on the 
process of ECM remodeling is worthy of detailed study.  It is clear that the absence of 
mechanical loading is extremely detrimental to the remodeling process, but the advantages of an 
appropriate mechanical environment are not specifically understood.  It will be important to 
perform detailed studies comparing ECM remodeling under appropriate and deficient loading 
environments, including biomechanical analysis (passive and active, depending on the tissue), 
tissue architecture analysis, degradation rate, cell migration and phenotype, and others.  Based on 
the existing literature using ECM scaffolds for repair of tissues, it seems that these studies would 
be best performed in the Achilles tendon, urinary bladder, or body wall. 
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APPENDIX A 
PRODUCTION OF ECM SCAFFOLDS 
Developing the methods necessary to produce scaffolds derived from naturally derived ECM is 
challenging.  The scaffold must be completely decellularized and of a form that can be used 
surgically for a variety of pre-clinical and clinical applications.  This must be done in the most 
benign way possible to reduce adverse affects on the scaffold that might compromise its ability 
to promote a constructive remodeling response (e.g., compromised mechanical behavior, loss of 
collagen, glycosaminoglycans, and growth factors, etc.).  Furthermore, it is possible to modify 
the ECM material in such a way that allows us to answer important questions about the 
remodeling process.  This Appendix presents two sections describing different aspects of ECM 
scaffold production.  The first section deals with decellularization of tissues to obtain an ECM 
scaffold.99  The second section details the methodology for labeling ECM with 14C for 
subsequent use in degradation studies.102  The efficiency of labeling for a number of tissues that 
may be of interest for tissue engineering applications is described. 
A.1 DECELLULARIZATION OF TISSUES 
Biologic scaffolds derived from decellularized tissues and organs have been successfully used in  
both pre-clinical animal studies and in human clinical applications.24, 57, 77, 110, 153, 173, 199, 277  
Removal of cells from a tissue or an organ leaves the complex mixture of structural and 
functional proteins that constitute the ECM.  The tissues from which the ECM is harvested, the 
species of origin, the decellularization methods and the methods of terminal sterilization for 
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these biologic scaffolds have varied widely.  Each of these variables affects the composition and 
ultrastructure of the ECM and accordingly, affects the host tissue response to the ECM scaffold 
following implantation.  The objective of this manuscript is to provide an overview of the 
various methods that have been used to decellularize tissues, and the potential effects of the 
various decellularization protocols on the biochemical composition, ultrastructure, and 
mechanical behavior of the ECM scaffold materials.   
A.1.1 Rationale for Decellularization of ECM  
Xenogeneic and allogeneic cellular antigens are, by definition, recognized as foreign by the host 
and therefore induce an inflammatory response or an immune-mediated rejection of the tissue.  
However, components of the ECM are generally conserved among species and are tolerated well 
even by xenogeneic recipients.29, 30, 67, 82  ECM from a variety of tissues,  including heart 
valves,10, 37, 107, 143, 157, 231, 243 blood vessels,66, 72, 245, 267 skin,58 nerves,129, 148 skeletal muscle,38 
tendons,53 ligaments,290, small intestinal submucosa,11, 13, 162, urinary bladder,57, 90, 97, and liver182 
have been studied for tissue engineering and regenerative medicine applications.  The goal of a 
decellularization protocol is to efficiently remove all cellular and nuclear material while 
minimizing any adverse effect on the composition, biological activity, and mechanical integrity 
of the remaining ECM.   
Any processing step intended to remove cells will alter the native 3-dimensional 
architecture of the ECM.  The most commonly utilized methods for decellularization of tissues 
involve a combination of physical and chemical treatments.  The physical treatments can include 
agitation or sonication, mechanical massage or pressure, or freezing and thawing.  These 
methods disrupt the cell membrane, release cell contents, and facilitate subsequent rinsing and 
removal of the cell contents from the ECM.  These physical treatments are generally insufficient 
to achieve complete decellularization and must be combined with a chemical treatment.  
Enzymatic treatments, such as trypsin, and chemical treatment, such as ionic solutions and 
detergents, disrupt cell membranes and the bonds responsible for intercellular and extracellular 
connections.  Tissues are composed of both cellular material and ECM arranged in variable 
degrees of compactness depending on the source of the tissue.  The ECM must be adequately 
disrupted during the decellularization process to allow for adequate exposure of all cells to the 
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chaotropic agents and to provide a path for cellular material to be removed from the tissue.  The 
intent of most decellularization processes is to minimize the disruption and thus retain native 
mechanical properties and biologic properties. 
A.1.2 Description of Decellularization Protocols 
The most robust and effective decellularization protocols include a combination of physical, 
chemical, and enzymatic approaches.  A decellularization protocol generally begins with lysis of 
the cell membrane using physical treatments or ionic solutions, followed by separation of cellular 
components from the ECM using enzymatic treatments, solubilization of cytoplasmic and 
nuclear cellular components using detergents, and finally removal of cellular debris from the 
tissue.  These steps can be coupled with mechanical agitation to increase their effectiveness.  
Following decellularization, all residual chemicals must be removed to avoid an adverse host 
tissue response to the chemical.  The efficiency of decellularization and preservation of the 
extracellular matrix can be assessed by several methods.   The mechanisms of physical, 
enzymatic, and chemical decellularization for a variety of tissues are reviewed in the following 
sections and in Table A-1.  
Table A-1.  Commonly used decellularization methods and chaotropic agents.   
Method Mode of Action Effects on ECM References 
Physical    
Snap Freezing Intracellular ice crystals disrupt cell membrane ECM can be disrupted or fractured during rapid freezing 
108, 132-136, 232 
Mechanical force Pressure can burst cells and tissue removal eliminates cells Mechanical force can cause damage to ECM 
90, 182 
Mechanical Agitation 
Can cause cell lysis, but more commonly used to 
facilitate chemical exposure and cellular material 
removal 
Aggressive agitation or sonication can disrupt 
ECM as the cellular material is removed 
72, 90, 182, 243 
Chemical    
Alkaline; Acid Solubilizes cytoplasmic components of cells; disrupts nucleic acids Removes GAGs 
74, 83, 90, 223, 295 
Non-Ionic Detergents    
Triton X-100 Disrupts lipid-lipid and lipid-protein interactions, while leaving protein-protein interactions intact 
Mixed results; efficiency dependent on tissue, 
removes GAGs 
53, 57, 72, 74, 106, 182, 290 
Ionic Detergents    
Sodium Dodecyl 
Sulfate (SDS) 
Removes nuclear remnants and cytoplasmic 
proteins; tends to disrupt native tissue structure, 
remove GAGs and damage collagen 
58, 129, 130, 146, 182, 231, 290 
Sodium Deoxycholate More disruptive to tissue structure than SDS 58, 129, 130, 146, 182, 231, 290 
Triton X-200 
Solubilize cytoplasmic and nuclear cellular 
membranes; tend to denature proteins 
Yielded efficient cell removal when used with 
zwitterionic detergents 
58, 129, 130, 146, 182, 231, 290 
Zwitterionic Detergents    
CHAPS Efficient cell removal with ECM disruption similar to that of Triton X-100 
72 
Sulfobetaine-10 and -16 
(SB-10, SB-16) 
Exhibit properties of non-ionic and ionic 
detergents Yielded cell removal and mild ECM disruption 
with Triton X-200 
58, 129, 130, 146, 182, 231, 290 
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Table A-1. Continued. 
Method Mode of Action Effects on ECM References 
Chemical (cont’d.)    
Tri(n-butyl)phosphate Organic solvent that disrupts protein-protein interactions 
Variable cell removal; loss of collagen content, 
although effect on mechanical properties was 
minimal 
53, 290 
Hypotonic and 
Hypertonic Solutions Cell lysis by osmotic shock 
Efficient for cell lysis, but does not effectively 
remove the cellular remnants 
72, 104, 193, 276, 290 
EDTA, EGTA Chelating agents that bind divalent metallic ions, thereby disrupting cell adhesion to ECM 
No isolated exposure, typically used with 
enzymatic methods (e.g. trypsin) 
10, 95, 198, 262 
Enzymatic    
Trypsin Cleaves peptide bonds on the C- side of Arg and Lys 
Prolonged exposure can disrupt  ECM structure, 
removes laminin, fibronectin, elastin, and GAGs 
10, 95, 198, 262 
Endonucleases Catalyze the hydrolysis of the interior bonds of ribonucleotide and deoxyribonucleotide chains 
Exonucleases Catalyze the hydrolysis of the terminal bonds of ribonucleotide and deoxyribonucleotide chains 
Difficult to remove from the tissue and could 
invoke an immune response 
68, 72, 231, 290 
 
 
 
 
A.1.3 Physical Methods 
Physical methods that can be used to facilitate decellularization of tissues include freezing, direct 
pressure, sonication, and agitation.  Snap freezing has been used frequently for decellularization 
of tendinous and ligamentous tissue 132-136, 232 and nerve tissue.108  By rapidly freezing a tissue, 
intracellular ice crystals form that disrupt cellular membranes and cause cell lysis.  The rate of 
temperature change must be carefully controlled to prevent the ice formation from disrupting the 
ECM as well.  While freezing can be an effective method of cell lysis, it must be followed by 
processes to remove the cellular material from the tissue.  
Cells can be lysed by applying direct pressure to tissue, but this method is only effective 
for tissues or organs that are not characterized by densely organized ECM (e.g. liver, lung).  
Mechanical force has also been used to delaminate layers of tissue from organs that are 
characterized by natural planes of dissection such as the small intestine and the urinary bladder.  
These methods are effective, and cause minimal disruption to the 3-D architecture of the ECM 
within these tissues.  
Mechanical agitation and sonication have been utilized simultaneously with chemical 
treatment to assist in cell lysis and removal of cellular debris.  Mechanical agitation can be 
applied by using a magnetic stir plate, an orbital shaker, or a low profile roller.  There have been 
no studies performed to determine the optimal magnitude or frequency of sonication for 
disruption of cells, but a standard ultrasonic cleaner appears to be as effective at removing 
cellular material as placing the tissue on an orbital shaker.  In all of these procedures, the optimal 
speed, volume of reagent, and length of mechanical agitation is dependent on the composition, 
volume, and density of the tissue.   
A.1.4 Chemical Methods: Alkaline and acid treatments 
Alkaline and acid treatments are also used in decellularization protocols to solubilize the 
cytoplasmic component of the cells as well as remove nucleic acids such as RNA and DNA.  For 
example, acetic acid, peracetic acid (PAA), hydrochloric acid, sulfuric acid, and ammonium 
hydroxide (NH4OH) can effectively disrupt cell membranes and intracellular organelles 74, 83, 90, 
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223, 295.  However, these chemicals also dissociate important molecules such as GAGs from 
collagenous tissues.   
A variety of porcine tissues including small intestinal submucosa (SIS) and layers of the 
urinary bladder [e.g., submucosal layer (UBS) and the basement membrane plus tunica propria 
(UBM)] have been decellularized using peracetic acid at concentrations of approximately 0.10 to 
0.15% (v/v).  This treatment is highly efficient at removing cellular material from these thin 
ECM structures, and simultaneously also disinfects the material by entering microorganisms and 
oxidizing microbial enzymes.121, 225  The effects of PAA treatment on the ECM components have 
been studied extensively.  Several types of collagen including types I, III, IV, V, VI, and VII 
have been identified in SIS and/or UBM following treatment with PAA,13, 41 however, the 
microstructure of the collagen fibers has not been closely examined following such treatment.  
The ECM retains many of the native GAGs including hyaluronic acid, heparin, heparin sulfate, 
chondroitin sulfate A, and dermatan sulfate following PAA treatment.118  It has also been shown 
that laminin and fibronectin are present in the ECM scaffolds following exposure to PAA.41, 122  
PAA treatment preserves the structure and function of many of the growth factors that are 
resident in the ECM, including TGF-β, b-FGF, and VEGF.120, 274  PAA does not appear to have 
any adverse effect on the mechanical behavior of the biologic scaffold.90  Both SIS and UBM 
have been shown repeatedly to serve as excellent substrates for in vitro cell culture,15, 17, 122, 123 
and have been successfully used for many tissue engineering applications in vivo following 
decellularization and disinfection with PAA. 
A.1.5 Chemical Methods: Non-ionic detergents 
Non-ionic detergents have been used extensively in decellularization protocols because of their 
relatively mild effects upon tissue structure.  Non-ionic detergents disrupt lipid-lipid and lipid-
protein interactions, but leave protein-protein interactions intact so that proteins within a tissue or 
organ following non-ionic detergent treatment should be left in a functional conformation.248   
Triton X-100 is the most widely studied non-ionic detergent for decellularization 
protocols.  Exposure of tissue to Triton X-100 for periods ranging from several hours to 14 
days.53, 57, 72, 74, 106, 182, 290  Decellularization of tissues with Triton X-100 has shown mixed 
results.  When Triton X-100 was used to decellularize a heart valve, complete removal of nuclear 
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material was observed with maintenance of the valvular structure after 24 hours.  However, 
cellular material was found in the adjacent myocardium and aortic wall.107  With regard to the 
ECM components, Triton X-100 led to a nearly a complete loss of GAGs and decreases in the 
laminin and fibronectin content of the valve tissue.107  Other studies showed that Triton X-100 
was not effective at completely removing cellular material from a blood vessel, tendon, and 
ligament after exposure for up to 4 days.53, 72, 290  Nuclear material was observed by histological 
staining in all of the tissues and immunohistochemical staining showed the presence of the 
cytoskeletal protein vimentin in the anterior cruciate ligament after treatment with Triton X-100. 
It was found that treatment with Triton severely altered the tendon with respect to the tensile 
strength of collagen fibers isolated from the tendon.  Conversely, treatment with Triton showed 
no effect on the collagen content in the anterior cruciate ligament.  Treatment with Triton X-100 
also showed mixed results with regards to GAG content.  All GAGs were removed from a heart 
valve after treatment with Triton X-100 for 24 hours, while there was no difference in the 
sulfated GAG content in the ACL after treatment with Triton X-100 for 4 days.   Although Triton 
X-100 can be an effective decellularization method, its efficacy is dependent upon the tissue 
being decellularized and the other methods with which it is combined in a given decellularization 
protocol. 
A.1.6 Chemical Methods: Ionic detergents 
Ionic detergents are effective for solubilizing both cytoplasmic and nuclear cellular membranes, 
but tend to denature proteins by disrupting protein-protein interactions.248  The most commonly 
used ionic detergents are sodium dodecyl sulfate (SDS) and sodium deoxycholate and Triton X-
200.58, 129, 130, 146, 182, 231, 290   
SDS is very effective for removal of cellular components from tissue.  Compared to other 
detergents, SDS yields more complete removal of nuclear remnants and cytoplasmic proteins, 
such as vimentin.290  SDS tends to disrupt the native tissue structure, and causes a decrease in the 
GAG concentration and a loss of collagen integrity.  However, it does not appear that SDS 
removes collagen from the tissue.   
Sodium deoxycholate is also very effective for removing cellular remnants, but tends to 
cause greater disruption to the native tissue architecture when compared to SDS.  There are no 
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reports of tissue decellularization using sodium deoxycholate alone, so it is difficult to isolate its 
effect on the remaining ECM of a tissue.  Sodium deoxycholate was also combined with several 
zwitterionic detergents to decellularize nerve tissue, however, it was found that only a 
combination of Triton X-200 with the zwitterionic detergents yielded a completely decellularized 
nerve ECM.129, 130 
A.1.7 Chemical Methods: Zwitterionic detergents 
Zwitterionic detergents exhibit the properties of both nonionic and ionic detergents.  Zwitterionic 
detergents have a greater tendency to denature proteins than nonionic detergents.  Examples of 
zwitterionic detergents include 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate 
(CHAPS), which has been studied for decellularization of blood vessels,72 and sulfobetaine-10 
(SB-10) and -16 (SB-16), which have been used for decellularization of nerves.129, 130  CHAPS 
treated artery tissue has histologically normal collagen and elastin morphology and the collagen 
content appears to remain similar to that of the native artery.  CHAPS treatment results in a 
significant decrease in the burst pressure and maximum stress of arterial tissue, but the decrease 
is comparable to the burst pressure of arteries subjected to treatment with Triton X-100 and 
hypotonic/hypertonic solutions.72  Nerves have been decellularized with SB-10 and SB-16 in 
combination with Triton X-200, an ionic detergent.  The combined treatments had a less 
detrimental effect on the structure of the nerve ECM than combined treatments with Triton X-
100 and sodium deoxycholate.129, 130 
A.1.8 Chemical Methods: Tri(n-butyl)phosphate 
Tri(n-butyl)phosphate (TBP) is an organic solvent that is used to inactivate viruses in blood with 
out compromising  the coagulation factor activity.  Recently, TBP has been used as a chaotropic 
agent for decellularization of tendon and ligament grafts.  Treatment with TBP yielded complete 
removal of nuclear remnants from rat tail tendon and the midsubstance of an anterior cruciate 
ligament (ACL) graft, although the removal of cellular material was incomplete at the insertion 
of the ligament to bone.  TBP treatment did not have an effect on the tensile strength of collagen 
fibers isolated from the rat tail tendon as compared to native control, but for the ACL, treatment 
 126
with TBP led to a decrease in collagen content.53, 290  TBP appears to be a promising chaotropic 
agent for decellularization that has minimal effect on the mechanical behavior of the ECM and is 
worthy of further study. 
A.1.9 Chemical Methods: Hypotonic and hypertonic treatments 
Osmotic shock with a hypotonic or hypertonic solution such as deionized water or low ionic 
strength solution is used to lyse the cells within tissues and organs.72, 104, 193, 276, 290  A treatment in 
a hypotonic solution (10mM Trizma HCl, 5mM EDTA) for 11 hours followed by an 11 hour 
treatment in a hypertonic solution (50mM Trizma HCl, 1M NaCl, 10mM EDTA) can cause cell 
lysis, but does not generally remove the resultant cellular remnants from the tissue.  Additional 
enzymatic or chemical treatments are typically necessary to facilitate removal of cellular debris.  
Removal of DNA remnants from the tissue can be particularly difficult due to the “sticky” nature 
of DNA and its tendency to adhere to ECM proteins.   
A.1.10 Chemical Methods: Chelating agents 
Chelating agents, such as EDTA and EGTA, form a ring-shaped molecular complex that firmly 
binds and isolates a central metal ion.  It has been shown that divalent cations, such as Ca2+ and 
Mg2+, are necessary for cell attachment to collagen and fibronectin at the Arg-Gly-Asp 
receptor.93, 150, 151, 201.  By binding the divalent cations that are present at the cell adhesions to the 
ECM, these agents facilitate removal of the cellular material from the tissue.  EDTA is typically 
used in combination with trypsin. 
A.1.11 Enzymatic  Methods 
Enzymatic techniques of decellularization include the use of protease digestion, calcium 
chelating agents, and nucleases.10, 95, 198, 262  Trypsin is one of the most commonly used 
proteolytic enzymes in decellularization protocols.  Trypsin is a highly specific enzyme that 
cleaves the peptide bonds on the carbon side of arginine and lysine if the next residue is not 
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proline.273  The maximal enzymatic activity of trypsin occurs at 37°C and at a pH of 8.  
Nucleases such as endonucleases catalyze the hydrolysis of the interior bonds of the 
ribonucleotide or deoxyribonucleotide chains whereas exonucleases catalyze the hydrolysis of 
the terminal bonds of deoxyribonucleotide or ribonucleotide ultimately leading to the 
degradation of RNA or DNA.  
The efficacy of enzymatic treatments for removal or separation of the cellular material 
from the ECM has been studied for a variety of tissues.  Some studies show efficient removal of 
cellular material from porcine pulmonary valves after treatment with 0.05% trypsin/0.02% 
EDTA  for 24 hours with agitation,243 while other studies show less efficient decellularization.  
For example, porcine aortic valves subjected to treatment with 0.5% trypsin, 0.05% EDTA, 
0.02% Gentamicin, 0.02 mg/ml DNase and 20 µg/ml RNAse-A in Milli-Q water for up to 17 
hours at 37°C with agitation rendered the cells non-viable, but did not lead to removal of cellular 
material from the tissue.107   
Enzymatic methods of decellularization are not without an adverse effect upon the 
extracellular components of tissues and organs.  Prolonged treatment with trypsin/EDTA causes 
disruption of the normal pulmonary valve ECM structure, but does not affect the amount of 
collagen in the tissue.243  Trypsin/EDTA did, however, substantially reduce the laminin and 
fibronectin content of the ECM.   Prolonged exposure to trypsin/EDTA greatly decreases the 
elastin content and GAGs over time, with o-sulfated GAGs (chondroitin sulfates, keratin 
sulfates, and dermatan sulfates) showing the greatest decrease.  Such treatments can contribute to 
a decrease in tensile strength of up to 50%.  The remaining ECM after such enzymatic 
decellularization protocols still supports endothelial cell growth in vitro despite the removal of 
ECM components.107, 243  It is desirable to limit the duration of exposure to trypsin/EDTA 
treatments to minimize the disruptive effects upon the ultrastructure and composition of the 
ECM. 
A.1.12 Protease Inhibitors 
During the decellularization protocols, a number of proteases can be released from the disrupted 
cells.  For long duration chemical treatments, the presence of proteases can cause damage to the 
native ECM ultrastructure.  For this reason, it may be desirable to include protease inhibitors 
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such as phenylmethylsulfonylfluoride (PMSF), aprotonin, and leupeptin to the solutions in which 
the tissue is immersed.  A buffered solution of pH 7 to 8 further inhibits many proteases, and the 
control of temperature and time of exposure to the lysis solutions can also limit the activity of the 
proteases. 
A.1.13 Antibiotics 
One concern for long duration chemical decellularization methods is the presence of bacteria 
which can contaminate the remaining ECM material.  A number of protocols have therefore 
included antibiotic solutions such as penicillin, streptomycin, or amphotericin B 3, 116, 146, 167, 290.  
However, if antibiotics or antibiotic residues remain in the scaffold material after the 
decellularization protocol, regulatory agencies may consider the material a drug rather than a 
medical device, which increases the complexity of regulatory approval. 
A.1.14 Effects of Tissue Variability upon Decellularization 
The efficiency of a given decellularization method or protocol is dependent upon the tissue of 
interest.  Despite identical times of exposure and a greater concentration of trypsin (0.5% vs. 
0.05%), Grauss et al.107 found that a trypsin based decellularization protocol was ineffective at 
removing the cellular material from the rat aortic heart valve, while Schenke-Layland, et al.243 
showed complete removal of cells from a porcine pulmonary valve.  It is likely that subtle 
nuances in the application of the protocols had an effect on the efficiency of removal that are not 
entirely clear, such as the application of three-dimensional agitation by Schenke-Layland, et al. 
243. Studies by Cartmell and Dunn 53 and Woods and Gratzer,290 which studied decellularization 
of rat tail tendon and porcine ACL, respectively, showed differences in the decellularization 
results that cannot be easily explained by differences in the protocols studied.  These studies 
show that the effectiveness of decellularization and the alterations to the ECM vary depending on 
the source of the tissue, the composition of the tissue, the tissue density, and other factors.  For 
each tissue that is studied, it will be necessary to optimize the decellularization protocol to obtain 
acceptable cell removal. 
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A.1.15 Verification of Cell Removal 
There are a number of methods available to determine the efficiency of the removal of cellular 
material from tissues.  Standard histological staining with Hematoxylin and Eosin can serve as a 
first line of inspection to determine if nuclear structures can be observed.  Alternative 
histological stains such as Masson’s Trichrome, Movat’s Pentachrome, or Safrin O can be used 
to examine tissues for the presence of various cytoplasmic and extracellular molecules.  
Immunohistochemical methods can also be utilized for specific intracellular proteins, such as 
actin and vimentin.290 
Inspection for the presence of DNA can be performed by staining the specimen with 
DAPI or Hoechst, which are both fluorescent molecules that bind to the AT clusters in the minor 
groove of DNA.140, 142, 172, 226  In addition, assays using propidium iodide and PicoGreen have 
been developed to provide quantitative data regarding the presence of DNA within a 
specimen.160  DNA probe techniques have been utilized to track the fate of DNA from allografts 
after implantation, and could also be utilized to determine whether any DNA is present in the 
decellularized tissue.137  Polymerase chain reaction (PCR) or electron microscopic methods are 
possible but not typically used to examine for the presence of remnant nuclear material or 
cytoplasmic debris due to the technical complexity and expense of these procedures for routine 
work.   
In addition, to determining what has been removed, it is also necessary to confirm that 
desirable components of the ECM are retained, such as adhesion proteins like fibronectin and 
laminin, GAGs, growth factors, elastic fibers, and collagens which will be required for 
infiltration of the matrix by cells of choice in vitro or in vivo.  Mechanical testing of the ECM 
after treatment provides insight into presence and integrity of the structural proteins within the 
scaffold. 
Although the above methods provide important information regarding the effectiveness 
of the decellularization methods, the biologic consequences of small amounts of nuclear material 
or cytoplasmic debris within the remaining scaffold materials is unclear.  There are no reports 
showing a direct cause-effect relationship between such cellular remnants and an adverse host 
response to date. 
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A.1.16 Removal of Residual Chemicals 
The decellularization methods described above include a wide variety of chemicals which are 
used because of their inherent abilities to damage cells.  If the chemicals remain within the tissue 
in high concentrations after treatment, then it is likely that they will be toxic to host cells when 
the scaffold is implanted in vivo.  There is a need for development of assays to quantify the 
presence of residual chemicals in the decellularized scaffold material.  Similarly, some of the 
processes that have been described above include enzymes commonly derived from bovine 
sources (i.e., DNase, RNase, and trypsin).  These enzymes can potentially invoke an adverse 
immune response by the host. 
A.1.17 Conclusion 
Complete decellularization of most tissues will require a combination of physical, enzymatic, 
and chemical treatments, and the protocol will be dependent on the tissue of interest.  It is 
generally desirable to use the mildest protocol possible that yields an acellular material without 
disruption of the structural and functional component of the ECM.  A typical progressive 
approach would be to start with treatment in a hypotonic or hypertonic solution followed by a 
mild nonionic or zwitterionic detergent.  If necessary, an enzymatic treatment of tryspin/EDTA 
can be added prior to the detergent treatment to assist in breaking the bonds between the cell 
membranes and the ECM.  Finally, if these treatments are still inadequate to remove the cellular 
material, an ionic detergent such as SDS, deoxycholate, or Triton X-200 can be added to the 
decellularization protocol.   
It is clear that physical, enzymatic, and chemical treatments can have substantial effects 
on the composition, mechanical behavior, and host response to biologic scaffolds derived from 
the decellularization of native tissue and organs, and could have important implications for 
subsequent use for in vitro and in vivo applications.  The removal of adhesive proteins and GAGs 
from the scaffold could slow cell migration onto the scaffold and the bioactivity of the scaffold 
itself.  Disruption of the collagen network can change the mechanical behavior and collagen fiber 
kinematics of the scaffold, which can have an effect on the load bearing capacity of the scaffold 
and alter the mechanical environment to which the cells are exposed.  Degradation is another 
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important factor that relates to the mechanical behavior and bioactivity of the scaffold that could 
be affected by decellularization treatments.  The chemical treatments could compromise the 
ECM scaffold in a way that makes it more susceptible to enzymatic degradation in vivo, which 
would lead to a rapid decrease in the strength of the scaffold.   
It is unlikely that any combination of methods will remove 100% of all cell components 
from a tissue or organ.  However, it seems apparent that methods which remove most or all of 
the visible cellular material result in biologic scaffold materials that are safe for implantation.  A 
number of naturally occurring ECM devices and related decellularization protocols have 
received regulatory approval for use in human patients, including human dermis (Alloderm®, 
LifeCell, Corp.), porcine SIS (SurgiSIS®, Cook Biotech, Inc.; Restore®, DePuy Orthopaedics, 
Inc.), porcine urinary bladder (ACell, Inc.), and  porcine heart valves (Synergraft®, CryoLife, 
Inc.). 
All of the tissues that have been discussed thus far have been thin connective tissues 
which generally have a sheet-like shape.  The major challenge for decellularization of ECM 
scaffolds that must be addressed is removal of cellular material from complex 3-D organs while 
retaining their native architecture and morphology, as this will be a necessary step for using this 
technology for tissue engineering of whole organs.  One approach that has been considered is 
perfusing chaotropic agents through the existing vasculature of the intact organ.   The growing 
list of biologic scaffolds used for tissue engineering/regenerative medicine applications makes 
the continued development of decellularization protocols a clinically relevant and important 
effort. 
A.2 RADIOACTIVE LABELING OF ECM 
Scaffolds derived from extracellular matrix (ECM) have been widely studied for tissue 
engineering/regenerative medicine applications.  Pre-clinical studies have shown that many of 
these scaffolds facilitate constructive remodeling of injured tissues and circumvent the default 
process of scar tissue formation.24  Several scaffolds composed of ECM are now commercially 
available for human clinical application.57, 65, 110, 173, 196, 199, 203, 208, 277  The species of origin, tissue 
of origin, and processing techniques for the ECM can differ markedly for these devices.  It is 
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well established that factors such as method of decellularization, use of a chemical crosslinking 
agent, and means of sterilization can substantially affect the host response to the scaffold and the 
rate of scaffold degradation.99, 179, 205  The rate of ECM scaffold remodeling, the fate of scaffold 
degradation products, the source of cells that participate in the remodeling process, and the 
factors that influence the remodeling process are also important factors and are worthy of 
investigation. 
As an ECM scaffold is remodeled in vivo, the fate of the ECM components is rarely 
considered and therefore poorly understood, and methodologies for investigating the in vivo 
degradation of ECM scaffolds and fate of the degradation products are needed.  Radioactive 
labeling is commonly used in the pharmaceutical industry to determine the metabolic fate of 
developmental drugs.42, 171  The most frequently utilized isotope is 14C because it can be stably 
incorporated into organic compounds and has a long half-life of 5760 years.42, 171  With advances 
in detection techniques, such as accelerator mass spectrometry (AMS), exceedingly small 
amounts of a drug can be tracked.  14C levels on the order of 100 to 1000 times the 
environmental baseline level of 1.2x10-12 can be accurately determined with such methods.42, 171  
A similar approach may be useful when applied to in vivo ECM scaffold remodeling.  The 
predominant protein within ECM scaffolds is Type I collagen, which in turn is rich in glycine, 
proline, and hydroxyproline.  Proline is internalized by cells and converted to hydroxyproline 
during the intercellular production and maturation of collagens.  Proline may be broken down 
into CO2 or utilized for the synthesis of glutamine, glutamate, ornithine, and arginine.229  
Hydroxyproline released from tissue cannot be recycled biosynthetically into proteins,255 but 
may be degraded to metabolic precursors and indirectly incorporated into other amino acids.229  
Therefore, 14C labeled proline is a logical choice to incorporate radioactivity into ECM derived 
scaffolds.  The present manuscript describes a method for labeling porcine ECM with 14C for use 
in scaffold fabrication and quantifies the amount of radioactivity incorporated into a number of 
clinically interesting porcine tissues. 
 133
A.2.1 Study Design and Preparation of 14C labeled ECM 
A total of six pigs had 14C labeled proline incorporated into most of their tissues during the first 6 
months of life.  After sacrifice, a number of organs were harvested, including the aorta, heart, 
urinary bladder, small intestine, mesenteric lymph nodes, liver, spleen, pancreas, and trachea, for 
isolation of extracellular matrix and determination of 14C levels within each tissue.  The specific 
methods for labeling the ECM with 14C and quantifying the amount of 14C within the recipient 
tissues are described below. 
The production of radioactively labeled tissues by injection of 14C labeled proline into 
growing pigs was performed as part of this study was approved by the University of Pittsburgh 
Radiation Safety Committee and Institutional Animal Care and Use Committee of the University 
Pittsburgh (protocol number 0309053).  The animal care complied with the NIH Guidelines for 
the Care and Use of Laboratory Animals.   
The methods for labeling the porcine tissues with 14C have been reported previously,100, 
229.  Briefly, 14C labeled proline (Amersham Life Science; 256mCi/mmol, 50µCi/ml) was diluted 
1:10 in PBS.  Piglets were given weekly intravenous injections (i.e., ear vein) of 10µCi of 14C 
labeled proline from 3 to 26 weeks of age. The pigs were then sacrificed and a number of tissues 
were harvested including the heart, aorta, small intestine, urinary bladder, liver, lymph nodes, 
spleen, pancreas, heart, and trachea.  These tissues were then processed (e.g., cleaned, 
decellularized, and disinfected) to isolate the desired ECM scaffold material.  The 14C levels of 
each ECM scaffold were then determined. 
A.2.2 Liquid Scintillation Counting 
The radioactivity in each sample of interest was measured by liquid scintillation counting (LSC) 
using a LS1800 B-counter (Beckman Coulter, Somerset, NJ).  For the SIS-ECM graft at time 
zero, the remodeled SIS-urinary bladder tissue, the remodeled SIS-tendon tissue, and all other 
harvested tissues, approximately 80 mg of tissue was incubated with 1 ml of Solvable (Packard 
Instruments, Meriden, CT) at 50°C for 2-4 hours.  Ten ml of scintillation fluid was then added to 
each sample and the radioactivity was determined.  The tissue radioactivity was reported as 
CPM/g. 
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A.2.3 Efficiency of 14C Labeling 
Determination of the 14C levels by liquid scintillation counting (LSC) in the tissues harvested 
from the pigs after 23 weekly injections of 14C labeled proline showed variability in the level of 
labeling, with the tissues falling into three general groups (Table A-1).  ECM from the aorta, 
liver stroma, SIS, and tracheal cartilage contained the highest levels of radioactive proline at a 
level of approximately 3500 CPM/g.  The second group included ECM scaffolds prepared from 
the aortic valve, pulmonary valve, left ventricle wall, urinary bladder matrix, lymph node, 
pancreas, and tracheal mucosa.  This second group showed 14C levels at approximately 1500 
CPM/g.  The last group included only the ECM from the spleen, which showed 14C at 
background levels despite weekly intravenous injections of radioactively labeled proline.   
A.2.4 Significance of 14C Labeling 
Scaffolds derived from naturally occurring extracellular matrix proteins have received a great 
deal of attention in the field of tissue engineering due to their innate bioactivity and the fact that 
are completely degradable.  In addition, site-specific, constructive remodeling occurs with 
minimal scar tissue formation.13, 25, 76, 128, 152, 163  Even when ECM scaffolds are chemically 
treated to yield a more permanent, nondegradable device, the possibility of partial degradation 
still exists.  The present manuscript describes a method for labeling ECM with 14C such that the 
extent of degradation of scaffolds constructed from this ECM can be accurately determined and 
the fate of the degradation products can be followed. 
The 14C concentration of an ECM scaffold can be increased by at least three orders of 
magnitude by the intravenous injection of radiolabeled proline during the rapid growth period of 
pigs; however, not all tissues are labeled equally.  14C was not detected above baseline levels in 
splenic ECM, while aorta, liver stroma, SIS, and tracheal cartilage and had 14C concentrations 
approximately 500 times greater than baseline.  This inter-tissue difference may be due to the 
extent of organ development at birth and/or the rate of collagen turnover for the specific tissues.  
The aorta, liver, and small intestine are organs with high metabolic activity so they are constantly 
depositing new collagen.  The high levels of 14C in tracheal cartilage were surprising since 
cartilage does not remodel very rapidly.  However, the trachea must develop mechanical 
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integrity quickly, so an abundance of collagen may be synthesized early in life, and then remain 
at the site for a prolonged period of time.  Due to the differences in labeling efficiency, it is 
necessary to evaluate the level of 14C in each tissue of interest prior to implantation.   
There are a number of advantages to labeling scaffolds with 14C to monitor their 
degradation.  First, the 14C is integrally bound to the scaffold at the molecular level, so 
breakdown of the ECM is required for its release.  By binding the radioactive isotope to proline, 
it is a specific and accurate determinate of ECM turnover.  Due to the development of detection 
methods like accelerator mass spectrometry, this model is exceedingly sensitive to changes in the 
14C concentration.  Therefore, this approach poses minimal to zero risk to the subject and the 
investigator. 
The approach of labeling ECM with a radioactive isotope is not without limitations.  
First, this approach requires access to facilities that are able to house and properly handle 
radioactive materials.  The processes to obtain sufficient amounts of labeled tissue and the follow 
up to monitor removal of the radioactive isotope from the body are time consuming, resource 
demanding, and expensive.  Furthermore, while LSC is useful for tissues that are heavily labeled 
with 14C, the 14C concentrations are often below the sensitivity of LSC in the remodeling tissue 
as the scaffold degrades and in tissues that accumulate the degradation products.  In these cases, 
it is necessary to have access to AMS equipment. AMS has increased sensitivity for detection of 
14C because the actual molecules of 14C are counted and compared to the number of 12C 
molecules, as opposed to counting individual radioactive decay events as in LSC.  A detailed 
description of the specimen preparation and methodology for AMS can be found in several 
comprehensive reviews.42, 117, 171 
The degradation of scaffolds for tissue engineering/regenerative medicine affects the 
mechanical integrity of a scaffold and the host response to the scaffold.  As a result, the rate of 
degradation and the fate of the degradation products is a concern to regulatory agencies that must 
evaluate the safety and efficacy of such devices.  Radioactive labeling of a scaffold with 14C is 
one option to track the degradation products.  There may be other approaches that could 
incorporate other radioactive labels into tissues to track their degradation, including 3H, 26Al, 
41Ca, or 129I, which have found use in other biomedical applications.42 3H labeling would be 
advantageous in the current model due to its relative safety and short half-life, but the concern 
would be that the as a reactive side group, the 3H might be hydrolyzed or otherwise removed 
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from the proline independent of ECM degradation.  If the target tissue was bone, the 41Ca could 
be an obvious choice to track degradation.  Another non-radioactive approach that has been 
recently reported involved genetically engineering cells so that they tag all elastin fibers with an 
oligohistidine (His(6)) epitope that can be tracked independent of new tissue formation.214  Any 
of these approaches would require extensive time and resources in order to produce sufficient 
scaffolding material to do appropriate in vivo studies.   Development of additional novel 
methodologies will be needed as new applications for ECM scaffolds are investigated and as our 
need to understand the rate of scaffold degradation and fate of degradation products increases. 
A.2.5 Conclusions 
Intravenous injection of 14C labeled proline into an animal during the early phase of life is an 
effective means to incorporate radioactivity into tissues that are utilized to make scaffolds 
derived from ECM.  Radioactive labeling allows for accurate and sensitive determination of the 
rate of degradation of the scaffold and the fate of the degradation products, which are important 
considerations for tissue engineering applications.  While this approach is attractive due to its 
sensitivity and safety, it requires access to AMS facilities and is expensive.  Development of 
additional approaches to track the degradation of scaffolds will be necessary for widespread use. 
 
Table A-1.  Counts of 14C per minute per gram of labeled porcine tissues using liquid scintillation counting.  The more metabolic tissues (aorta, liver, 
small intestine) tended to have higher levels of 14C at approximately 3500 CPM/g.  Interestingly, splenic ECM was not found to have an elevated 14C 
concentration. 
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